MikeLigalig.com

Sharon Kleyne & Dr. David T. W. Wong Call for More Research Money for Saliva Diagnostics on Kleyne Talk Radio. Nature's Tears EyeMist Trade Secret pH-Balanced Water Sponsors Power of Water Water Life Science Sharon Kleyne VoiceAmerica.

GRANTS PASS, ORE. (PRWEB) OCTOBER 28, 2020
Air Date: 26th October 2020
Guest: Dr. David T.W. Wong, DMD, DMSC, Felix & Mildred Yip Distinguished Professor, Associate Dean of Research and Director of the Oral/Head and Neck Oncology Research Center at UCLA; Fellow of the American Association for the Advancement of Sciences (AAAS), Fellow of AADR, past member of the ADA Council of Scientific Affairs and past president of American Association of Dental Research (AADR); currently chair of the NCI Liquid Biopsy Consortium and chartered member and co-chair of the NIH CSR Cancer Biomarker Study Section (CBSS).
https://www.voiceamerica.com/episode/126500/encore-saliva-diagnostics
*
For years, research money has been difficult to raise for saliva diagnostics, the study in which saliva can be examined to reveal disease and illness. Fortunately, thanks in part to the work of Dr. David T. W. Wong of UCLA and others worldwide, the situation is rapidly improving and education about the oral cavity and necessary hygiene for immunity protection is becoming more widespread.
Sharon Kleyne, host of the internationally syndicated The Power of Water & Your Health sponsored by Nature's Tears EyeMist, naturally pH balanced water technology for acid mantle protection, on VoiceAmerica World Talk Radio & Apple iTunes, says that there has been pushback against saliva research and compares it to her own organ of the eye research. "There was little research into dry eye and atmospheric evaporaton and it's taken years to educate people about the potential immunity weakness of the eye," says Kleyne.
Wong praises Kleyne's insight. "The pushback has been significant," says Wong, "and partially rightly so, because the science wasn't there. But now this pandemic has brought saliva research to the front line." Wong describes how the antibodies in blood can also be found in saliva. So, we can now measure the antibodies in saliva. We are heading towards tests to be able to test everybody's immunity through their saliva.
"Dr. Wong," asks Kleyne, "Do you think we aren't educated about saliva? Do you think we've ignored that research?"
"You're right," Wong agrees. "It's rather like the Rodney Dangerfield of bio fluids (saliva). It's not being respected."
"Teach us what you've been learning about our mouths, what I call the oral cavity," says Kleyne.
"The oral cavity, Sharon, is as you described part of the body and it communicates with the environment of the outside world," Wong answers. "Within it, the oral cavity carries out important functions from mastication to speech and other important bodily functions." Wong reveals the startling fact that everybody produces 600 milliliters of spit every day—at least two cans of soda of saliva a day.
"Isn't that tied into when the baby is born," asks Kleyne, "that all of a sudden there's a tone that we can walk into a room, not see the person, but recognize them by their tone of voice? Is the saliva an influence on that?"
"Isn't that interesting!" replies Wong. "I'm not exactly aware of that, but Dr. Jill Maron of Tufts University would love to hear about that. I'll check in with her about this."
When Kleyne asks Wong about research and the pandemic, Wong says that "this pandemic really advances the clinical utility and usefulness of this bio fluid that has its value to inform anyone anywhere who is infected and not infected. I think that landscape is changing and in a few years we'll be looking at saliva with a very different set of lenses. My hope and commitment is to scientifically credential it and advance it for clinical utility."
"I bet," says Kleyne, "you've been very frustrated trying to teach this to people who weren't listening."
"You know, Sharon," replies Wong, "you're so insightful perhaps if we could have crossed paths earlier you could have been my advocate."
"Correct me if I'm wrong," says Kleyne, "but I'm looking at this saliva research as key to diagnosing other illnesses."
"Well said," says Wong. "Well said." Wong describes how sixteen years ago the National Institute of Health invested in the scientific community and posed a question. It asked researchers to scientifically credential saliva, a non-evasive material produced by our body that could be utilized for early disease detection. "The entire world is seeking early detection in the most non-evasive way. During this pandemic, half of research funding has been for saliva," says Wong.
Kleyne applauds this major breakthrough," says Kleyne. People are so impatient with the testing during this pandemic. "The portal entry of the pathogens to our bodies is the oral cavity and nasal cavity," says Wong. "IGA antibodies exist in the mouth, offering protection, if you will. It is important to guard the portal entry to assist the mouth's antibodies in fighting off pathogens such as the virus."
*
If you care about immunity protection for the organ of the eyes, listen to these programs. They feature wisdom, knowledge, new technology and health tips for better living every week on the internationally syndicated The Power of Water & Your Health sponsored by Nature's Tears EyeMist, naturally pH balanced water technology for acid mantle protection on VoiceAmerica World Talk Radio & Apple iTunes with Program Director Rose Hong of Global Dragon TV with Sharon Kleyne.
LISTEN to the internationally syndicated The Power of Water & Your Health sponsored by Nature's Tears EyeMist, FDA approved, naturally pH balanced water technology for acid mantle protection, on VoiceAmerica World Talk Radio & Apple iTunes. This program features Dr. Jill Maron, Professor of Pediatrics and Vice Chair of Pediatric Research at Tufts Children's Hospital, Boston, MA.
Follow this link: https://www.voiceamerica.com/episode/126500/encore-saliva-diagnostics
Some recent Sharon Kleyne talk radio programs feature:
Dr. Jill Maron https://www.voiceamerica.com/episode/126368/the-power-of-neonatal-saliva
Dr. David T.W. Wong, DMD, DMSC https://www.voiceamerica.com/episode/125933/saliva-diagnostics
Nancy Yonally Coleman & James Derick https://www.voiceamerica.com/episode/125837/be-safe-strategies-for-you-and-your-families-to-go-back-to-school-and-work-safely-during-covid
Dr. David Clarke https://www.voiceamerica.com/episode/125671/hidden-stresses-and-your-health
If you would like to watch a brief, entertaining educational film that demonstrates the application of the new Dry Eye Solution technology Nature's Tears EyeMist, sponsor of Sharon Kleyne's talk radio program, go here: https://www.youtube.com/watch?v=l0gOr8TB45U



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Allied Pain & Spine Institute provides cutting-edge treatments to relieve pain and improve the quality of life for patients with a wide variety of injuries, diseases and spinal disorders.

SAN JOSE, CALIF. (PRWEB) OCTOBER 28, 2020
Allied Pain & Spine Institute is pleased to announce that Dr. Parish Vaidya has been promoted to Chief Medical Officer. He joined the practice in 2015, bringing years of experience in interventional pain management, non-surgical orthopedics, electrodiagnostics and integrative medicine. Dr. Vaidya attended Pennsylvania State University and received his medical doctorate from the Lewis Katz School of Medicine at Temple University. He completed his residency in physical medicine and rehabilitation at the University of Texas Health Science Center at Houston and his advanced subspecialty fellowship in pain medicine at Baylor College of Medicine. This was followed by a second fellowship in integrative medicine at the University of Arizona Andrew Weil Center for Integrative Medicine. Adding to his clinical responsibilities, Dr. Vaidya also continues to expand his administrative role at Allied Pain & Spine Institute.
Dr. Priyanka Ghosh joined Allied Pain & Spine Institute earlier this year. In addition to offering her expertise in interventional cancer pain, Dr. Ghosh is a specialist in interventional pain therapies for many complex orthopedic conditions and has focused training in treating head, neck and facial, pelvic and abdominal pain. She graduated from Brown University and earned her M.D with distinction at the University of California, San Francisco. While simultaneously attending medical school, Dr. Ghosh continued to pursue her passion for research with a National Institute of Health (NIH) funded fellowship. Dr. Ghosh completed her residency at Harvard Medical School in the Department of Anesthesia, Critical Care and Pain Medicine at Beth Israel Deaconess Medical Center (BIDMC). She then obtained the prestigious Weill Cornell Tri-Institute Pain Fellowship, where she trained at three of the nation's leading hospitals: Memorial-Sloan Kettering Cancer Center, Hospital for Special Surgery and New York Presbyterian Hospital.
Seasoned business and technology executive, Mike Patel, is the new Chief Operating Officer at Allied Pain & Spine Institute and Trinity Surgery Center. He will be sharing over 20 years of career experience in the advancement and improvement of healthcare delivery through the optimization of technology to drive sustainable healthcare innovation. Mr. Patel possesses a demonstrated track record of successfully leading change and process improvements in clinical, revenue cycle, strategy and compliance/regulations. Prior to Allied Pain & Spine Institute, Mr. Patel served as Chief Information Officer & VP of Business Services at Verity Medical Foundation, an MSO that managed multi-specialty medical groups and IPAs.
"We are proud to announce these talented, recent additions to our successful multidisciplinary practice. As valued team members, they will assist us in continuing to deliver exceptional medical care to our patients," says Dr. James Petros founder of Allied Pain & Spine Institute.
More About Allied Pain & Spine Institute:
Allied Pain & Spine Institute has multiple clinic locations to serve patients in the San Jose Metro area. For more information or to schedule a consultation please visit https://myalliedpain.com or call 408-528-8833.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

According to data released by Power to Decide, an estimated 165,740 Utah women of reproductive age (13-44) in need of publicly funded contraception live in counties impacted by the implementation of the Title X Family Planning Program "domestic gag rule."

WASHINGTON (PRWEB) OCTOBER 28, 2020
According to data released by Power to Decide, an estimated 165,740 Utah women of reproductive age (13-44) in need of publicly funded contraception live in counties impacted by the implementation of the Title X Family Planning Program "domestic gag rule." In fact, 24% of Utah's 29 counties lost all of their Title X resources, as there are no longer any Title X funds going to Utah.
The domestic gag rule requires health providers receiving Title X funds to withhold some information from patients about abortion services and care. In addition, health centers are required to cease providing abortion care with non-Title X funds at sites that offer Title X supported services, such as contraceptive care, breast and cervical cancer screening and STI testing. The new rule requires that abortion services, no matter how they are funded, must be performed at a separate physical site, which is impossible for many health centers. In the face of these challenges, family planning providers are doing their best to provide high-quality service to their patients and fill gaps left in the wake of the disruption caused by the rule.
"The implementation of the domestic gag rule could impact over 165,000 women in need in Utah," said Gillian Sealy, Interim CEO, Power to Decide. "This federal rule exacerbates an already challenging contraceptive access landscape for women struggling to make ends meet. Even before the implementation of the domestic gag rule, over 200,000 low income women in Utah live in contraceptive deserts where they face barriers such as transportation, child care and taking unpaid time from work to get the contraception they need."
Data from Power to Decide show that 203,600 women living at or below 250% of the poverty level in Utah live in contraceptive deserts, counties in which there is not reasonable access to a health center offering the full range of contraceptive methods. Nationally, more than 19 million U.S. women of low income live in contraceptive deserts.
In this challenging landscape, states like Utah can take steps to partially alleviate the impact of damaging federal policies and to proactively expand access to contraception in various ways. Utah has already expanded Medicaid to low income adults, which helps decrease the percentage of uninsured women, and by extension, give them contraceptive coverage. In addition, Utah allows pharmacists to prescribe contraception. Other policies that would help include requiring insurance to cover an extended supply of prescription contraceptives, and enacting policies that protect insurance coverage of the full range of contraceptive methods. More information about these policies can be found here.
Power to Decide is a private, non-partisan, non-profit organization that works to ensure all people—no matter who they are, where they live or what their economic status might be—have the power to decide if, when and under what circumstances to get pregnant and have a child. Please visit us at http://www.PowerToDecide.org or follow us on Facebook and Twitter.

"The implementation of the domestic gag rule could impact over 165,000 women in need in Utah. This federal rule exacerbates an already challenging contraceptive access landscape for women struggling to make ends meet." said Gillian Sealy, Interim CEO, Power to Decide.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Just published survey results paint a picture of an industry in serious financial distress, but with the lessons learned and tools acquired to overcome today's challenges and position for long-term growth. Many of the best-practices of the COVID-19 crisis will have a lasting impact on every stakeholder in the American healthcare system for decades to come.

LAFAYETTE, CALIF. (PRWEB) OCTOBER 28, 2020
Over the last several months, the financial hardships faced by health systems in the United States as a result of the COVID-19 crisis have been well documented by us and many others. For many systems, the forced reduction in patient volumes and the addition of unexpected costs have had a devastating impact on balance sheets. And although patient volumes have begun to recover from their April lows, many system executives don't expect business to look anything like usual until 2022.
But along with all this bad news, a thread of consistently good news is clearly visible throughout the healthcare industry's response to the crisis. Since the beginning of the COVID-19 national health emergency, healthcare providers have demonstrated nimbleness, unity and innovative ingenuity in ways that would never have been explored were it not for the novel coronavirus. For us as patients, and for every other stakeholder in the American healthcare system, these newfound qualities will have a positive, lasting impact.
This uplifting interpretation is affirmed by the results of a recent survey of healthcare industry execs and finance leaders by healthcare consulting firm KaufmanHall. Their findings, titled "2020 State of Healthcare Performance Improvement Report: The Impact of COVID-19", paint a picture of an industry that continues to reel from financial damage, but whose "ability to leverage the positive impacts of the pandemic as they work to mitigate its negative impacts will have a significant effect on their long-term health and the health of the communities they serve."
Some of the survey respondents were interviewed. When sharing their thoughts on how the pandemic will change their organizations and, potentially, the healthcare industry, their responses fell into five qualities or categories:
1. An enhanced sense of "systemness" – "the pandemic generated new levels of collaboration among the component parts of health systems"
2. A newfound nimbleness in adapting to rapid change – "One health system stood up a digital health strategy in six days. Another system set up a temporary hospital at a conference center in eight days."
3. A realized return on investment in analytics – "the ability...to quickly pull together views of data that had not been created before, providing valuable information to inform decision-making when regular assumptions went out the window."
4. Strengthened relationships – "how health systems within their market coordinated their response to the pandemic." "how their relationships with schools, local and state governments, and community organizations grew even stronger, and think a long-term impact will be a better understanding of the essential role of the health system in the community."
5. A fresh look at different payment models – "the pandemic has exposed weaknesses in a volume-driven fee-for-service model."
The report calls out a number of health system best practice take-aways labeled "No Regrets" in the areas of Revenue and Operating Margin, Expenses and Care Delivery, many derived from – or supporting – the qualities listed above. We have followed the report's findings with our own observations about how these practices are being applied in the areas of patient payment and patient engagement.
Take-aways in the area of "Revenue and Operating Margin" each have direct relevance to patient payments and the patient's financial experience. They include:

Implementing proactive revenue cycle policies – "Pre-registration, pre-authorization, advance financial counseling, and point-of-service collection policies have had heightened value during the pandemic." These capabilities clearly reside in the patient financial engagement category where their value to health systems had been thoroughly demonstrated long before the pandemic. We have written frequently about the shift of healthcare costs to patients over the last several years. As a result, many systems were already struggling to collect patient payments. The crisis, with its job losses and growing numbers of uninsured, is aggravating the problem and underscoring the importance of applying technologies, like our own Loyale Patient Financial Manager, to deal with it.

Building analytical capabilities – "With volumes uncertain, robust analytics are helping to monitor fluctuations in volume and predict recovery trajectories." Analytics to uncover business intelligence in patient billing and payment behavior is proving to be vitally important to health systems. Until now, systems rarely had visibility into the complex matrix of what the industry calls patient revenue cycle. Systems now are able to leverage patient-pay analytics to reduce the cost of billing and drive continual improvement in patient payment performance.

The "No Regrets" take-aways listed in the KaufmanHall report in the area of Expenses call out health system investments that have paid off as providers responded to the unique challenges presented by the crisis. These include investments in safety for staff and patients. They also include developing relationships with domestic suppliers to overcome supply chain disruptions. One other category has relevance in the area of patient revenue cycle, redeploying staff.

Redeploying staff – "Moving staff into new roles, although it did require some training, helped interviewees' organizations fill critical vacancies and avoid furloughs or reductions in force." In the area of patient financial engagement, health systems are finding that by automating labor intensive processes, expanding patient self-service and improving the productivity of personnel, staff members can be freed for higher-value, patient-facing duties that improve patient satisfaction and contribute to better financial performance.

The "No Regrets" take-aways in the area of Care Delivery Models include "breaking down clinical barriers" to leverage the increased versatility revealed by the crisis, and "educating the public," which addresses health systems' efforts to educate the public about the pandemic and "effective preventive measures." This kind of community-minded outreach has "eased concerns and built trust in the health system." As healthcare providers plan for their post-COVID-19 recoveries, this trust will be vital to their efforts to reinvigorate their brands. The area with the most direct relevance to patient revenue cycle, however, is labeled "Taking a giant leap."

Taking a giant leap – "The pandemic forced (health systems) to take a leap into the deep end (of telehealth). Interviewees expressed pride in the ability of their organizations to adapt quickly to a new care model and confidence in the implications for rapid changes in care delivery in the future." We have written extensively about the astounding success of telehealth during the crisis, and the opportunity this exciting new channel represents for health systems and patients alike - most recently in an article titled, "The Future for Virtual Health Care in a Consumer-Driven Marketplace." In it, we looked to our own clients to point out that "The next phase in the development of this exciting new channel calls for holistic patient experiences that build on the remarkable accomplishments that have already been achieved." We are convinced – and our clients' outcomes confirm – that by integrating patients' financial and clinical experiences throughout the care journey, all of the benefits listed above will follow.

The participants in the KaufmanHall health system survey we've referenced have experienced varying levels of financial disruption, with "seventy four percent extremely or moderately concerned about the financial viability of their organization in the absence of an effective vaccine or treatment." And one third of respondents saying they "saw year-over-year operating margin declines in excess of 100% from Q2 2019 to Q2 2020."
Speaking to the unique challenges this crisis has presented in the areas of patient volumes, expenses, workforce, telehealth and competition, each described their system's response, noting that "one third of survey respondents believe the pandemic has affected competitive dynamics in their market by making consumers more likely to seek care at retail-based clinics."
In our view, nearly every provider should be concerned about the growing competitive threat of retail and other alternative providers. But this is a threat that can be overcome. By upgrading patients' experiences to include every dimension of care from beginning to end, we're confident that health systems will complete the transformation that COVID-19 accelerated. As that vision becomes a reality across the industry, we believe the patient-provider relationship will become more satisfying and more mutually rewarding than ever. As a company, that's what we're aiming for.
Kevin Fleming is the CEO of Loyale Healthcare
About Loyale
Loyale Patient Financial Manager is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.
Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale's industry leading technology at all HCA hospitals and Physician Groups.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Americans must get back to work to help the economy recover, however unreliable and sometimes harmful testing is delaying the reopening of many US businesses. New COVID-19 tests—with 100% accuracy—offer fast results without the need for uncomfortable nasal swabs, according to USA Rapid Test.

CLEARWATER, FLA. (PRWEB) OCTOBER 28, 2020
The improper use and application of COVID-19 nasal swab PCR tests are endangering people's health, while rapid antibody tests are giving too many false negatives and delaying the reopening of American businesses. The United States economy is still operating about 20% below where it was in early March(1) and experts don't anticipate any major economic traction until 2021.(2) Getting Americans back to work safely is key to the country's economic recovery. To do so, says USA Rapid Test, a fast, safe, and definitive COVID-19 on-site protocol for testing needs to be available for every business owner.
"The current method of testing, nasopharyngeal tests, or nasal swab tests are often administered by people with little to no formal medical training. In addition to the harm they could cause the individual, this inappropriate handling of the nasal swab has resulted in discomfort and injury," said David Lee Jensen, Chief Executive Officer at USA Rapid Test. Improper testing may cause a host of issues like stabbing pain, watery eyes, persistent inflammation, damaged septum and even harm to the delicate tissues that help with the sense of smell.(3)
Stalled Economy
While it seemed as though the economy was making progress, much of that initial recovery has stalled as COVID-19 cases start climbing again.(2) COVID-19 cases are now at the same levels as they were in July(4), and many of the temporary job losses and business closures are now becoming permanent.(4) New jobless claims are up to the highest level since late August, with almost 900,000 people filing for unemployment benefits.(5) And federal assistance for individuals and business owners is waning—already, 88% of U.S. small business owners have exhausted Paycheck Protection Program loans designed to help keep their workers employed.(6)
To jumpstart the economy and get Americans back to work, quick and accurate testing to determine who stays and who goes home is of the utmost importance. It's the best way to assure patrons and the general public that a business is safe. What is needed is a COVID-19 test that delivers on-site testing with extremely accurate results without the use of a potentially harmful nasal swab. "Our Rapid Antibody Test is completed within 15 minutes with a near-perfect accuracy.(7) The test uses just a drop of blood, similar to checking blood sugar, to determine whether a person is likely immune to or has been exposed to COVID-19 or not," Jensen said.
The company suggests implementing a protocol where the Rapid Antibody Test is used to screen all employees and they also offer an FDA Emergency Use Authorized (EUA) Oral Rinse PCR test which provides the same confirmatory information as a nasal swab while being far less invasive and uncomfortable for those tests appearing to confirm a virus. The oral rinse test is simple—just swish less than an ounce of liquid in your mouth, deposit back into the tube and seal—once submitted to the laboratory, results are made available within 24 to 48 hours.
Made in The USA
"There's a lot of misinformation out there about coronavirus testing, however the bottom line is that we have to have some way to get our economy growing again. Tests need to be safe and provide an efficient way to know which employees may be infected and which aren't. Business owners need the right tests and information to reopen safely and confidently," Jensen says"
While other companies are developing so-called "rapid COVID-19 tests", many have been plagued by accuracy concerns.( In other cases, tests are marketed as "made in the USA", but they're manufactured from parent companies located in other countries, such as China, and then reassembled—in many cases incorrectly—in the U.S. Unlike these products, all USA Rapid Test products are fully manufactured in Ohio. Plus, over 700 test results submitted to the U.S. Food and Drug Administration confirm their accuracy.(7)
American-made COVID-19 testing products, provided to our businesses nationally, are essential for getting employees back to work and stimulating the country's economic recovery but using the wrong test can hurt employees and provide non-accurate results, which could endanger an entire workforce. Having a protocol can ensure a safe, confident approach to re-opening.
About USA Rapid Test:
USA Rapid Test is the Clearwater, FL. based distributor of the Rapid Antibody Tests and the Oral Rinse PCR Test to enable the safest and fastest way to test any individual for the COVID-19 virus. The Rapid Antibody Testing yields results in 15 minutes or less and the oral rinse reporting results in 24 to 48 hours—from their laboratory. The antibody tests have a Supreme Test accuracy of 100% Sensitivity and 99.2% Specificity. Both products are entirely made in the USA under a CLIA-H (High Complexity) Laboratory. USA Rapid Test's mission is to give American business owners the ability to test their employees quickly, safely and confidently in order to get America back to work once again. For more information, visit http://www.usarapidtest.com.
1.    "Tracking America's Recovery." CNN, Cable News Network, 2020, cnn.com/business/us-economic-recovery-coronavirus.
2.    Zandi , Mark. "Opinion: Why the US Economy Won't Gain Any Traction until 2021." CNN, Cable News Network, 21 Oct. 2020, cnn.com/2020/10/21/perspectives/us-economy-pandemic-recovery/index.html.
3.    Cummins, Eleanor. "Why Some People's Covid-19 Tests Hurt More Than Others." Medium, Elemental, 4 Aug. 2020, elemental.medium.com/why-some-peoples-covid-19-tests-hurt-more-than-others-64bcf7aea3bf.
4.     Stewart, Emily. "How America Gave up on Fighting the Pandemic and Saving the Economy." Vox, Vox, 19 Oct. 2020, vox.com/21523204/coronavirus-unemployment-stimulus-economy.
5.    Chaney, Sarah, and Gwynn Guilford. "U.S. Jobless Claims Rose to 898,000 Last Week." The Wall Street Journal, Dow Jones & Company, 15 Oct. 2020, wsj.com/articles/weekly-jobless-claims-coronavirus-10-15-2020-11602714104.
6.    Radicioni, Brianna. "Research: The Real Impacts of COVID-19 on Small Business." Babson Thought & Action, 29 Sept. 2020, entrepreneurship.babson.edu/small-business-covid-research/.
7.    fda.gov/media/136113/download | Accessed 27 October 2020
8.    Commissioner, Office of the. "Coronavirus (COVID-19) Update: FDA Informs Public About Possible Accuracy Concerns with Abbott ID NOW Point-of-Care Test." U.S. Food and Drug Administration, FDA, 2020, fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-informs-public-about-possible-accuracy-concerns-abbott-id-now-point.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

LunaFast today announced a new holistic fasting retreat in Tulum to put people back in control of their immunity. On December 12th, 2020, LunaFast will be hosting the Awaken Your Inner Healer Retreat to help people detox, cleanse, and optimize their immune systems.

MIAMI (PRWEB) OCTOBER 28, 2020
"We want to awaken people to their innate healing power," said Bianca Abbott, Nurse Practitioner and Co-Founder of LunaFast. "We've helped hundreds of clients increase their immunity with fasting, now we're providing a retreat where people can cleanse their bodies, reconnect to their spirit, and release the trauma of 2020."
As their name implies, LunaFast aligns their fasts with the new moon cycle. The Awaken Your Inner Healer Retreat will align with the winter solstice, 12/12 to 12/21. Clients start by registering online to complete a health assessment and determine if they are a good candidate. Once approved, they will join Co-Founders Bianca Abbott and Monika Arenas in Tulum.
Once there, they will be guided through a series of fasts that help them transition from fruits and vegetables, to juice, to three days of water and back into a plant-based alkaline diet. All of this is done in the jungles of Tulum and optimized with ceremonial activations, kundalini yoga, ecstatic dance, movement classes, temazcal sweat lodges, healing massages, and much more.
Starting now, people seeking to increase their immunity can cleanse in paradise and live their most vibrant lives.
Monika Arenas, Registered Dietitian and Co-Founder of LunaFast said, "One fast is life changing, but the greatest transformations come from disconnecting from everyday life and diving into deep healing immersions. At our Awaken Your Inner Healer Retreat, we'll guide you step by step to optimal health with fasting without the pain and stress that often accompanies detoxification protocols."
LunaFast's new retreat puts clients back in control of their own immunity. Abbott and Arenas add, "The question every LunaFaster will be asking is, 'Am I ready to commit to my greatest life?'"
To learn more about the new program and to sign up goto LunaFast.com/tulum
About LunaFast:
LunaFast is a ten day holistic cleansing program started by Miami healthcare professionals and entrepreneurs Bianca Abbott and Monika Arenas in 2019. They have led hundreds of people through profound healing experiences and are committed to leading the modern fasting movement. Bianca can be reached at 917-734-0686, Monika at 786-387-1219, info@lunafast.com, @thelunafast on instagram, and facebook.com/thelunafast.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Medical Assisting program at Sullivan University's Lexington campus has been ranked the top medical assisting program in Kentucky.

LOUISVILLE, KY. (PRWEB) OCTOBER 28, 2020
The Medical Assisting program at Sullivan University's Lexington campus has been ranked the top medical assisting program in Kentucky.
The number one ranking of Sullivan's Associate of Science in Medical Assisting has been announced by Medical Assistant Advice, an online site of educators and medical assistant professionals who bring their experience and expertise to guide current medical assistants or those who are seeking information on the profession.
In the rankings announcement, Medical Assistant Advice says that Sullivan's program - which takes around 18 months to complete - trains students in both the front and back office functions of medical assisting. The program is accredited by the Commission on Accreditation of Allied Health Education Programs (CAAHEP) upon recommendation of the Medical Assisting Education Review Board (MAERB).
"The skills you master include scheduling appointments, patient record keeping, billing and insurance, drawing blood, taking vital signs, administration of medications, EKGs (Electrocardiogram), and assisting the physician during minor procedures carried out at the medical office," the announcement says. "Besides, you will learn about keyboarding essentials, public speaking, professional development, and also participate in two externships at local medical settings."
"Recognition of program quality by outside agencies or peers demonstrates excellence," said Sullivan University Medical Assisting Program Director Jill Ferrari. "This will only solidify our reputation in our community more soundly as being a competent source of quality graduates for employment."
Medical assistants are the medical professionals who complete administrative and clerical tasks in hospitals, doctors' offices and clinics. They also take a patient's temperature, check their blood pressure and discuss ailments and symptoms with the patient. In addition, medical assistants also have a keen understanding of medical billing and computerized medical records.
"People who genuinely care about others make the best medical assistants," Ferrari said. "This job is ideal for those who want a job that provides a variety of experiences in an office environment or other medical setting. Sullivan University has the faculty and staff support that provide the most thorough preparation for this profession."
The career outlook for medical assistants is strong.
The U.S. Bureau of Labor and Statistics reports that the medical assisting job market is projected to grow at 19 percent through 2029, "much faster" than the average career growth rate of 4 percent. In Kentucky, the growth rate through 2028 is 13.7 percent, according to Projections Central, which projects employment and job growth in all 50 states.
In 2017, 80 percent of Sullivan graduates passed the national Certified Medical Assistant (CMA) exam of the American Association of Medical Assistants (AAMA), on the first try, compared to the national average pass rate of 60 percent.
"As illustrated in our certification exam pass and employment rates, most of our graduates pass the certification test after graduation, and are then able to get a job in the field" Ferrari said.
Ferrari said the career-ready relevancy of the curriculum is strengthened through the support of a community advisory board that is made up on employers, program graduates and community members who advise Sullivan on how to make the curriculum as relevant as possible for future medical assistants. The advisory board also assists in evaluating the program, which leads to improvements based on members' recommendations.
"Current and future students will benefit from this accomplishment because employers like to hire well-qualified medical assistants who are ready for the job on day one," Ferrari said. "We've been told in the past by employers that our graduates are well-prepared. Now, thanks to this ranking, more employers and prospective students know that."
Medical Assistant Advice synthesizes data from the College Navigator, Commission on Accreditation of Allied Health Education Programs, Accrediting Bureau of Health Education Schools, and Integrated Postsecondary Education Data System. Medical assisting programs are scored on MedicalAssistantAdvice.com Editorial Staff Ratings, Graduation Rate, Average Net Price, Admission Rate, Full-Time Retention Rate, and Total Number of Students Enrolled for the Medical Assisting Program.
About Sullivan University
Sullivan University is accredited by the Southern Association of Colleges and Schools Commission on Colleges to award Associate, Bachelor's, Master's, and Doctoral degrees. Contact the Commission on Colleges at 1866 Southern Lane, Decatur, Georgia 30033-4097, call 404-679-4500 for questions about the accreditation of Sullivan University or visit them online at http://www.sacscoc.org.
The University offers numerous certificates, diplomas, and degrees in career-orientated programs, ranging from business, pharmacy, human resources, I.T. and cybersecurity, supply-chain management, culinary and baking and pastry arts, hospitality studies, conflict management, nursing, allied health sciences, HVAC-R, interior design, and legal studies. Sullivan University has campuses in Louisville and Lexington, an extension in Fort Knox on the U.S. Army Post and Learning Centers in Louisa and Mayfield. Sullivan University also has many programs available partially or wholly online. For more information, visit http://www.sullivan.edu.

"Recognition of program quality by outside agencies or peers demonstrates excellence. This will only solidify our reputation in our community more soundly as being a competent source of quality graduates for employment." -Sullivan University Medical Assisting Program Director, Jill Ferrari



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Wesley Eubanks, President and CEO of The Pictsweet Company, Discusses the Importance of Knowing Where Food Comes From

NEW YORK (PRWEB) OCTOBER 28, 2020
Pictsweet Farms has introduced a claim that no other national brand of frozen vegetables can make: all of its vegetables are "100% Grown on American Soil." Recently, Wesley Eubanks, President and CEO of The Pictsweet Company, teamed with YourUpdateTV on a national satellite media tour to discuss the importance of knowing where food comes from and the Pictsweet Farms "100% Grown on American Soil" commitment.
A video accompanying this announcement is available at: https://youtu.be/LMNQ07kiT64
The company, which has always sourced the large majority of its products domestically, issued the formal commitment in response to consumer feedback.
In a recent survey from Pictsweet Farms Research, 87% of consumers prefer their vegetables to be grown at home. However, determining where vegetables come from can be confusing, with packaging that isn't clearly marked. Pictsweet Farms is looking to elminiate the guesswork for consumers, so they can be confident that the Pictsweet Farms frozen vegetables they buy were grown, packaged and distributed in the U.S.
Pictsweet Farms partners with family farmers in 32 states across the U.S., growing vegetables under the rigorous quality guidelines and specifications outlined by the Pictsweet Farms Agriculture Department. According to Eubanks, "American farmers are highly skilled and grow vegetables on some of the most diverse farmland in the world, producing food that is safe and nutritious."
Consumers can look for the "100% Grown on American Soil" seal on the front of every Pictsweet Farms frozen vegetable package in their local grocery store's frozen food aisle, including the brand's Signature Vegetables, Vegetables for Roasting, Vegetables for Grilling, Steam'ables and Southern Classics.
From asparagus to zucchini, when consumers buy Pictsweet Farms frozen vegetables, they can be confident they know where their vegetables come from.
For more information, visit pictsweetfarms.com
About Wesley Eubanks:
Wesley Eubanks is president and CEO of The Pictsweet Company. He has been with the company for 27 years and has previously served as senior vice president, sales and marketing and vice president of operations. Eubanks is active in the frozen food supply chain and currently serves as a board member of FMI – The Food Industry Association and the American Frozen Food Institute (AFFI).
About YourUpdateTV:
YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NJ Top Docs practice, The Cardiovascular Care Group Now Offers a New Minimally Invasive Procedure That Prevents Stroke.

SCOTCH PLAINS, N.J. (PRWEB) OCTOBER 28, 2020
The Cardiovascular Care Group, in 2017, was the first group in New Jersey to treat carotid artery disease using a new procedure called TransCarotid Artery Revascularization (TCAR). The Group continues to be the leader in this novel treatment to prevent strokes having recently performed its 100th procedure—the most in the state of New Jersey and all of New York City. TCAR is a clinically proven, minimally invasive and safe approach for high-risk patients who require carotid artery treatment.
Carotid artery disease is a form of atherosclerosis, or a buildup of plaque, in the main arteries in the neck that supply oxygen-rich blood to the brain. If left untreated, carotid artery disease can lead to stroke; it is estimated to be the source of stroke in up to one-third of individuals, with 427,000 new diagnoses of the disease made every year in the U.S. alone.
"TCAR is an important new option in the fight against stroke, and is particularly suited for the large portion of patients we see who are at higher risk of complications from carotid surgery due to age, anatomy, or other medical conditions," said Dr. Scott Sundick of The Cardiovascular Care Group, one of the two board-certified vascular surgeons who first performed the procedure in New Jersey. Dr. Clifford Sales, managing partner of TCVCG, notes "TCAR provides a much improved alternative to carotid artery stenting that has, historically, been approached from the groin. The complication rate is significantly lower and patients are discharged within 24 hours of the procedure."
TCAR is unique in that blood flow is temporarily reversed during the procedure so that any small bits of plaque that could potentially break off are diverted away from the brain and removed from the body, preventing a stroke from happening. A stent is then placed inside the artery to enlarge the artery, minimizing the risk of a future stroke.
Prior to TCAR, the main treatment option for severe carotid artery disease was an open surgical procedure called carotid endarterectomy (CEA). CEA removes plaque from inside the carotid artery restoring normal blood flow to the brain, but the incision leaves a visible scar the length of the neck.
The TCAR procedure was developed by Sunnyvale, California-based Silk Road Medical, Inc. and includes the ENROUTE Transcarotid Neuroprotection (NPS) and Stent System – the first devices designed and FDA-approved specifically for TCAR. Over 10,000 TCAR procedures have been performed worldwide through clinical trial and commercial use. TCAR has been studied extensively, and the clinical data have been excellent.
For more information about Carotid Artery Disease and various treatment options, visit https://tcvcg.com/treatments/causes-and-care-for-carotid-artery-disease/.
To learn more about this NJ Top Docs practice, please visit: https://njtopdocs.com/nj-doctors/veins/
---
About Us
NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.
For more information, please click here to contact us or visit http://www.njtopdocs.com.
You can also follow us on Facebook, Twitter, & Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

i-payout is the world's leading provider of customized SaaS software for global disbursements and related, payment management solutions. In pursuit of one of its missions – the delivery of highly effective and individualized Compliance and Client Support services – the Company has added two accomplished professionals to its managerial staff that oversee the Operations and Compliance departments.

FORT LAUDERDALE, FLA. (PRWEB) OCTOBER 28, 2020
"I am pleased to announce that the capabilities of our Operations department and Compliance department have been significantly enhanced with the addition of exceptional, new leadership," said Eddie Gonzalez, i-payout's President and C.E.O. "Dailenys Garcia takes the reins in Operations as department V.P. and Yizrel Melendez is now heading-up our Compliance department in her managerial role. Both women have accomplished a great deal as they progressed in their careers to these new positions of responsibility."
Dailenys Garcia: Vice President – Operations. Ms. Garcia, a 4-year veteran at i-payout, has moved up through the company and with each move she effectively managed increased responsibilities. Most recently Dailenys served
as Customer Support Manager where she guided our 24/7 Customer Support Center. Customer Support Representatives provide assistance to the users of i-payout global payments system. A great many of those system users are located around the world. And because of that the Company's Customer Service Reps provide that support in the native languages of 60 different countries. One of Dailenys' accomplishments was the establishment of challenging Key Performance Indicators that focus on shortening the already rapid time-to-resolution of help requests. Dailenys effectively managed processes and staff to ensure that those KPIs were met and exceeded.
Dailenys' versatility will serve her well as she guides the multi-faceted responsibilities of the Operations department.
As a result of leading the Customer Service department, she fully understands what it takes to fulfill our customers' needs. Going forward, she'll will help shape the work flows in Operations to further elevate our ability to meet the needs of our clients and work effectively with external partners. She guides a team of Client Support Specialists in the Operations department who are personally assigned to individual clients. They, proactively, reach out to their assigned clients to help them get the maximum benefits from our software.
Yizrel Melendez: Department Manager – Compliance. Ms. Melendez comes to i-payout after serving with distinction at Citi Bank for just under 4 years. Prior to that she worked in the Compliance department at Bank America for 7 years during her 10 year tenure with them.  As a Lead Analyst at Citi, Yizrel focused on high-risk international clients and jurisdictions - ensuring that all profiles where complying with Bank Secrecy Act, U.S., Patriot Act, KYC and Anti-Money-Laundering laws in the United States. Yizrel developed training materials at Citi for the AML Compliance Unit to ensure that evaluations and investigations were carried out using the appropriate, mandated procedures and documentations as required by jurisdictions around the world.
About i-payout
i-payout is the world's leading financial software company providing a custom platform that facilities global payments. It serves multi-national clients in over 180 countries. System users have over 40 ways to make payments, worldwide. In addition to payment disbursal and related payment management services, the Company's suite of solutions covers regulatory compliance, fraud/data security, escheatment services as well as the identification of year-end taxes due, as required by country and regional jurisdictions.
With its headquarters in Fort Lauderdale, Florida i-payout, now in its 14th year of operation, is recognized for its highly adaptable software platform. It enables the Company to fully customize payment solutions to the specific needs of each client and shape its processes to solve problems unique to each client. i-payout supports a diverse group of verticals including gig networks, insurance companies, eSports, royalties, marketplaces, clinical trials, direct sellers, and more.
The Company was founded in 2007 by Edwin Gonzalez, President & C.E.O. Mr. Gonzalez has held leadership roles within the financial software industry for over 20 years. At i-payout, he collaborates with a highly accomplished group of fintech professionals. Many of which have decades of experience in the fintech space.
For further information visit http://www.i-payout.com.
For inquiries write to discover@i-payout.com or call (866) 218-4668 Ext 8013



START your own Wordpress site, business or personal website, or online store at www.siteground.com

KitoTech has been awarded a group purchasing agreement for Non-Invasive Skin Closure Devices with Premier

SEATTLE (PRWEB) OCTOBER 29, 2020
KitoTech Medical, Inc. has been awarded a group purchasing agreement for Non-Invasive Skin Closure Devices with Premier. Effective November 1, 2020, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for microMend Skin Closure Products.
Premier is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and 200,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
"We are excited to have Premier select our microMend wound closure products for placement in their "new" Non-Invasive Skin Closure Device Category. We believe that Premier can provide an opportunity to help our new technology serve the members of all the Premier Acute and Non-Acute Care Facilities throughout the U.S.," said Deon Miller, KitoTech's Chief Commercial Officer.
Dr. Ronald Berenson, President and CEO of KitoTech, stated, "Similar to KitoTech, Premier is focused on improving the quality and lowering the costs of healthcare. They have an outstanding reputation and relationships with an extensive network of hospitals, clinics, and other medical facilities. We are confident that they will make microMend a valuable addition to the care of the many patients that are treated by their providers."
About microMend
KitoTech's first product, microMend, consists of an array of miniature staples (Microstaples) attached to an adhesive backing that combines the holding strength of a suture with the simplicity of applying a bandage. It is designed to provide medical personnel with a cost-effective, time saving and easy-to-use option for closing lacerations, skin tears, surgical incisions, and other wounds.
About KitoTech Medical
KitoTech Medical is a medical device company spun out of the University of Washington that is using its patented Microstaples Technology platform to develop and commercialize products for wound closure and wound care. Additional product and company information can be found online at http://www.micromendskinclosure.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

HPI announces sales pro, Elizabeth Stoneman, as their new National Sales Executive. The addition of Elizabeth will continue to fuel HPI's development across the country.

WESTBOROUGH, MASS. (PRWEB) OCTOBER 29, 2020
Powered by a surge in national growth, HPI has tapped Elizabeth Stoneman as their new National Sales Executive. Elizabeth will fuel HPI's market development and maximize their distribution channel across the country. She brings over 10 years of sales experience in the industry and is an expert on strategic development, relationship management and self-funding.
"The addition of Elizabeth to our team is an exciting milestone for HPI," said Drew Rozmiarek, Senior Vice President of National Sales and Emerging Markets. "Elizabeth will play a critical role in our future success. When hiring for this position, I was looking for someone with tremendous all-around knowledge of self-funding, RBP sales experience and a strong reputation in the industry. Elizabeth checked all of those boxes and then some. She brings a fresh point of view on our continued growth strategies, has a stellar reputation in the market and came highly recommended from many trusted industry leaders."
Stoneman most recently served as Regional Sales Director at Trustmark, for which her responsibilities included new business acquisition, consultative functions and serving as the subject matter expert on Reference Based Pricing. Previously, she held a sales coordinator role at Humana.
"I'm thrilled to be joining a team known for its creative strategies," said Stoneman. "HPI is growing nationally and has a reputation for longstanding, successful relationships. I look forward to contributing to its expansion and can't wait to see what the future holds."
About HPI
HPI redefines what is possible with self-funded health plans. As a leading national third-party administrator, they partner with health plan brokers and employers to provide innovative self-funding strategies and customized plans tailored to each client's needs and population. HPI's solutions give employers greater cost transparency and control, while elevating the member experience. It is their flexible approach, entrepreneurial spirit and commitment to quality, technology, and service that enable them to deliver premium value to their customers.
For more information, visit http://www.hpitpa.com
MEDIA CONTACT:
Su Doyle, VP of Strategic Marketing
HPI
508-475-6103
sdoyle@healthplansinc.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In a recent publication of the Journal of Cosmetic Science, Skinuva Brite was compared head to head to hydroquinone 4%. The study used the patient's responses along with five independent physician evaluators to grade the before and after images. The results showed that Skinuva Brite was tolerated well in all the patients and the pigmentation was nearly 30% better on the side of the face treated with Skinuva Brite over hydroquinone. These results support Skinuva Brite being a safe alternative topical product for hyperpigmentation.

BEVERLY HILLS, CALIF. (PRWEB) OCTOBER 29, 2020
There is a consumer demand for a safe and effective non-hydroquinone skin brightening product that can be used daily. Although hydroquinone can be an effective topical product for hyperpigmentation, its long term use has been considered controversial by many providers given its potential side effects including skin intolerance, discomfort, and redness. Skinuva Brite was developed to fill this need and provide patients a safe alternative to hydroquinone, one that is clinically shown to work even better than hydroquinone. Skinuva Brite has accomplished just that!
In a recent publication of the Journal of Cosmetic Science, Skinuva Brite was compared head to head to hydroquinone 4%. The study used the patient's responses along with five independent physician evaluators to grade the before and after images. The results showed that Skinuva Brite was tolerated well in all the patients and the pigmentation was nearly 30% better on the side of the face treated with Skinuva Brite over hydroquinone. These results support Skinuva Brite being a safe alternative topical product for hyperpigmentation.
"I'm extremely proud of Skinuva's continued commitment to providing safe and effective products for problematic skin conditions such as scars with Skinuva Scar and now hyperpigmentation with Skinuva Brite using science and clinical data from our studies," says Christopher Zoumalan MD, Founder and CEO of Skinuva.
He continues by saying, "Treating hyperpigmentation is a very challenging problem to plastic surgeons, dermatologists, and consumers alike, and we now have a product that has been shown to be safe and effective in treating hyperpigmentation, but also been shown to be more effective than hydroquinone. This is incredible data, and we're absolutely thrilled to provide a product that can help our patients out that suffer from hyperpigmentation."
Skinuva is currently available to both doctors and consumers. To place an order, please visit http://www.skinuva.com.
Resources:
Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study
BRANDON D. KALASHO, ARDALAN MINOKADEH, SANDY ZHANG-NUNES, RICHARD A. ZOUMALAN, NIMA L. SHEMIRANI, ANDREA R. WALDMAN, VADIM PLETZER, and CHRISTOPHER I. ZOUMALAN, Zoumalan Plastic Surgery, Beverly Hills, CA (B.D.K., R.A.Z., C.I.Z.), Skin Care and Laser Physicians of Beverly Hills, Los Angeles, CA (A.M.), Department of Ophthalmology, Keck School of Medicine of USC, Los Angeles, CA (S.Z.-N.), Eos Rejuvenation, Beverly Hills, CA(N.L.S.), Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY (A.R.W.), KlinConsult, Wellington, New Zealand (V.P.)
Accepted for publication April 13, 2020.

Treating hyperpigmentation is a very challenging problem to plastic surgeons, dermatologists, and consumers alike, and we now have a product that has been shown to be safe and effective in treating hyperpigmentation, but also been shown to be more effective than hydroquinone.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Masks and More Outlet, a division of online e-commerce company PulseTV, is bringing a little joy and smiles to children at local hospitals by donating Halloween cloth masks for those having to be in the hospital at this time.

TINLEY PARK, ILL. (PRWEB) OCTOBER 29, 2020
Co-founder Anisa Ali said, "Halloween is such a fun day for the kids and we wanted to bring a little joy with these masks printed with all of the kid-favorite Halloween themed characters. Children's sizes range from ages 3-8 and age 9 on up to adults."
Advocate Christ Medical Center in Oak Lawn, Silver Cross in New Lenox, St. James in Olympia Fields and Riverside Hospital in Kankakee are the hospitals being supplied with these Halloween themed masks.
This is not the first time the company has come to the aid of those in need. Early in the pandemic parent company PulseTV donated sanitizer and masks to local fire and police departments in the area as well as nearly 1,000 KN95 masks to Riverside Hospital who was in short supply of medical grade masks at the time.
Anisa continued, "It is important for everyone to pitch in and do what we can to help our local communities. This is why we started to produce hand sanitizer and even now we are producing rubbing alcohol which is in short supply. Doing something for children who are unfortunately sick or unavailable for Halloween was just something we felt compelled to do."
PulseTV.com is a North American online retailer that has been marketing exclusively online since 1998. For more information or to set up an interview, contact: Mary Kolacki, Communications Director M.Kolacki@PulseTV.com or call 708- 478-4500 ext. 109



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Orange County Business Journal (OCBJ) recently named Planet DDS as one of Orange County's best workplaces.

NEWPORT BEACH, CALIF. (PRWEB) OCTOBER 29, 2020
For the second consecutive year, Planet DDS, the nation's leading provider of cloud-based enterprise dental practice management software, was recently named as one of the 2020 Best Places to Work in Orange County. 
The Orange County Business Journal's county-wide survey and award program is designed to identify, recognize, and honor the best places of employment in Orange County, California.
Hundreds of organizations from across the county entered the two-stage selection process to determine the Best Places to Work in Orange County. The first stage entailed an evaluation of each employer's workplace policies and practices, while the second stage consisted of an employee survey to measure employees' experience. Planet DDS' combined scores earned the company a spot on the list. According to the OCBJ, companies that are honored with this distinction are recognized for their best practices in treatment, recruitment, and retention of employees.
Planet DDS CEO Eric Giesecke, noted "Making the list is a direct result of our strong company culture, which is reinforced by each and every one of our team members. It's a culture that has also led to strong financial growth, reflected in our inclusion four years running on the OCBJ's list of fastest-growing companies"
The ranking of the winning organizations was released via a special section of the Orange County Business Journal's October 26th issue.
For more information on the survey process for the Best Places to Work in Orange County program, visit http://www.bestplacestoworkoc.com.
Denticon by Planet DDS is the only proven, time-tested software offering that was built from the ground up for multi-location groups in the cloud. Denticon allows dental organizations to break free from the constraints of desktop software with a comprehensive solution that includes the tools needed to standardize, centralize, and grow. All while reducing IT cost and enhancing security. Learn more about Denticon at http://www.planetdds.com.
The Orange County Business Journal is a media and publication company that delivers the most complete package of news and information on Orange County's companies, industries, and business people. It is comprehensive, authoritative, concise, and entertaining. Since 2009, the OCBJ has been compiling a yearly list of Best Places to Work in Orange County. Learn more at ocbj.com.

"Making the list is a direct result of our strong company culture, which is reinforced by each and every one of our team members. It's a culture that has also led to strong financial growth, reflected in our inclusion four years running on the OCBJ's list of fastest-growing companies."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Innovative behavior-change technology drives healthy habit formation without goal-setting, tracking, or weigh-ins.

SILICON VALLEY, CALIF. (PRWEB) OCTOBER 29, 2020
Fresh Tri, a behavior change technology company working with employers and individuals across the United States to transform health through mindset training and habit change, has been selected to be a digital platform for Consumer Good Forum's "One for Good" Initiative.
One for Good, a Consumer Goods Forum program that began in Hagerstown, Maryland, in 2017, supports community members in adopting healthier diets and lifestyles. Partnering with Healthy Washington County, members of Consumer Goods Forum — retailers and manufacturers — have rolled out One for Good in retail outlets and communities across Hagerstown.
In addition to supporting this initiative with its neuroscience-based habit-formation app, Fresh Tri will work with One for Good stakeholders to support the recently announced Go for Bold Million Pound Challenge, or Bold Goal, by Healthy Washington County. Part of the decade-long goal is for more than 40 percent of employees and Washington County residents to attain a BMI of less than 25 by fiscal year 2023. Healthy Washington County, a local health care-improvement coalition formed in March 2015, will assist the county in reaching its community-wide goals.
Launched in September 2018JL, the Fresh Tri app empowers people to create healthier lifestyles through mindset training and sustainable habit formation. Drawing on insights from the fields of neuroscience and behavior science, Fresh Tri guides users in creating healthier lifestyles without conventional goal-setting, calorie counting, or activity-tracking, all of which can backfire and lead to guilt, shame, relapse, and giving up.
Instead, Fresh Tri trains users to build an Iterative Mindset, a personalizable, test-and-learn method revealed through the company's research and co-design with Walmart associates. Using this approach, users select science-validated habit practices, iterate on behaviors to fit their lives, and train in Iterative Mindset skills.
About Fresh Tri
Fresh Tri is a behavior change technology company with offerings focusing on mindset, practice and iteration that invite users to test-drive healthy habits, removing the guesswork and feelings of failure that can often accompany lifestyle changes. Fresh Tri allows users to iterate their way to success. There is no "fail" — only practice and iteration. Fresh Tri uses a simple, positive approach based on the brain science of habit formation. Find out more about Fresh Tri: freshtri.com, Instagram, Facebook



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Virtual ribbon cutting and tour featured remarks from New Jersey Governor Phil Murphy, FDA's Peter Marks, as well as panel discussions with industry leaders from ARM, NIIMBL, Century Therapeutics, BioNJ, NJEDA, NJIT and NJII on the rise of Cell & Gene Therapy in New Jersey.

NEWARK, N.J. (PRWEB) OCTOBER 29, 2020
The New Jersey Innovation Institute (NJII) and Choose New Jersey hosted a virtual ribbon cutting, tour and panel discussions to mark the opening of BioCentriq, NJII's cutting-edge cell and gene therapy development and clinical manufacturing center located on the campus of the New Jersey Institute of Technology (NJIT) in Newark, New Jersey.
New Jersey Governor Murphy's pre-recorded opening remarks emphasized the important role centers of innovation like BioCentriq will play in a post-pandemic economy.
President of New Jersey Institute of Technology Dr. Joel Bloom reinforced the governor's message by stating, "There is a massive need for what BioCentriq can provide, and our ability to fill that gap will translate into results that literally save and improve the quality of countless lives. We have the capacity to help companies develop processes, conduct clinical production trials, and train employees."
Jose Lozano, president and CEO of Choose New Jersey hosted the event.
"New Jersey is a top hub for cell and gene therapy," said Lozano. "We are home to groundbreaking cell and gene therapy companies that are leading the way in next-generation therapeutics. Today's ribbon cutting at BioCentriq is another exciting chapter for New Jersey's innovation economy. We look forward to seeing how BioCentriq will advance the industry in years to come."
Opening remarks were made by Joel Bloom, Ed.D. and president of NJIT, Governor Phil Murphy, Robert Cohen, president digital, robotics, and enabling technology at Stryker and Simon Nynens, CEO of NJII.
Pall Biotech, The National Institute for Innovation in Manufacturing Biopharmaceuticals, BMS, Cytiva, Panasonic Healthcare and Novartis were recognized, along with the 12 industry leaders who make up the biopharma advisory council, for their contributions of equipment, funding and expertise.
Dr. Peter Marks, MD., Ph.D., director of the center for biologics evaluation and research (CBER) at the U.S. Food and Drug Administration (FDA) spoke about the importance of cell and gene therapies and the role of the FDA in streamlining, removing hurdles and providing support to improve the availability of these therapies. He also talked about the importance of collaborative efforts like BioCentriq to help accelerate advancements and innovation.
Haro Hartounian, Ph.D. and SVP and GM of the Biopharma Division, and senior vice-president and general manager of BioCentriq, gave a detailed view of the new center and the work being done by the Biopharma division at NJII. Dr. Hartounian also premiered a video tour of the facility. In addition, he led a panel discussion on the future of cell and gene therapy manufacturing with Kelvin H. Lee, Ph.D. director of the National Institute for Innovation in Manufacturing (NIIMBL), Janet Lynch Lambert, CEO of the Alliance for Regenerative Medicine and Greg Russotti, Ph.D., chief technology officer of Century Therapeutics, LLC.
"BioCentriq's mission is to bring together industry, technology developers, academia and regulatory agencies to help advance the development and manufacturing of cell and gene therapies," said Dr. Hartounian. "We are thrilled to open the doors to our center at a time when demand for process development and clinical manufacturing of cell and gene therapies exceeds capacity available from existing contract development and manufacturing organizations. Our goal is to provide a collaborative space where innovative approaches and technologies can be utilized to help make emerging therapeutics available to the patients that so desperately need them."
The event concluded with a panel discussion that featured local leaders who described the resources New Jersey offers to companies who bring their cell and gene therapy projects and businesses to the state. Panelists included Debbie Hart, president & CEO of BioNJ; Jose Lozano; Kathleen Coviello, executive vice president for Technology, Life Sciences & Entrepreneurship at the New Jersey Economic Development Authority (NJEDA); and Kevin D. Belfield, Ph.D. and dean, College of Science & Liberal Arts, NJIT.
To learn more and view the recorded event please visit: https://www.choosenj.com/webinar/first-look-at-biocentriq/.
Shown in BioCentriq Ribbon Cutting at NJIT Life Sciences & Engineering Center Building in Newark, NJ photo from left to right are Robert Cohen, president, digital, robotics, and enabling technology, Stryker, Simon Nynens, CEO, New Jersey Innovation Institute (NJII), Joel Bloom, Ed.D., president, New Jersey Institute of Technology (NJIT), Dan Wessner, director of sales, Pall Biotech, Haro Hartounian, Ph.D., SVP and general manager, NJII, Fadi P. Deek, Ph.D., provost and senior executive vice president, NJIT and Jose Lozano, president & CEO, Choose New Jersey.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

HeardThat separates speech from noise to deliver enhanced voice quality in noisy environments

VANCOUVER, BRITISH COLUMBIA (PRWEB) OCTOBER 29, 2020
Singular Hearing, a subsidiary of Singular Software and creator of HeardThat, announced today it launched an early release of its HeardThat app for Android. For those with hearing loss, noisy environments like shops and restaurant patios can make it nearly impossible to hold conversations. HeardThat turns Android devices into powerful hearing assistive devices to make voices more clear.
HeadThat's AI and machine learning software was built using thousands of hours of recorded speech and noise to learn the difference between speech and ambient noise. Rather than amplifying or reducing all sound entirely, HeardThat separates speech from noise to deliver enhanced voice audio while minimizing background noise.
Smartphones have the processing power, memory and battery life to support HeardThat's powerful algorithms, unlike small wearable hearing devices. The app works in conjunction with earphones or hearing aids when connected to an Android, either directly or via Bluetooth.
HeardThat also works with transcription apps, like Google's Live Caption, on the Google Pixel and other supported phones.
"Years of research and development have gone into creating HeardThat," said Singular Hearing CEO Dr. Bruce Sharpe. "Our team has built an app that delivers enhanced voice clarity like no other solution on the market. As a standalone app, HeardThat is an incredibly powerful tool. Because HeardThat is software-based, it is easy for anyone to try. It also enables us to update it quickly as it is improved."
Android users can download the app at https://play.google.com/store/apps/details?id=com.singsoftnext.deephearing. All features are free for a limited time.
For more information on HeardThat, including a demo, visit http://www.heardthatapp.com.
Supporting images can be found here.
About Singular Hearing
Singular Hearing is a subsidiary of Singular Software. Founder and CEO Bruce Sharpe and his team of AI experts have extensive experience in audio technology and a deep passion for finding effective solutions for everyday problems. They leverage machine learning and speech processing to create innovative products that help people live better by hearing better.
Singular Hearing is the creator of HeardThat, an award-winning innovative app that turns smartphones into sophisticated hearing-assistive devices. HeardThat helps those with hearing challenges by delivering clear speech in noisy environments.
HeardThat won the What's Next Innovation Challenge Sponsored by AARP Innovation Labs at the 17th Annual What's Next Longevity Venture Summit and was named the first runner-up in the What's Next Business Plan Competition at the 17th What's Next Longevity Venture Summit. For more information, please visit http://www.heardthatapp.com.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Rural health in North Carolina to get boost from successful value-based care program

DURHAM, N.C. AND KANSAS CITY, MO. (PRWEB) OCTOBER 29, 2020
Blue Cross and Blue Shield of North Carolina (Blue Cross NC) and Caravan Health are working together to support the expansion of Blue Premier, Blue Cross NC's value-based care program, to more areas of the state. The two companies will establish a new accountable care organization (ACO) that will work with community and rural hospitals to bring the benefits of value-based care to their communities.
The ACO will enable more North Carolina health systems to collaborate with Blue Cross NC and Caravan to provide high-quality, cost-effective care as part of Blue Premier. Under Blue Premier, participating providers and Blue Cross NC are jointly accountable for meeting quality and cost measures. The ACO will bring the benefits of value-based care for patients – including improved quality and better-coordinated care – to North Carolinians who don't live near a hospital already in Blue Premier.
Hospitals and doctors in rural areas already play a significant role in improving health and coordinating care for their patients. The new ACO will help providers better manage and treat chronic conditions, share in the cost savings through value-based care, and move to a more sustainable financial model than traditional fee-for-service health care – potentially even helping them stay in business following the financial distress caused by COVID-19.
"Extending value-based care through Blue Premier is an important next step in supporting community and rural hospitals, especially as the pandemic has exposed the flaws of fee-for-service," said Von Nguyen, MD, Blue Cross NC chief medical officer effective Nov. 1, 2020. "Caravan Health will be an essential part of making the benefits of value-based care available to more Blue Cross NC members through access to better, more affordable care."
"We're excited to team up with community health systems in North Carolina to provide robust primary care and comprehensive accountability for their patients," said Tim Gronniger, Caravan Health CEO and president. "The opportunity to align efforts across multiple lines of business dramatically reduces the cost of change for providers, and I thank the team at Blue Cross NC for their foresight in how they've designed Blue Premier. Our team is digging in and looking forward to working side-by-side with providers in North Carolina."
Improving Rural Health
Community and rural providers have seen challenges in adopting value-based care. The smaller population and gaps in technology can make it difficult to achieve the scale needed to show quality improvements and cost reductions. In North Carolina, with an estimated 28 percent of the state's population living in areas deemed rural by the U.S. Census Bureau, many residents face shortages of medical providers in their communities. About 26 percent of the providers in Blue Cross NC's network are in rural areas.
The ACO from Blue Cross NC and Caravan will help address these challenges. Providers will have access to Caravan's methodologies and resources to help them measure and improve quality. These resources include enhanced data analytics, patient engagement technologies and accountability tools, and on-the-ground support from a regional team.
How Blue Premier Works
Blue Premier is one of the most rapid and comprehensive shifts to value-based care in the nation by any health plan. Under value-based care, provider pay is based on quality of care, not on the quantity of procedures, tests and appointments performed.
Blue Premier agreements cover multiple years and build toward shared financial risk between Blue Cross NC and providers, which sets Blue Premier apart from other value-based care arrangements. Eight of North Carolina's largest health systems, plus more than 200 independent primary care practices, already are in Blue Premier, and future expansion will take value-based care to more areas of the state. Providers in Blue Premier collaborated with Blue Cross NC to generate an estimated $153 million in cost savings, quality improvements and a slowdown in the rate of spending on health care in 2019, the program's first year.
How Caravan Health Works
In 2018, Caravan Health pioneered its collaborative ACO model to help providers earn strong, predictable results in the Medicare Shared Savings Program. Larger size is critical to create the scale needed for ACO success. The new health system participants will join a Caravan family of more than 250 health systems, 26,000 clinicians, and over 585,000 attributed Medicare lives. Caravan ACOs lead the nation each year, returning more than $108 million in total shared savings to providers and saving Medicare more than $191 million since 2015 while delivering high scores for quality.
In North Carolina, providers in the Blue Premier ACO will mitigate their risk through Caravan's risk-sharing solution, which focuses on practice transformation and achieving quality goals.
The Caravan Health and Blue Cross NC teams plan to launch the ACO in January 2021. North Carolina hospitals interested in participating may contact a Caravan Health representative to learn more at caravanhealth.com/contact.
About Blue Cross and Blue Shield of North Carolina
Blue Cross and Blue Shield of North Carolina (Blue Cross NC) is committed to making health care better, simpler, and more affordable. We have been driving better health in North Carolina since 1933, working to tackle our communities' greatest health challenges. Blue Cross NC serves its customers and communities of more than 3.8 million members, including approximately 1.1 million on behalf of other Blue Plans. Visit Blue Cross NC online at http://www.bluecrossnc.com.
About Caravan Health
Caravan Health helps providers make accountable care work regardless of their size, location, history, or demographics. Caravan gives community health systems and providers a way to create more scale, drive more change, and generate more revenue. The 250+ health systems who have turned to Caravan achieved single-year savings greatly exceeding the national average. Health systems and providers across the country are using our proven population health programs to ensure better outcomes for their patients every day. With Caravan Health, now the numbers work. For more information visit http://www.caravanhealth.com.
###

"We're excited to team up with community health systems in North Carolina to provide robust primary care and comprehensive accountability for their patients," said Tim Gronniger, Caravan Health CEO and president.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Forward LTE from LifeStation is a turnkey program available to healthcare providers with existing members using 3G medical alert equipment that must be updated to 4G LTE.

UNION, N.J. (PRWEB) OCTOBER 29, 2020
Millions of seniors across the country rely on medical alert systems to age safely in their homes. A large percentage of these systems use cellular technology to communicate with the 24/7 emergency monitoring centers that respond when needed. Telecom providers are sunsetting their 3G networks and healthcare providers need a plan to ensure a smooth upgrade for members who rely on the service for their most critical moments. That is why LifeStation is pleased to announce the launch of "Forward LTE", the only turnkey program for upgrading your member base from 3G to LTE.
LifeStation has leveraged their experience with healthcare partners, cellular providers and hardware manufacturers to create a partner playbook, dubbed "Forward LTE". It's designed to service any healthcare provider, whether they are a part of LifeStation's existing partner network, or if they currently work with a different medical alert provider.
"It's so critical to get ahead of the curve on this", says Ryan Bateman, Manager, Healthcare and Hospitals at LifeStation. "Cellular towers are already coming down and we need to make sure that members are cared for without disruption. The medical alert community and their partners can't afford to have a miss on this one."
Forward LTE consists of three parts. Here's how it works:
1.    Product Selection – LifeStation determines the ideal equipment for each member by utilizing our proprietary Customer Technology Worksheet. Based on level of activity, fall risk, and geography (combined with coverage maps), we determine the ideal equipment for each member. LifeStation offers both in-home and mobile devices, with AT&T and Verizon coverage available.
2.    Member Communication – We maximize your member adoption with our proven algorithm that combines targeted mailings, phone-based interactions, and digital touchpoints.
3.    Measurement and Follow-up – A LifeStation account manager closely monitors the progress of your program and will coordinate with our Customer Care Team to ensure member satisfaction.
According to Mike Mednansky, Executive Director at Park Terrace Senior Living, "LifeStation delivered a great plan that addressed our specific needs and made this straightforward and easy. They customized it for our members and I have the confidence to tell my stakeholders that we're on the right path."
LifeStation is currently piloting Forward LTE with an initial group of healthcare providers. If your business would like to be included in the next round of implementations, please contact us at (844) 215-6883, or email partnercare@lifestation.com.
About LifeStation
LifeStation is a leading provider of medical alert monitoring and telehealth technology services in the United States. LifeStation's mission is to leverage innovative services to transform the lives of seniors and help them live safely and independently. Of equal importance is the wellbeing of caregivers and providing them with the peace of mind they need.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The company rounds out its leadership team with SVP of HR, Chief Development Officer and SVP of Sales and Marketing

CHICAGO (PRWEB) OCTOBER 29, 2020
Maestro Health, a tech-enabled third-party administrator (TPA) for employee health and benefits, officially announced the appointments of Kim Howe as Senior Vice President of Human Resources, Franck Brice as Chief Development Officer and Joe Meyer as Senior Vice President of Sales and Marketing. With decades of experience in the healthcare and insurance industries, their combined leadership will help Maestro Health expand to new markets and accelerate growth within the health and benefits space.
Howe comes to Maestro Health with three decades of human resources and operations experience in the health and benefits space. As SVP of Human Resources, she has worked to enhance Maestro Health's employee benefits offerings, diversity, equity and inclusion initiatives, performance management program and employee onboarding. Prior to Maestro Health, Howe served over 13 years at AXA Equitable. She started as the Director of HR Operations & Payroll and transitioned to a Senior Director role overseeing finance transformation and strategic initiatives, including Equitable's eventual IPO.
"It's been a busy year for the human resources team at Maestro Health," Howe said. "We've listened to employees and provided them with the tools, processes and programs they need to be successful in their roles. More importantly, we're prioritizing our employees' overall wellbeing, including their physical, mental, financial and social health, just like the clients we serve."
Brice joins Maestro Health from AXA where he led AXA Next's U.S. Health program. In that role, he designed and deployed a global operating model, launched algorithm-based insurance products, created a global health and wellness platform and optimized fraud detection using artificial intelligence. At Maestro Health, Brice is responsible for furthering Maestro Health's mission to lower costs and improve health outcomes for clients.
"I've always been passionate about helping organizations innovate through technology to solve business problems," Brice said. "Joining forces with Maestro Health in a more direct role was a logical next step for both me and AXA. As Chief Development Officer, I can help draw stronger connections between Maestro Health and other AXA Next units, resulting in better outcomes for our clients."
In Meyer's role as SVP of Sales and Marketing, he is responsible for leading all sales and marketing functions and go-to-market strategies in support of Maestro Health's new brand identity in the market. He's spent 20 years in the health plan space, holding leadership roles at Cigna, MedCost, Blue Cross/Blue Shield of North Carolina and Atrium Health. Throughout his career, Meyer has built a strong track record of revenue growth and market innovation with a keen focus on serving the needs of clients.
"Having worked on both the provider and payer side, I've witnessed firsthand how the U.S. healthcare system has failed to serve the needs of employers and the patients trying to utilize the system," Meyer said. "It's clear employers and their trusted advisors need more from their health plans, like innovative and transparent self-funded benefits solutions driven by strong cost and clinical care management programs. I look forward to using my industry expertise and strong relationships to drive revenue growth and extend Maestro Health's reach across the market."
Learn more about Maestro Health's leadership team here.
About Maestro Health
Maestro Health works with employers and their trusted advisors to administer self-funded health plans. By blending administrative services, clinical care management and cost management, we help employers optimize their benefit plans to drive better outcomes at a lower cost.
When partnering with Maestro Health, employers can save money on healthcare and focus on what really matters—their people.
To learn more, visit: http://www.maestrohealth.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Company Transitioning to Clinical Development in 2021

SAN DIEGO (PRWEB) OCTOBER 29, 2020
DevaCell Inc. today announced that David Pyrce has joined the company as Chief Executive Officer. Mr. Pyrce brings over 30 years of biotechnology and pharmaceutical industry leadership, together with deep Wall Street experience and will lead all aspects of DevaCell's growth strategy focused on the development of ONCoatTM-enabled, synthetic vector-based therapeutics across three key market segments - oncolytic viral therapy, vaccines, and gene therapy/gene editing.
"We are very pleased to welcome David into leadership of the DevaCell team," said Larry Stambaugh, Chairman of DevaCell. "David's extensive biotech and pharma drug development expertise, and proven executive management skills, will significantly accelerate DevaCell at a time when management is focusing on transitioning the company's novel synthetic vector-based therapeutics into the clinic by mid-year 2021." Mr. Stambaugh continued, "In addition, David's extensive long-term relationships on Wall Street, as well as the biotech and pharma industries, will be key to securing strategic capital partners to fund preclinical and clinical development activities, together with establishing biotech and pharma collaborators, that will create additional clinical programs using DevaCell's pipeline of next generation therapeutics."
Mr. Pyrce is a biotech, pharma and Wall Street veteran, mostly recently serving as Senior Vice President, Strategy, Innovations and Chief Commercial Officer of NantKwest, a cell therapy company. Prior to NantKwest, David was the Founder, Chairman and CEO of Genomic Principles, a molecular diagnostics and neoantigen-based therapeutics company. Earlier in his career, David held executive management positions in business development, marketing and sales for BioMarin Pharmaceuticals/Glyko, Glaxo/SmithKline Beecham, and Baxter Healthcare. On Wall Street, David was the Founder, CEO and Managing General Partner of Bear Creek Capital Management and Bear Creek Capital Partners, a healthcare-focused hedge fund. David was also Senior Sell-Side Analyst at Wells Fargo Securities. David received his MBA from the Stuart School at the Illinois Institute of Technology in Chicago, and has dual bachelor degrees in Chemistry and Biology from Northern Illinois University.
Inanc Ortac, Ph.D, Founder and Chief Scientific Officer of DevaCell commented, "It is an honor, especially at our current pivotal stage of moving into clinical programs, to have David bring his deep skill set, from startup entrepreneur to successfully completing multiple IPOs and help to translate our platform technology to a truly transformative product pipeline of high impact therapeutics," Dr. Ortac continued, "The innovative science and development of DevaCell's platform technology from discovery to preclinical development over the past several years has positioned the company very well to become a leader in next-generation therapeutics. We welcome David to the DevaCell team."
Mr. Pyrce commented, "I take great pride in being trusted with the role of CEO at DevaCell. As the coronavirus pandemic has shown, the need for innovative, next generation therapies has never been greater and I truly believe that DevaCell's synthetic vector-based therapeutics platform is truly game changing, offering the potential to deliver highly effective therapeutics on a systemic basis, while also enabling repeat administration, something that has not been previously available." Mr. Pyrce continued, "With a focused strategy to transition the company's first therapeutics program into human clinical trials in 2021, the company is at a key inflection point, and I'm honored to be given the opportunity to help bring novel, high-impact therapeutics to patients as quickly as possible."
About DevaCell Inc
DevaCell is a San Diego based synthetic vector-based therapeutics firm focused on developing a product pipeline of best-in-class therapeutics across three key segments: Oncolytic virus therapies, vaccines, and gene therapy/gene editing applications. DevaCell's DEVA (designer encapsulated viral assembly) is the foundational innovation for the company's transformative nanoparticle-based, ONCoatTM synthetic vector platform technology, which is enabling the development of a portfolio of innovative therapeutic products candidates. The company's lead oncolytic virus program includes product candidates that have been engineered to express multiple transgenes that include novel combinations of immunomodulators, checkpoint inhibitors, and ligands for T-cell costimulatory or coinhibitory receptors and metabolic modifiers. In preclinical development is an infectious disease vaccine for COVID-19, and in discovery research are applications in gene therapy/gene editing.
Contact
DevaCell Inc
David Pyrce
951-551-0949
dpyrce@devacell.com
DevaCell.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Scientific, Evidenced-Based Instrument Rates, Recognizes Workplace Health Programs and Workforce Heart Health

CHICAGO (PRWEB) OCTOBER 29, 2020
The results of the American Heart Association 2020 Workplace Health Achievement Index were announced this week, and CHC Wellbeing achieved national Gold Level recognition for taking significant steps to build a culture of health in the workplace. CHC is one of 776 organizations that completed the Index assessment this year, evaluating the time period of July 30, 2019 to June 30, 2020. Of the organizations that completed the Index assessment, 35% received gold recognition, the highest percentage to date, 29% silver and 25% bronze.
CHC is a family-owned, mission-centered, people-first company that is committed to doing good while doing well. The organization has been helping employers and individuals thrive for two decades by offering a full spectrum of support across physical, emotional, social and financial wellbeing. The company was also a Gold recipient for the 2019 Index.
The American Heart Association, a global force for longer, healthier lives, created the Index with its CEO Roundtable, a leadership collaborative of more than 45 members from some of America's largest companies who are committed to applying evidence-based approaches to improve their employees' overall health. The Index is a web-based scorecard that looks at organizational best practices and aggregates employee health data to evaluate the overall quality and comprehensiveness of workplace health programs. Studies show that worksites with a culture of health with comprehensive, evidence-based policies and programs, and senior leadership support are more likely to have engaged employees and a healthier, more productive workforce.
"We work hard for our clients, and our local community, to empower healthier, happier, more productive organizations, individuals and families. To be successful in achieving our mission, we must also care well for our own colleagues," said Ramki Ramanarayanan, CEO of CHC Wellbeing. "It's an honor to be recognized again this year as a Gold Level company. We are committed to creating a world-class culture where wellbeing is always prioritized, and we use this Index as one way of measuring our progress toward this purpose."
A unique feature of the Index is that it calculates an average heart health score for employees of participating companies that securely submit aggregate health data through Life's Simple 7,the American Heart Association's definition of ideal cardiovascular health based on seven risk factors. Life's Simple 7 includes smoking status, physical activity, weight, diet, blood glucose, cholesterol and blood pressure. Companies receive benchmarking reports, which allow them to identify potential areas of improvement so that they can advance their annual performance and recognition.
About CHC Wellbeing
CHC Wellbeing goes beyond wellness to true potential, helping individuals excel in every facet of their lives: physically, emotionally, socially and financially. With a proven track record of serving over a thousand clients, our evidence-based wellbeing strategies reduce costs, improve productivity and nurture an environment where people do their best work. Learn how you can reach your true potential by visiting http://www.chcw.com.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A national provider in mental health and substance use disorder treatment services welcomes new clinical director, Susan Shirley.

LANTANA, FLA. (PRWEB) OCTOBER 29, 2020
Lucida, a leader in mental health and substance use disorder treatment, announced today the addition of Susan Shirley as its new clinical director. Susan steps into the role with over 30 years of clinical experience in the mental health and addiction sphere along with impressive expertise in leadership in both nonprofit and enterprise settings. She plans to implement transformative modifications to improve the client experience by building on current programming, streamlining clinical care and strengthening staff relations.
Whether it be in nonprofit, for profit, in a facility, hospital, institution, or her own private practice, Susan has expert knowledge in mental health and addiction rehabilitation services, how to streamline those services and what policies are necessary to create a successful program. She has worked in a variety of leadership positions over the last 17 years, both in Florida and in Louisiana, instituting clinical standards and processes that ensure overall growth and staff retention. Susan is also a nationally certified parent coordinator and a founding member of the National Association of Divorce Professionals. She helps parent coordination, mediation and evaluates custody for divorce cases nationally.
As the clinical director of Lucida, Susan has already begun initiating modifications and introduced new service procedures to help not only with the client experience but to create sound, evidence-based programming. To help streamline these modifications, Lucida will see schedule restructuring to ensure that clinical staff is available seven days a week and employ cohesive therapeutic models to ensure there is no lapse in treatment curriculums. Susan is also working to ensure that communication lines are clear and that unique client planning is available from the time the individual is admitted to their discharge and on as the client steps down into a lower level of care. She is working transparently with staff to fortify team relationships and working to establish a team mindset. She believes that with purposeful leadership, the Lucida staff will feel reassured in their roles and gain a renewed passion for helping people work through their mental health and substance use disorders.
"I live by Gandhi's famous quote 'Be the change you wish to see in the world' and I hope to bring this mantra into action as I work alongside Lucida's dedicated staff to help people find healing," mentioned Susan. "We see broken lives walk through our doors every day and it is my goal to not only create a healing experience but to also ensure that clients feel that we are truly invested in their long-term recovery."
As Lucida moves forward, staff, clients and client families can feel confident that this growth will create long-lasting outcomes. With Susan's leadership skills, a change in structural procedures, reinforcing evidence-based practices and creating a strong team atmosphere, Lucida can look to the future with a renewed passion to help people find hope and healing.
About Promises Behavioral Health
Promises Behavioral Health is a family of behavioral health programs with regional brands such as The Right Step, The Ranch, and Promises. The company currently operates facilities across Texas, Tennessee, Florida, Pennsylvania and Massachusetts. Promises offers comprehensive, innovative treatment for substance abuse, sexual addiction, trauma, eating disorders and other mental health disorders. Through its programs, the company is committed to delivering clinically sophisticated treatment that promotes permanent lifestyle change, not only for the patient but for the entire family network. For more information, please visit http://www.promisesbehavioralhealth.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This educational focused agenda will share perspectives, valuable insights, and stellar expertise to tackle this complex issue and the evolving landscape of Opioid Management

YORBA LINDA, CALIF. (PRWEB) OCTOBER 29, 2020
LabRoots, the leading scientific social networking website, offering premier, interactive virtual events and webinars, today announced its new virtual event, Opioid Crisis to be held on November 5th, 2020. Free to attend, this high-level forum is designed to inform and raise awareness about critical substance use prevention and effective standards of care and showcase innovative strategies and practices to manage the opioid epidemic.
Opioid overdose deaths in the United States have increased dramatically over the past decade and continues to gain national attention. Key academia is actively engaged in this battle to enhance medical education and clinical care to physicians about pain management and substance use disorders (SUDs) to respond to this crisis. This program, bringing together thousands of leaders from industry and academic institutions, research scholars, clinicians, healthcare and behavioral professionals, includes a variety of informative topics such as medications for opioid use disorder, stigma surrounding opioid use disorder, informatics and opioid stewardship, and health system delivery of opioid use disorder treatments.
The full line up of notable speakers will concentrate on many facets of opioid response while exploring buprenorphine induction strategies and comparing traditional and home induction methods and identifying appropriate patient populations for each method, stigma toward medication assisted treatment (MAT) and articulating the components of stigma, understanding the three types of stigma and how stigma can impact social support, the disease state model of substance use disorder and the evidence surrounding common misconceptions regarding substance use disorder, the importance of educating patients and their physicians on opioid use: lessons learned from medical cases, and compliance to pain management test results based in prescriptions and the important pain management medications in use today and the routes of metabolism, and how to interpret pharmacogenomics variances in the genes that encode cytochrome P450 with relevance to pain medication, to round out the day.
An impressive keynote delivery kicks off the event presented by Professor Bertha Madras (the Honorable) titled, 'The Opioid Crisis: Made in America...Fade in America.' "Opioid overdose deaths in the United States are approximately nine times higher than in the European Union. The opioid crisis was made in America, but when will it fade in America? Initially catalyzed by misuse of prescription drugs, from 2010 onwards the cause of deaths began to shift with the advent of inexpensive heroin and fentanyl marketed to opioid-seeking populations. The COVID-19 pandemic is fueling this unprecedented crisis, with 2020 predicted to witness at minimum, an 8% rise in drug-related deaths," said Bertha Madras, Professor of Psychobiology at Harvard Medical School and Director of the Laboratory of Addiction Biology at McLean Hospital. "The LabRoots' presentation will highlight the complex origins of the crisis, outline the need to reverse engineer initial mistakes in the healthcare system, and describe broadly-based solutions, along with challenges to implementation: rising normalization of drug use, persistent barriers to effective treatment, and COVID-related disruptions of normalcy."
In addition to the featured expert discussions, a panel presentation: 'The NIH HEAL Initiative: A Bold Interagency Response to the Opioid Crisis,' highlights the program schedule describing the Helping to End Addiction Long-TermSM Initiative, or NIH HEAL InitiativeSM, a trans-NIH research effort focused on improving prevention and treatment of opioid misuse and addiction and enhancing pain management. Attendees will learn firsthand how the NIH HEAL Initiative is addressing unmet research needs to curb the opioid crisis and understand the extent of the U.S. opioid epidemic, and how widespread use of prescription opioids and the lack of effective pain treatment fueled the crisis.
"Dealing with opioid addiction is one of the most significant problems the U.S. and the health system faces today, and we are pleased to add this topic of crucial interest to our event schedule this year," commented Greg Cruikshank, Chief Executive Officer at LabRoots. "LabRoots' one-stop platform continues to deliver educational sessions to the scientific community while bringing vital issues to the forefront - specifically discussing in depth the history of opioids, addressing the impact of opioid abuse, and defining clinical approaches to treating substance use disorder to aid in managing and reducing the opioid epidemic and improve the health of our communities."
Produced on LabRoots' robust platform with the capability to connect across all desktop and mobile devices, the interactive environment encompasses a lobby, auditorium, poster hall, exhibit hall, and networking lounge allowing a complete educational experience for all participants. As an approved provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program, LabRoots offers the opportunity to earn 1 Continuing Education Credit per presentation for a maximum of 14 credits.
To register and for more information, click here. Use #LRopioids to follow the conversation!
About LabRoots
LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Benco Dental has selected Meridian LMS to manage learning for their new customer education program.

RESTON, VA. (PRWEB) OCTOBER 29, 2020
Learning technology provider Meridian Knowledge Solutions today announced that Benco Dental has selected Meridian LMS to manage learning for their new customer education program.
Benco Dental is the largest privately owned, full-service distributor of dental supplies, dental equipment, dental consulting & dental equipment services in the U.S. With 50 regional showroom locations and five distribution centers, they serve more than 30,000 dental professionals in all 50 states.
"We wanted a learning solution that offered an intuitive user interface for both learners and administrators," said Andrew Roth, Director, Benco Center of Excellence "We expect our new education offerings, made available via Meridian, will help us to increase client engagement and satisfaction."
Benco also selected Meridian for their ease of use and eCommerce capabilities, which will be important as they expand to offer additional learning opportunities over time.
"Corporations that offer robust education programs to clients are realizing the positive effect learning can have on their bottom line," said Patrick Devlin, Chief Business Development Officer at Meridian. "Improved retention, account expansion and higher levels of customer satisfaction are just a few of the benefits that occur from extending learning beyond employees to buyers, partners and resellers."
About Benco Dental
Benco Dental, headquartered in Northeastern Pennsylvania, is the largest family-owned dental distributor in the United States, offering a full array of supplies, equipment and services to dentists across the nation. Founded in 1930 by Benjamin Cohen, the company has remained family-owned and focused on its unique mission to "deliver success, smile after smile." Within the past 88 years, the company has grown from a single downtown location to a national network that includes five distribution centers, and three design showrooms, one at the company's Pa. headquarters, one in Southern California, and one in Texas. Benco, which has been named one of Fortune Best Workplaces in Health Care and Biopharma for the past three years, one of the NAFE Top Companies for Executive Women for the second consecutive year, and Pennsylvania's Best Places to Work for 12 of the past 14 years, is proud to feature a highly skilled team of more than 400 professionally trained sales representatives and over 300 factory-trained service technicians. For more information, visit http://www.benco.com or call 1.800.GO.BENCO.
About Meridian Knowledge Solutions
Meridian's award-winning learning management system allows organizations, where training is critical to operations to share knowledge, increase revenue streams and manage compliance requirements for their employees, members, customers, partners and resellers.
Meridian has been chosen by leading organizations including U.S. Department of Homeland Security, Johnson Controls, HAI Group, The Society of Actuaries and Kodak Alaris. Meridian is headquartered in the Washington DC metro area.
For more information, visit https://www.meridianks.com or follow @MeridianKS on Twitter.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Healthcare industry veteran to lead the organization's healthy pregnancy, birth and early parenting initiatives with a focus on growth and diversity

WASHINGTON (PRWEB) OCTOBER 29, 2020
Lamaze International announced today that Dr. Andrea J. Boudreaux, FACHE, takes the organization's helm as chief executive officer on November 1, 2020. Linda Harmon, who has served Lamaze International for nearly 30 years, will retire on October 31, 2020.
Boudreaux is the first African American CEO in the 60-year history of Lamaze International, marking a major milestone in the organization's commitment to diversity, equity and inclusion for childbirth educators, parents and infants.
"I am very proud of the thinking, transparent communications and application of equitable and consistent care that defined the whole experience of selecting Dr. Boudreaux as the new leader of Lamaze," said Alice Turner, LCCE, CD(DONA), president of Lamaze International. "Her qualifications make her the ideal fit to lead our organization into the next phase of its growth providing trusted, evidence-based information to parents and childbirth educators."
Boudreaux is a seasoned healthcare executive with more than 15 years of progressive leadership in the nation's largest healthcare organizations. Most recently, she served as a senior partner with Manhattan-based JCG Consulting Group, where she led all clinical transformation efforts with clients across the nation to improve care delivery, as well as COVID-19 response and operations management. In that capacity, Boudreaux led a 19-state service line development, opened an integrated clinic for the treatment of Hepatitis C patients, and redesigned a care delivery model for a regional health plan.
"I am thrilled to join Lamaze International at such a critical time for childbirth education," Boudreaux said. "I am most excited about the opportunity to reach areas of our globe that have been marginalized, increase access to care for those in need and reduce the alarming disparities in education and care for woman of color."
As a tireless advocate of diversity, equity and inclusion initiatives, Boudreaux has focused on helping organizations operationalize diversity. As a regional chief diversity officer with HCA, she was instrumental in improving patient outcomes and expanding services across the $50-billion organization.
"Diversity, equity and inclusion is about more than simply hiring minorities," she said. "It is about transforming business practices to specifically outreach to underserved communities."
Boudreaux is board certified in Healthcare Management as a Fellow in the American College of Healthcare Executives, demonstrating her commitment to continued learning and excellence in healthcare practice. A medical psychologist by training, Boudreaux spent nearly a decade in clinical practice working diligently to improve the health of children and adolescents through the integration of behavioral health and primary care. Her research interests include the integration of spirituality and religion, psychotherapy and addressing the underutilization of mental health services, especially within the African American community.
Boudreaux, a proud graduate of Howard University and Texas A&M University, will be based in the new Washington, D.C. headquarters of Lamaze International. She is very active in her community and has held multiple non-profit board positions, including her current role as vice chair of The POWER Foundation and Momentum Collective Inc. Boudreaux also serves as an alumni member of the Texas A&M School of Public Health Advisory Board.
About Lamaze International
Lamaze International is a non-profit organization and trusted global leader with a mission to advance safe and healthy pregnancy, birth and early parenting through evidence-based education and advocacy.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Findings of recent independent study which evaluates the impact of Partners' APS remote medication dispensing technology designed for the post-acute community.

SPRINGFIELD, N.J. (PRWEB) OCTOBER 29, 2020
Partners Pharmacy is proud to release the findings of a recent independent study which evaluates the impact of Partners' APS remote medication dispensing technology designed for the post-acute community. Partners' APS brings the pharmacy into the facility reducing outside interaction between pharmacy couriers and nursing home staff. A key factor as facilities continue to face the impacts of the COVID-19 pandemic. The study, conducted over an 18- month period which involved 52 nursing facilities was validated by Centric Consulting, a national business, technology and digital consulting firm. Performance elements included customer feedback and benefits, including quality, time savings, workflow savings, ease of use and adoption, space savings, and reduction in drug waste. Michelle Brown of Centric's Operational Excellence Practice led the validation and verification.
Brown reviewed study data, derived calculations and metrics. She also conducted interviews of the individual(s) who led the field study and built the measurement system and output metrics. Centric Consulting concluded that the field study approach was sound and the resulting key metrics and benefits were calculated in an appropriate manner, and they accurately reflect the results of the data collected.
Timothy Dimond of Centric Consulting stated, "Centric Consulting has concluded that the field study approach was sound and the resulting key metrics and benefits were calculated in an appropriate manner, and they accurately reflect the results of the data collected. Centric was proud to be part of this validation study of Partners APS and its recognized benefits to the post-acute and senior living populations.
Anthony Spero, COO of Partners Pharmacy was very pleased with the confirmation of the data collected for the white paper study. Mr. Spero states, "The next generation of Passport takes the efficiency of our AP Passport technology to the next level. Partners Advanced Pharmacy Solutions, or APS, is an integrated multi dose dispensing system made especially for long-term care. This ecosystem of four units combine in an easy-to-use solution ideal for today's time-strapped nursing staff especially during this pandemic when we know facilities are managing staffing challenges along with the challenges of limiting outside interactions. The new software is enhanced for ease of use and interacts with the electronic health record. The white paper study validates the features and benefits as a key solution in long term care settings."
To access the Partners APS white paper study conducted by Centric Consulting, please visit http://www.partnersaps.com.
About Partners Pharmacy - Partners Pharmacy is one of the largest long-term care pharmacy providers in the U.S. Each regional Partners location provides the same unmatched personalized service through the combined resources of local teams and expanding national resources. Partners collaborates with the communities it serves to improve outcomes, reduce costs and increase operational efficiencies that permit more time for direct patient care. Performance elements and manufacturing of Partners APS are developed by American company Tech Pharmacy Services in Houston, Texas. Tech Pharmacy Services designs, develops, implements and services technology based solutions to meet 21st century pharmaceutical service needs. For more information about Partners APS, visit
http://www.PartnersAPS.com or email info@PartnersAPS.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Award recognizes G-CON as a global industry leader for Innovative Bioprocessing Technology

COLLEGE STATION, TEXAS (PRWEB) OCTOBER 29, 2020
IMAPAC, the organizer of Biologics Manufacturing Korea, recently awarded G-CON Manufacturing with the 2020 Korea Bioprocessing Excellence Award in Innovative Bioprocessing Technology. The award honors outstanding experts, institutions, and technologies in the field of bioprocessing and cell/gene therapy. G-CON is honored to be in the company of the many distinguished organizations and individuals who have been considered for this award in the past.
G-CON received the award for its ÜBERcellFLEX prefabricated modular cleanroom infrastructure for the manufacturing of autologous cell therapies. ÜBERcellFLEX is part of the iCON product line developed by G-CON and IPS-Integrated Project Services, LLC and represents a line of gene/cell therapy products that operating companies can buy today, ready- to-order with little to no engineering time.
"It's with great pride and gratitude, that G-CON has accepted this award on behalf of the entire iCON team" said Dennis Powers, Vice President of Business Development and Sales Engineering for G-CON Manufacturing. "Being recognized for our innovative platform approach to facility design and construction further reinforces the growing need in our industry that IPS and G-CON recognized three years ago when we launched iCON."
Available in both 12-foot and 24-foot wide POD configurations, the ÜBERcellFLEX processing suites enable faster and more predictable project schedules for new facility construction and a standardized solution to meet speed to market requirements — filling all major needs in the cell therapy arena. Multiple units can be installed to scale up/out from phase 1 clinical production to commercial manufacturing.
About G-CON Manufacturing
G-CON Manufacturing designs, builds, and installs prefabricated G-CON POD cleanrooms. G-CON's POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD cleanroom units surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end. For more information, please visit G-CON's website at https://www.gconbio.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this webinar, the featured speaker will discuss T-cell receptor (TCR) and B-cell receptor (BCR) sequencing data generated by Adaptive's immunoSEQ Technology, which has been used extensively in preclinical and clinical pipelines from early drug discovery to biomarker endpoints. The webinar will explore how the immunoSEQ Assay can be leveraged to study drug candidate selection, optimize dosing, determine smart drug combinations, select biomarker endpoints, optimize patient selection, predict response to therapy and monitor for adverse events.

TORONTO (PRWEB) OCTOBER 29, 2020
Immunosequencing, the science of profiling T- and B-cell receptors, has broad utility across the clinical development spectrum. Adaptive Biotechnologies' quantitative immunoSEQ Technology has the ability to answer early, preclinical questions such as those around drug candidate selection, dosing and effective drug combinations. As a therapeutic pipeline matures to the clinical trial stage, the immunoSEQ Assay can also help confirm drug safety and efficacy, establish biomarker endpoints, optimize patient selection, predict response to therapy and monitor for adverse events.
This webinar will use real-world data to demonstrate how immunosequencing can be leveraged at various points in the drug development and clinical trial process to improve the development of new therapies.
Join Patrick Raber, PhD, Senior Manager of Research and Business Development, Adaptive Biotechnologies for the live webinar on Friday, November 13, 2020 at 10am PST (1pm EST).
For more information or to register for this event, visit From Bench to Biomarker: Applications of the immunoSEQ Assay Across the Clinical Development Pipeline.
The immunoSEQ Assay is For Research Use Only. Not for use in diagnostic procedures.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

USOSM – a specialty management services company headquartered in Irving, Texas – has entered into a new partnership with OMA, an oral and maxillofacial surgery practice with six board-certified surgeons and four locations. The partnership is USOSM's first in the state of Oklahoma. USOSM now has partnerships spanning seven states: Texas, Colorado, Georgia, Tennessee, Minnesota, Alabama and Oklahoma.

IRVING, TEXAS (PRWEB) OCTOBER 29, 2020
U.S. Oral Surgery Management (USOSM) – a specialty management services company headquartered in Irving, Texas, that exclusively serves premier oral and maxillofacial surgeons – has entered into a new partnership with Oral and Maxillofacial Associates LLC (OMA) an oral and maxillofacial surgery (OMS) practice with six board-certified surgeons and four locations. The partnership is USOSM's first in the state of Oklahoma.
"We're excited to announce our first Oklahoma partnership, which is with OMA. This practice has been serving the Oklahoma community for more than 25 years. During that time, it has developed a well-earned reputation for outstanding patient care and clinical excellence, two characteristics that are also core to our values. We're honored to partner with such an outstanding practice, and we look forward to continuing to build strategic relationships in Oklahoma and throughout the nation," said Richard Hall, USOSM president and CEO.
OMA treats patients in Oklahoma City, Edmond, Midwest City and Norman. The surgeons offer a wide variety of OMS procedures to address both common and rare OMS needs, from wisdom teeth removal to teeth implants, sleep apnea correction and more.
"Our practice and USOSM have similar philosophies and values. We are both dedicated to putting patients first and to achieving the highest levels of clinical excellence in oral surgery. We both strive to advance and improve the quality of care for the people we serve; and together, we will make an even bigger difference in the health and lives of our patients. We look forward to this partnership, to working together and continuing to improve on the high-quality clinical care that OMA has been providing to our communities for over 25 years," said Dr. Vincent E. Montgomery, a surgeon with OMA.
Headquartered in Irving, Texas, USOSM has partner practices spanning seven states: Texas, Colorado, Georgia, Tennessee, Minnesota, Alabama and Oklahoma. USOSM collaborates with premier oral and maxillofacial surgeons to offer a partnership solution for continued and accelerated practice success. USOSM provides operational, marketing and administrative support services, reinvests resources, and applies best practices to improve clinical and financial performance and produce steadier, more profitable growth for all.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss why outsourcing biomarker assays is different than contracting other bioanalytical work. Attendees will gain insights into the important aspects to take into consideration.

TORONTO (PRWEB) OCTOBER 29, 2020
A lot has already been written about the difference between biomarker assays and PK assays. However, in our daily work in a CRO setting, we still find that many potential sponsors are struggling with the challenges specific to biomarker outsourcing. It is not easy to clearly define a biomarker's Context of Use (CoU) in a study or to get all the stakeholders involved in understanding the biology and use of the study data. It requires mutual understanding and close collaborations.
In this webinar, the speakers will explain why biomarker assay outsourcing is different and will describe good practices and how a pharmaceutical company and a CRO can efficiently collaborate in this process. PRA realizes that biomarker assays require special attention in order to provide reliable and useful data.
Join Radboud van Trigt, PhD, Director of Bioanalytical Science – Biomarkers, PRA Health Sciences and Amanda Hays, Ph.D., Director of Bioanalytical Science, PRA Health Sciences in a live webinar on Friday, November 13, 2020 at 10am EST (3pm GMT/UK) to gain insights from PRA about biomarker assay outsourcing.
For more information or to register for this event, visit Important Considerations for Outsourcing Biomarker Assays.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will identify the three organizational habits that create an adaptive, high-performance corporate culture capable of powering innovation. Attendees will understand how to apply jobs-to-be-done theory to build shared organizational beliefs about unmet customer needs, enabling the realization of product-market fit and making innovation outcomes more predictable.

TORONTO (PRWEB) OCTOBER 29, 2020
Relying on conventional wisdom leads to an estimated 72 percent of all new products and services failing to meet expectations.
On the other hand, successful medtech companies marry – from the very beginning – a technologist working on an as-yet unproven technology with a marketing person who is testing hypotheses about unmet market needs. It is a marriage that lasts until either the product is successfully launched or the technology is dropped.
Powerful go-to-market and reimbursement strategies are two critical elements required to deliver great medtech products to the marketplace.
Go-to-market strategy: Go-to-market (GTM) plans and performance directly impact every value creation moment throughout a company's existence. That means GTM issues need to be top-of-mind every hour of every day. GTM is also difficult because success requires companies to simultaneously address product-centric challenges, organization-centric challenges, and marketplace-centric challenges. Tackling these three complex challenges requires the development of product-market fit, organizational fit, and business-model fit solutions, respectively.
Reimbursement strategy: Given the current healthcare environment, it is critical to articulate product value not only to clinicians but also other key stakeholders, such as payers. Reimbursement and revenue are inextricably linked; defining the clinical and economic value that a new technology has to its diverse stakeholders is essential to adoption, payer coverage and payment and ultimately revenue. Successful companies integrate their market access and reimbursement planning into the earliest phases of product development.
Join Mark Girardi, Senior Vice President, Boston Healthcare Associates and Donald B. Hawthorne, President, GTM Hawthorne in a live webinar on Thursday, November 12, 2020 at 1pm EST to learn how not to be conventional by exploring the key elements of successful go-to-market and reimbursement strategies that deliver great product and company value.
For more information, or to register for this event, visit Creating Great MedTech Products: Why Conventional Wisdom Doesn't Work.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/




START your own Wordpress site, business or personal website, or online store at www.siteground.com

180 Medical, one of America's fastest-growing providers of home-delivered disposable medical supplies, including sterile-use intermittent catheters, ostomy supplies, and incontinence products, has been named one of Oklahoma's Best Places to Work for the 11th year by the Best Companies Group and the Journal Record. The Best Places Awards are determined through a process of researching Oklahoma-based employers with more 250 employees and reviewing feedback from anonymous employee surveys.

OKLAHOMA CITY (PRWEB) OCTOBER 29, 2020
180 Medical, one of America's fastest-growing providers of home-delivered disposable medical supplies, including sterile-use intermittent catheters, ostomy supplies, and incontinence products, is pleased to announce its 11th year being named one of Oklahoma's Best Places to Work by the Best Companies Group and the Journal Record.
The Best Places Awards are determined through a process of researching Oklahoma-based employers and allowing employees to fill out anonymous surveys regarding their working conditions. 180 Medical is committed to the safety and well-being of all employees and believes that the way employees are treated directly correlates with the level of service they provide the customers of the organization.
This year, Best Companies Groups' anonymous employee survey included additional questions regarding how well their employer handled COVID-19 workplace communication and safety issues. During the early stages of the COVID-19 outbreak in United States, 180 Medical acted quickly to put their staff's health first by asking the majority of their employees who are able to perform their jobs remotely to begin working from the safety of their homes. Through digital connections, 180 Medical has made an easy transition for employees to successfully work from home while also fostering positive work relationships.
Director of Human Resources at 180 Medical, Angie Christopher, explained why this honor means something extra special during a global pandemic saying, "In light of the unprecedented year that we all have experienced due to COVID, it is a great feeling to know that our employees still feel that this is a great place to work, and that even in crisis, we strongly care for our employees and their families as much as we do our customers. Throughout the year and despite most of us working remotely during this time, we have grown closer as an organization, and we have developed new processes and protocols to ensure the safety of our employees.  We are proud that, no matter what, we can create an environment that employees continue to enjoy and are proud to work for this company."
Those interested in joining the 180 Medical team and working for one of the Best Places to Work in Oklahoma are encouraged to visit 180medical.com
About 180 Medical:
180 Medical is one of America's fastest growing home delivery providers of intermittent catheters, ostomy products, incontinence products, and other related urologic disposable medical supplies. Based in Oklahoma City, the company is dedicated to meeting the supply needs of customers with diagnoses such as urinary incontinence, spinal cord injuries, spina bifida, colon cancer, Crohn's disease, and many other conditions that require catheterization and ostomy supplies. 180 Medical is a subsidiary of ConvaTec, a leading global medical products and technologies company. For more information, please contact Angie Christopher, Director of Human Resources at 405-702-7700




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Catch has been building new and innovative ways for independent workers to access meaningful benefits like tax withholding, time off savings, and retirement investment. Now, Catch is also offering an integrated system to provide high quality health insurance options directly to individuals and families who don't have access to employer-sponsored coverage.

BOSTON (PRWEB) OCTOBER 29, 2020
In a year that has been rocked by mass unemployment and rapid adoption of gig and freelance work, staying covered with quality health insurance is more important than ever. For those juggling multiple jobs in the uncertainty of a global pandemic, the confidence of getting an affordable health plan can make all the difference in the world.
Since its launch in 2018, Catch has been building new and innovative ways for independent workers to access meaningful benefits like tax withholding, time off savings, and retirement investment. Now, Catch is also offering an integrated system to provide high quality health insurance options directly to individuals and families who don't have access to employer-sponsored coverage.
Catch is working with the Centers for Medicare & Medicaid Services (CMS) to offer Enhanced Direct Enrollment (EDE), a system that allows for end-to-end plan shopping, subsidy evaluation, and enrollment in every state on the Federally-facilitated Marketplace.
Put simply, Catch customers who need health insurance this Open Enrollment (Nov 1 - Dec 15) will be able to compare options, see if they're eligible to cut costs with federal subsidies, and enroll in the right plan all within the Catch app or website.
One of Catch's customers, Luis Camacho of Phoenix, shares, "What's great about Catch is that it's built to help small business owners and freelancers with things like health insurance, tax withholding, and retirement all in one place."
"The first of its kind. Catch helps independents put their paychecks, savings, investment, and health insurance all in one place," says Kristen Anderson, co-founder and CEO of Catch.
"Financial and insurance products work together," says Andrew Ambrosino, Anderson's co-founder and the company CTO. "You have to build in a way that allows for synthesis of this data. People can't keep straight how subsidies change year over year, or what tax exemptions there are because of legislation passed during COVID. That's our job: provide an easy and elegant way to automatically take care of you and your family no matter what."
Catch is one of fewer than a dozen providers offering the Enhanced Direct Enrollment pathway and has undergone strenuous security and privacy auditing to ensure all customer data is protected.
In an effort to serve independent workers best, says Anderson, "We're the only provider to offer EDE mobile-first. That means we've designed the system primarily for people to use our app or a mobile website. It's extremely important to make complex processes accessible to those who don't necessarily have easy access to a laptop or home computer."
You can sign up for health insurance through Catch's EDE pathway at health.catch.co.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

U.S. Dermatology Partners is proud to announce their Waco office is voted Best Dermatologist and Best Cosmetic Dermatology by Waco Trib's annual Heart of Texas Reader's Choice award

WACO, TEXAS (PRWEB) OCTOBER 29, 2020
U.S. Dermatology Partners Waco office is being recognized by their readers as Best Dermatologist and Best in Cosmetic Surgery in Waco Trib's annual Readers' Choice award.
This prestigious readers' choice poll is conducted annually to recognize and reward the people, places, and things that make the Heart of Texas special. Readers cast their votes for their favorites during the official two-week voting period from August 9-23rd.
"Thank you to our patients for voting us H.O.T. Best Dermatologist and Best Cosmetic Dermatologist for 2020. It's an honor to serve Waco and the surrounding areas. We look forward to continuing to provide superior and compassionate dermatology care to the community that Dr. Walker and I are proud to call our home for many years to come," said Young McMahan, MD
Dr. McMahan and Dr. Walker both serve as volunteer faculty staff at the Family Health Center to help provide dermatology education to the residents. Dr. McMahan continues to serve on the board of the McLennan County Medical Society and is in her second term as a delegate for the Texas Medical Association. Dr. McMahan and Dr. Walker are happy to welcome Shae Young. PA-C to their patient care team.
The office has been serving Waco and the surrounding community since 2015. The center includes Board Certified Dermatologist, Dr. Young McMahan, Dr. Greg Walker, Dr. Nick Snavely, and Shea K. Young, PA-C. Dr. McMahan joined the Waco practice of U.S. Dermatology Partners following her dermatology residency at the University of Texas Medical Branch in Galveston where she served as chief resident. Dr. Walker joined the practice after completing his dermatology residency at Baylor Scott and White in Temple, Texas. He spent the final year of his training as chief resident. Dr. Snavely completed a dermatology residency at the University of Virginia in Charlottesville, Virginia, and then completed an advanced dermatologic surgery fellowship at Oregon Health & Science University in Portland, Oregon.
About U.S. Dermatology Partners Waco
At U.S. Dermatology Partners Waco, your skin health is important to us. From protecting your skin from harm or restoring it to health, we have the expertise and technology to treat a vast array of skin conditions. Our specialized skin cancer procedures have produced substantial cure results and our expert treatment of acne, dermatitis, psoriasis, and other common skin conditions continue to expand. With the development of additional physician and nursing resources, treatment options, and advanced clinical trials, we are ready to help. At our Waco dermatology clinic, our goal is to provide you with the most convenient, restorative experience possible every time you visit – from initial consultation to treatment to follow-up. We hope you will make us your skin care partner for life.
About U.S. Dermatology Partners
As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners' patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network but also benefit from the practice's strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Verge Genomics announced today that it has joined the Neurofilament Light Surveillance Project (NSP), a consortium sponsored by the Bluefield Project to Cure FTD.

SAN FRANCISCO (PRWEB) OCTOBER 29, 2020
Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-inhuman genomic platform with machine learning, announced today that it has joined the Neurofilament Light Surveillance Project (NSP), a consortium sponsored by the Bluefield Project to Cure FTD that brings together leading academic institutions, nonprofit foundations, and pharmaceutical and biotech companies to identify new approaches to diagnosing and treating frontotemporal dementia (FTD). The NSP study is an ancillary study of ALLFTD, a multisite observational research project aimed at preparing for clinical treatment trials in FTD. Coordinating research efforts to fund and share results through the NSP project will greatly accelerate the understanding of the mechanism of this disease and the development of new targets and approaches to treatment.
"Frontotemporal dementia is a rare but fatal adult-onset neurodegenerative disease where symptoms typically begin in middle-age and death usually occurs within 10 years after symptom onset. Joining the NSP is part of Verge's steadfast commitment to developing treatments for patients with complex neurodegenerative diseases," said Jane Rhodes, Ph.D., M.B.A. "Through this consortium, Verge will have access to data to aid biomarker development for monitoring and detecting disease progression, as well as providing data to advance clinical study design that will accelerate our ability to identify and develop potential new treatments for this devastating disease."
The NSP (https://www.allftd.org/nsp) is a prospective, longitudinal, observational study that will collect blood samples from hundreds of participants over the course of three years. The study will help researchers to determine if plasma neurofilament light (NfL) may be used as a prognostic biomarker to select individuals with familial mutations at a high risk of converting to symptomatic disease within two years.
FTD encompasses a group of devastating neurodegenerative conditions that occur in people in their 50s or 60s and are characterized by dying neurons and the abnormal accumulation of proteins. Verge has active research and development programs aiming to find novel therapeutics for the treatment of neurodegenerative diseases, including FTD.
About Verge Genomics
Verge is focused on developing therapeutics for neurological diseases using human genomics to accelerate drug discovery. Verge has created a proprietary all-in-human platform, generating one of the field's largest and most comprehensive databases of ALS, FTD and Parkinson's Disease patient genomic data. The Company is led by experienced computational biologists and drug developers who are successfully advancing therapeutic programs in ALS and Parkinson's disease toward the clinic. For additional information, please visit http://www.vergegenomics.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

incentaHEALTH's patented "healthy selfie" screening technology now powering home-based diabetes prevention solution that helps individuals with prediabetes get healthy at home

DENVER (PRWEB) OCTOBER 29, 2020
incentaHEALTH announced today that the company achieved full recognition status for its virtual diabetes prevention program (DPP) from the Centers for Disease Control and Prevention (CDC).
#PreventDiabetes is built upon incentaHEALTH's core weight management program that has been helping individuals achieve and maintain a healthy weight through online coaching, patented photographed progress tracking, and incentives for meaningful change.
"Achieving CDC full recognition validates the effectiveness of our incentive-based digital behavior change program, our ability to engage participants virtually, and achieve clinically meaningful outcomes – all in an effort to help participants reduce their risk for developing Type 2 Diabetes," said incentaHEALTH Co-Founder and CTO, Todd McGuire.
"We are excited to bring a low cost alternative to the traditional classroom based diabetes prevention programs. We are redefining how people can get healthy at home even during these unpredictable COVID-19 times."
As part of the Diabetes Prevention Recognition Program, the CDC awards full recognition to diabetes prevention programs that meet its standards and effectively deliver a proven lifestyle change program. These include delivering CDC-approved curriculum, utilizing trained lifestyle coaches to help build participants' skills and confidence to make lasting lifestyle changes, and meeting or exceeding engagement and outcome metrics.
"According to the CDC, 1 in 3 American adults or about 88 million people have prediabetes. And 84% of those don't even know they have it," said Jeffrey Boone, M.D., incentaHEALTH Medical Advisor. "You can cut your risk in half by adopting a lifestyle change program like incentaHEALTH."
Sixty percent of participants in incentaHEALTH's #PreventDiabetes program achieved at least a 5% weight loss. This milestone is considered the standard for preventing and reducing risk of developing Type 2 Diabetes. In fact, a 5% weight loss will lower your risk by 58% for developing not only Type 2 Diabetes, but will also reduce your risk for other chronic diseases such as cardiovascular disease and some cancers. incentaHEALTH's success with these outcomes and cost savings can also be noted in Preventive Medicine.
incentaHEALTH member Brenda Yates joined #PreventDiabetes since she was at risk for developing Type 2 Diabetes due to gestational diabetes and a family history of diabetes. While enrolled in incentaHEALTH's #PreventDiabetes program she achieved a 14.3% weight loss. "I like the program because it holds you accountable. It holds me accountable to myself and my goals. It's changed my life. It's kept me from having any more pain. I no longer need pain prescriptions. Now I feel like I can do anything," said Yates.
incentaHEALTH is now seeking to partner with employers, health systems, researchers and medical groups who are looking for scalable solutions to the diabetes health crisis



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Definitive Healthcare adds broad expert data to its life sciences offering to help clients advance clinical development and commercialization of innovative drugs and therapies.

FRAMINGHAM, MASS. (PRWEB) OCTOBER 29, 2020
Definitive Healthcare, the leading provider of data, intelligence, and analytics on the healthcare market, today announced its acquisition of Monocl, the pre-eminent subscription-based provider of medical and scientific expert data and insights. With this acquisition, Definitive Healthcare broadens its support of customers within its fast-growing life sciences segment with essential data assets and analytics designed to propel the work of Medical Affairs departments.
"The acquisition of Monocl brings together two powerful intelligence platforms to provide best-in-class data, analytics and insight that will help biotech and pharmaceutical companies accelerate clinical research and commercialization of new drugs and therapies," said Jason Krantz, founder and CEO of Definitive Healthcare. "Monocl shares the Definitive philosophy of providing the highest quality data through an online interface that gives clients the ability to access and analyze real-time information and intelligence."
Monocl delivers deep professional profiles on millions of experts worldwide to help companies identify and engage industry experts with the greatest knowledge, influence, and relevancy within the disease categories their drugs and therapies address. Traditionally, this data has been time-consuming to identify, inefficient, and incomplete, but the Monocl platform has transformed expert identification and engagement by providing users with real-time access and searching for experts globally.
"Monocl further fortifies our team with experienced industry veterans and with a strong life sciences and healthcare network," Krantz added. "Our combined offering will expand the value of the Definitive solution set by enabling our clients to research and engage prominent experts to advance drug and therapy research and go-to-market strategies."
Through deep expert profiles and high data quality, targeted searching, and powerful filtering, the Monocl platform delivers algorithmically ranked experts of unmatched relevance to the user. Pharmaceutical professionals have the flexibility to identify and prioritize key influencers to support their specific objectives, evaluate spheres of influence, and share deep insights via digital workspaces for multi-team collaboration.
"Monocl has always been laser focused on delivering critical expert insights through software to provide our clients with a unique competitive and collaborative edge," said Bjorn Carlsson, CEO and co-founder of Monocl. "We are thrilled to unite the power of our groundbreaking expert platform with Definitive's comprehensive and complementary healthcare provider platform and medical claims analytics. This is truly an example of the whole being much greater than the sum of its parts."
With this acquisition, Definitive Healthcare fortifies its product offerings for life sciences companies by delivering relevant data sets and analytics to both commercial teams and Medical Affairs departments. In addition, Definitive expands its international presence from North America to Europe and Asia.
In 2020, Definitive Healthcare was, again, named to the Inc. 5000 Fastest-Growing Private Companies, Deloitte's Technology Fast 500, and to the Boston Business Journal's Fast 50. The Company was also recognized with the 2020 CODiE product award for Best Big Data Reporting and Analytics Solution and with the 2020 MedTech Breakthrough award for Best Healthcare Data Platform. For the second consecutive year, Definitive Healthcare was awarded a Silver Stevie Award for industry-leading Customer Service and Satisfaction. Definitive was also named Massachusetts' #1 Best Large Company to Work for in 2019 by the Boston Business Journal.
"It was really important for us to join forces with a partner that shares our commitment to customers and to providing products enabling the best insights possible. We could not have found a better match, and our entire team is thrilled to be joining the Definitive family," said Carlsson.
Monocl will continue to serve its worldwide customer base under its current brand, as a Definitive Healthcare Company, and will maintain its existing operations in the US and Sweden. Bjorn Carlsson will be a member of Definitive Healthcare's executive leadership team and will report directly to Jason Krantz.
About Definitive Healthcare
Definitive Healthcare is the most comprehensive and accurate source for data insights and analytics on the healthcare provider and influencer market. Its product suite provides the most comprehensive and highest quality data available anywhere on 8,800 hospitals and IDNs; 135,000 physician groups; 1.7 million physicians, nurses, and allied health professionals; 11,000 ambulatory surgery centers; 15,800 imaging centers; 85,500 long-term care facilities; 40,000 clinics; 1,800 ACOs and HIEs; 5.7 billion medical commercial claims covering 315 million patient lives, and insights on millions of Key Opinion Leaders in life sciences and healthcare. The company's data provides its 2,500 clients with the analytics and insight needed to effectively segment and research the healthcare provider market. Definitive Healthcare is backed by 22C Capital, Advent International, and Spectrum Equity. For more information, or to trial the service, visit https://www.definitivehc.com/.
About Monocl
Monocl empowers life science professionals with the complete global expert solution designed to drive impactful outreach and strategic engagement. Our cloud-based expert platform - powered by machine learning - continuously analyzes an unrivaled amount of data across all therapeutic areas and regions, providing invaluable context and actionable insights. For more information, including details on how to get product access, visit https://www.monocl.com/.
Media Contact
Tory Waldron
PR Manager
twaldron@definitivehc.com
(781) 454-6822



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CVR is committed to educating the next generation of vein care specialists

GREENBELT, MD. (PRWEB) OCTOBER 29, 2020
As of July 2020, Center for Vein Restoration's Venous and Lymphatic Medicine Graduate Medical Education Training Program, became the largest American Board of Venous and Lymphatic Medicine (ABVLM) approved training site in the United States. Since the Fall of 2017, the program has graduated four VLM fellows and currently has four fellows in training. The program is currently accepting applications for four fellowship positions for the 2021-2022 graduating class. The prestigious 12-month program allows trainees to develop expertise in all aspects of non-invasive duplex scanning of the venous and arterial systems, the diagnosis and management of superficial and deep venous disorders, and all methods for treating chronic venous insufficiency (CVI), as well as an opportunity to consult and treat patients suffering from venous disorders like Pelvic Congestion Syndrome and May Thurner's Syndrome. Fellows have a choice of training in New Jersey, Maryland, or Virginia.
"Fellows in our program represent the future of treating venous and lymphatic disorders nationwide," said CVR's CEO and Founder Dr. Sanjiv Lakhanpal, "We are committed to the education of physicians specifically trained in venous disorders so that we can continue to deliver on our mission – to improve lives in the communities we serve by providing state-of-the-art-vascular care."
The program has grown substantially in both size and geographic reach since 2017 under the leadership of Dr. Peter Pappas, Vascular Surgeon and Regional Medical Director for CVR in Northern New Jersey. As a nationally recognized clinical researcher and educator with over 25 years of academic experience in Vascular Surgery, he is uniquely qualified to serve as the Director of CVR's Venous and Lymphatic Medicine Program and as a member of its distinguished faculty.
"What sets our Fellowship Program apart is its association with the clinical leaders in vein care – Center for Vein Restoration – which provides trainees unfettered access to internationally recognized faculty, cutting-edge treatment technologies, and patients in every walk of life," says Dr. Pappas.
The curriculum for the program includes a quarterly rotation through the various aspects of disease diagnosis and treatment; a clinical literature journal club; a didactic lecture series; and a Navix or Pegasus Review Course. A month-long Observership at Innova Health in Virginia, under the supervision of Dr. Tony Comerota is also included.
To learn more and apply to CVR's Venous & Lymphatic Medicine Fellowship Program:

Visit and apply: centerforvein.com/fellowship

Contact Stephanie Westee, Program Coordinator at stephanie.westee@centerforvein.com

ABOUT CENTER FOR VEIN RESTORATION
Center for Vein Restoration (CVR) is the largest physician-led practice treating venous disease in the country. Having performed its first procedure in 2007 under President and CEO Dr. Sanjiv Lakhanpal, Center for Vein Restoration has since become nationally recognized as the clinical leader in treating chronic venous insufficiency. With 90 centers and growing, CVR has over 450 employees and conducts over 200,000 patient interactions annually. To learn more about CVR and its mission, visit http://www.centerforvein.com or by phone at 1-800-FIX-LEGS.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Do you have issues getting to sleep and staying asleep? A new product on the market, Cannabinoid Balance Sleep+ supports your body's natural sleep cycle, by awakening your endocannabinoid and nervous systems.

LA JOLLA, CALIF. (PRWEB) OCTOBER 29, 2020
For those with issues getting to sleep and staying asleep, then fast-acting Cannabinoid Balance Sleep + with melatonin could be a 'god-send'. Cannabinoid Balance Sleep+ supports your body's natural sleep cycle, by awakening your endocannabinoid and nervous systems. It is a great way to boost your body's natural ability to switch off and overcome the symptoms associated with poor quality sleep*. Cannabinoid Balance is made with NanoZorb Technology in an FDA registered facility so you can feel safe in the knowledge that you will wake up feeling refreshed, rested, and ready for the day ahead.
Cannabinoid Balance Sleep+ is made using NanoZorb Technology, which offers up to 90% absorption into the bloodstream vs 18% with other non-nano products.
Cannabinoid Balance Sleep + is:

Crafted from registered organic USA hemp

Non-THC / Non-GMO and CO2 Extracted

Free from Winterization, Decarboxylation, and pesticides

Formulated using proprietary NanoZorb Technology

So whether your symptoms be associated with MS, Parkinsons, Opioid Addiction, Epilepsy, High Blood Pressure, Stress, Anxiety, Low Energy, Arthritis, Tendonitis or something else, Cannabinoid Balance Original+ is crafted to support you.*
*The statements and products referred to by Cannabinoid Balance have not been evaluated by the FDA.
CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.
CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb Technology designed to make Cannabinoid Balance products more effective and efficient.
It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.
For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email contact@cbdproducts.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

RCM leaders to discuss best strategies to survive and thrive amid the pandemic and beyond

MILWAUKEE (PRWEB) OCTOBER 29, 2020
Healthfuse, the industry leader in managing and sourcing revenue cycle vendors for hospitals and health systems, announced today that its President and CEO Nick Fricano will moderate a Becker's Hospital Review live panel on Tuesday, November 17th, 2020 at 1:00 pm CST.
Fricano will lead the discussion around the COVID-19 pandemic and how it created an overnight financial crisis for hospitals nationwide, forcing hospital revenue cycle leaders to make tough choices, such as redeploying staff, sourcing new vendors and implementing new self-pay billing and collections processes. RCM leaders will draw upon their experiences to provide effective hospital vendor management strategies that can help hospitals financially recover from the pandemic, and better position their organizations as the country looks to the future.
Featured panelists include:

Leah Klinke, Assistant Vice President of Hospital Revenue Cycle at WVU Medicine

Ted Syverson, Vice President of Revenue Cycle at Monument Health

Debra Lowe, Head of Revenue Cycle at The Ohio State University Wexner Medical Center

Patrick Wall, Interim Vice President of Revenue Cycle at St Joseph's/Candler

Key takeaways from the panel will be:

Vendor trends and the effects the pandemic induced regionally and nationally

Lessons from front-line revenue cycle leaders

Proactive, growth-minded vendor management strategies

"COVID-19 has been a catalyst for significant change in the healthcare financial sector. Revenue cycle vendors have pivoted to help hospitals quickly adapt and respond, protecting both the patient financial experience and the revenue stream. I look forward to having a lively discussion with these RCM leaders about their strategies for handling the crisis and tips for how to move forward," said Nick Fricano, president and CEO of Healthfuse.
To register for the live panel please visit: https://go.beckershospitalreview.com/the-road-to-recovery-4-rcm-leaders-on-the-best-strategies-to-survive-and-thrive-amid-the-pandemic-and-beyond
About Healthfuse
Healthfuse works with 150+ hospitals and health systems to provide revenue cycle vendor management services that reduce cost and increase the collection performance of revenue cycle vendors. Its automated auditing solution for all hospital account collection provides clients with a 24/7 approach to improving the efficiency of all vendor functions and processes by eliminating variability. Healthfuse guides hospitals and health systems as they create a viable, sustainable revenue cycle vendor management office that increases outputs and saves money. Find us here: https://healthfuse.com Follow us here: LinkedIn, Twitter



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Members of Clever Care Health Plan to Have Access to Providence's Extensive Network of Quality Hospitals and Specialists

WESTMINSTER, CALIF. (PRWEB) OCTOBER 29, 2020
Clever Care Health Plan Inc., announced today its partnership with Providence Southern California, one of the largest health systems in California. This unique partnership combines Clever Care's focus on the healing methodologies of Eastern Medicine with the innovative practices of Western Medicine delivered by Providence's extensive network of doctors, specialists, and hospitals.
"Clever Care is proud to partner with Providence, a prominent and patient-trusted health care system that has been providing comprehensive medical care in California for decades," said Peter Winston, Vice President of Community and Provider Development at Clever Health Plan. "The partnership with Providence Southern California will raise the bar in quality of care by providing our patient population with better access and compassionate health care choices."
Clever Care will begin serving thousands of Medicare Advantage members in Los Angeles, Orange, and San Diego Counties with access to over 15,000 provider facilities and more than 50 leading Southern California hospitals.
"Providence is committed to healing mind, body and spirit and is honored to partner with Clever Care, which offers a broad range of evidence-based integrative treatment programs," Brad Byars, Executive Director, Strategy and Business Development, Providence Southern California, "Our partnership will further enhance our high-performing network of care that puts patients first and honors their cultures and traditions under the philosophy of whole person care."
Clever Care offers a unique combination of Eastern and Western medicine to promote wellness and preventive care to the Medicare Advantage population. Offerings like unlimited acupuncture and coverage of herbal supplements are just a few of the unique benefits available to Clever Care members. In addition, Clever Care provides in-house language support services to improve member access to the care they need.
"To support our members during the current pandemic, Clever Care is also launching "COVID Peace of Mind" benefits, which will provide members with $0 out-of-pocket costs for any COVID-related services, including hospitalizations and transportation costs," added Winston.
About Clever Care Health Plan
Clever Care Health Plan, Inc. is a private company based in Southern California that offers affordable and innovative enhanced benefits with a holistic approach to care. Formed to connect the benefits of Eastern and Western medicine through an extensive network of PCPs and specialists, Clever Care Health Plan offers a differentiated health care solution. Detailed information can be found at http://www.clevercarehealthplan.com.
About Providence Southern California.
Providence Southern California is a not-for-profit Catholic health network of 13 hospitals, approximately 90 clinics, TrinityCare Hospice and its TrinityKids Care pediatric hospice, Providence High School, home health care services, eight wellness centers and numerous physician groups. Together these ministries, including secular affiliates and some representing other faiths, generate $7.5 billion in net revenue and have approximately 35,000 employees – called caregivers – and nearly 5,200 physicians on staff. Providence Southern California is part of Providence, a health system of 111,000 caregivers serving in 51 hospitals, 829 clinics and a comprehensive range of services across Alaska, California, Montana, New Mexico, Oregon, Texas and Washington. PSJH strives to increase access to health care and bring quality, compassionate care to those we serve, with a focus on those most in need.
Clever Care of Golden State, Inc. is an HMO plan with a Medicare contract. Enrollment depends on contract renewal.
Other Physicians/Providers are available in our network.
H7607_21_CM0249A_EN_M Accepted 10272020



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Effective October 1, 2020, travel assistance services for FMCA RV Club's FMCAssist program are being provided by GMMI Inc., part of the Europ Assistance Group, and insurance for the FMCAssist program is underwritten by Chubb.

CINCINNATI (PRWEB) OCTOBER 29, 2020
Cincinnati, Ohio-based FMCA RV Club, the world's largest nonprofit association for RV owners, has a new provider for its popular FMCAssist Medical Emergency and Travel Assistance benefit. Effective October 1, 2020, travel assistance services are being provided by GMMI, Inc., part of the Europ Assistance Group, and insurance for the FMCAssist program is underwritten by Chubb, the world's largest publicly traded property and casualty insurance company.
"Our FMCAssist program has saved lives," said FMCA national president Jon Walker. "It has helped people get the care they need, when they need it, while away from the comforts of home."
FMCAssist Medical Emergency and Travel Assistance is included with each FMCA membership, with no additional fees or special enrollment required. Services include medical evacuation and repatriation; return home; return of dependent children; RV return (limited to North America); return of private passenger automobile (limited to North America); pet return; accidental death and dismemberment; and more. FMCA members are eligible for these services anytime they are 75 miles or more from their primary permanent residence, and full-time RVers are always considered more than 75 miles from home.
"These types of plans can cost hundreds of dollars in many cases, sometimes more. To have this benefit included with membership is what sets us apart from other RV clubs. I truly believe no other RV club can match what we offer," said Chris Smith, FMCA CEO.
For more information about everything FMCA has to offer, visit FMCA.com.
ABOUT FMCA: ENHANCING THE RV LIFESTYLE
FMCA is the world's largest nonprofit association for recreation vehicle (RV) owners. The organization maintains its national headquarters in Cincinnati, Ohio, and currently has nearly 150,000 active members. FMCA offers its members a number of benefits, including a subscription to its monthly magazine, Family RVing; a medical emergency and travel assistance program valued at $200-plus per family; a tire purchasing program; group rates on a roadside assistance program, RV and auto insurance, and RV tours and caravans; and discounts on mobile internet access plans from Verizon and Sprint. Perhaps the most important benefit of FMCA membership is the camaraderie and friendships that develop among people enjoying the common interest of RV travel. For more information, visit FMCA.com or call (513) 474-3622 or (800) 543-3622.
Insurance described herein offered by Family Motor Coach Association (FMCA). Insurance underwritten and provided by Federal Insurance Company and its U.S. based Chubb underwriting company affiliates or network partners. Chubb is the marketing name used to refer to subsidiaries of Chubb Limited providing insurance and related services. For a list of these subsidiaries, please visit our website at http://www.chubb.com. All products may not be available in all states. This communication contains product summaries only. Coverage is subject to the language of the policies as actually issued. Chubb, 202 Hall's Mill Road, Whitehouse Station, NJ 08889-1600.
Travel Assistance Services are provided by GMMI Inc., part of the Europ Assistance Group. ("GMMI"). Chubb does not have any ownership interest in GMMI Inc., part of the Europ Assistance Group. In all cases, the medical professionals, medical facilities or legal counsel suggested by GMMI, Inc., part of the Europ Assistance Group to provide direct services to the eligible person pursuant to the agreement and to this program are not employees or agents of GMMI Inc., part of the Europ Assistance Group or Chubb, and the final selection of any such medical professional, medical facility, or legal counsel is the member's choice alone. Neither GMMI Inc., part of the Europ Assistance Group nor Chubb assumes any responsibility for the quality or content of any such medical or legal advice or services. Neither GMMI Inc., part of the Europ Assistance Group nor Chubb shall be liable for the negligence or other wrongful acts or omissions of any of the healthcare or legal professionals providing direct services arising out of or pursuant to the agreement and to this program. The member shall not have any recourse against GMMI Inc., part of the Europ Assistance Group or Chubb by reason of its suggestion of or contract with any medical professional or attorney.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it eliminate tumor cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are paired with a therapeutic component, according to a study published in Cell in October.

NEW YORK (PRWEB) OCTOBER 29, 2020
A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it eliminate tumor cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are paired with a therapeutic component, according to a study published in Cell in October.
This nanobiologic immunotherapy targets the bone marrow, where part of the immune system is formed, and activates a process called trained immunity. This process reprograms bone marrow progenitor cells to produce "trained" innate immune cells that halt the growth of cancer, which is normally able to protect itself from the immune system with the help of other types of cells, called immunosuppressive cells.
This work for the first time demonstrates that trained immunity can be successfully and safely induced for the treatment of cancer. The research was performed in animal models, including a mouse model with melanoma, and the researchers said it is being developed for clinical testing.
Immunotherapies that are already part of standard cancer care, such as the drug that eliminated former President Jimmy Carter's metastatic melanoma, are also able to unmask cancer to the immune system, but they have limitations. The type of immunotherapy used for former President Carter, called a checkpoint inhibitor, fully benefits only a small number of patients and can have severe side effects.
Findings from this research demonstrate that the nanobiologic immunotherapy's trained immunity approach could be used as a stand-alone anti-cancer therapy, potentially with fewer adverse reactions, or in conjunction with checkpoint inhibitor drugs, the scientists say.
"Not only have we observed very strong anti-cancer effects of our nanobiologic immunotherapy," said lead author Willem J. Mulder, PhD, Professor of Diagnostic, Molecular and Interventional Radiology and member of the Biomedical Engineering and Imaging Institute at the Icahn School of Medicine at Mount Sinai. "The work involves the development and preclinical evaluation of a novel immunotherapy based on highly biocompatible nanomaterials called nanobiologics. Our study is a significant advancement for both trained immunity and cancer treatment, with real potential to move quickly into use in patients."
This research was part of a large collaboration between the Icahn School of Medicine and multiple other institutes and universities in the United States and Europe.
"This study is a game changer in the field of immunotherapy," said Zahi A. Fayad, PhD, Director of the Biomedical Engineering and Imaging Institute, and another author on the paper. "We are continuing the exploration of the technology at Mount Sinai and with our international collaborators."
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Opal Apples Kicks Off Season with Launch of Crave the Crunch Campaign

YAKIMA, WASH. (PRWEB) OCTOBER 29, 2020
Opal Apples, the only naturally non-browning, non-GMO apples grown in the U.S., today announced the launch of its Crave the Crunch campaign to officially kick off Opal season. The nationwide campaign, which rolls out this month, will seek to highlight Opal's distinctively crisp and 'crunchy' texture which fans of Opal have come to know and love.
As part of the new Crave the Crunch campaign, Opal Apples will continue its partnership with Registered Dietitian Cynthia Sass, to raise brand awareness through recipes, eating tips, social media messaging and as the company's official spokesperson. Under the partnership Sass created the Healthy to the Core Cookbook, which feature Opals in delicious fall-inspired sweet and savory recipes, just in time for the holiday season.
"Crave the Crunch highlights the distinct crunch that kids, families and apple lovers nationwide love most about Opals," said Joe Vargas, Marketing Director of FirstFruits Marketing. "In a time where consumers are increasingly craving easy, healthy snacks, we are thrilled to continue our partnership with Cynthia Sass to educate our consumers on the health benefits of Opals."
The Crave the Crunch campaign will feature new branded packaging, social media messaging, a public relations campaign, newsletters and in-store marketing.
Opals are beautifully bright yellow with a distinctively crunchy texture, floral aroma and a sweet and tangy flavor. Whether it's pre-cut slices for breakfast, an afternoon pick-me-up or incorporated into a variety of recipes, Opals are the perfect on-the-go snack.
Available from November through June, Opal Apples can be purchased at a variety of retailers across the nation including Kroger, Wal-Mart and Whole Foods, among others. For a store locator, click here.
To celebrate the season, try the Lemon Basil Hummus with Sliced Opal Apple recipe by Cynthia Sass:
Ingredients:

½ cup chickpeas

2 Tbsp. tahini

1 tsp. minced garlic

2 Tbsp. fresh squeezed lemon juice

¼ tsp. fresh organic lemon zest

¼ tsp. sea salt

3-4 fresh basil leaves, divided

2 Tbsp. water

1 Opal apple, sliced

Directions:
In a mini food processor puree chickpeas with tahini, garlic, lemon juice, zest, sea salt, 3-4 fresh basil leaves, and 2 Tbsp. water until smooth Serve with apple slices.
For more information and a complete list of retailers, visit opalapples.com.
About Opal Apples:
Opal apple is the crispy, sweet, naturally non-browning and Non-GMO apple. Grown only in Washington, this Golden Delicious-Topaz cross apple variety was introduced by FirstFruits Marketing in 2010 to wide consumer and media acclaim. Its distinctive color, flavor and texture are not the only qualities that make this product unique: Opal apple was created to make a difference in communities across the nation. Every year, FirstFruits Marketing donates a percentage of sales of every case of apples to worthy organizations that address issues like hunger, food safety, sustainability and the environment. UEB 32642 variety apples are grown exclusively in Washington and distributed under the OPAL brand name by FirstFruits Marketing in North America. Visit Opal Apples at http://www.opalapples.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Effort Impacts Over 250,000 Individuals with Physical Disabilities, Encouraging Health and Fitness

ROCKVILLE, MD. (PRWEB) OCTOBER 29, 2020
As an adaptive sports organization, Move United knows all about adapting, so the organization was quickly able to pivot its programs and activities online when the Coronavirus pandemic hit the nation back in March 2020. In the last six months, the national nonprofit organization has offered over 1,000 virtual programs to individuals with physical disabilities to encourage health and fitness.
Move United, the national leader in community adaptive sports, focuses on providing opportunities for individuals with disabilities to develop independence, confidence, and fitness through participation in community sports, recreation, and educational programs. Through its activities and its network of nearly 200 member organizations across the country, these past several months would normally be filled with clinics, practices, competitions, regional games, and other adaptive sports programming. But COVID-19 altered many of those activities.
According the American Psychological Association, emerging research on COVID-19 shows that the coronavirus pandemic has increased psychological distress particularly among people with disabilities. The pandemic not only impacted access to local sports, fitness, and wellness programs in communities across the country, but the physical distancing guidelines also led to higher levels of social isolation. "This isn't the time for people to be sidelined," said Move United Executive Director Glenn Merry. "Particularly during trying times like these, we know how important it is to maintain physical and mental health. These reasons immediately drove our attention to host sports, fitness, and wellness activities across digital platforms with our #AdaptAtHome program."
The 1,000+ live and on-demand sessions hosted by Move United, its member network, and partners had over 250,000 engagements since April 1. Participants hailed from all 50 states, the District of Columbia, and Puerto Rico. By offering programming virtually, the organization was able to reach beyond its existing network. "We know not everyone has access to an adaptive sports program in their community," Merry said. "By offering virtual programs, we are changing what people experience as barriers to access."
As another way to support individuals who may not have access to fitness equipment, Move United created an #AdaptAtHome Fitness Kit, which includes a ball, exercise band, cordless jump rope, and other resources so individuals can exercise wherever they are. By December, over 1,500+ fitness kits will be distributed free of charge. Live programs and recorded fitness sessions also showcase how each item can be utilized.
Participants in the virtual programs included adaptive athletes, disabled veterans, youth and adults with disabilities, adaptive sports coaches, program volunteers and staff, health providers, and others. 90% of participants agreed that the programming helps increase the overall level of physical fitness and 97% agree participating in virtual adaptive sports improves their mood and mental health. "We know the power of sports. Sports make us stronger physically, mentally, and emotionally," said Merry.
60 different organizations have been part of the #AdaptAtHome initiative, providing online programming in 45 different sports. The top offerings have included strength and conditioning, yoga, cycling, dance, and fitness. The virtual programs are offered free of charge to all participants. Move United has curated a resource library through the #AdaptAtHome page on its website. To learn more, visit moveunitedsport.org/adaptathome.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Collaboration to Leverage Kaden's Advanced Digital Behavioral Treatment Platform and Virtual Program to Reduce Barriers and Improve Patient Accessibility and Outcomes

NEW YORK (PRWEB) OCTOBER 29, 2020
Kaden Health, Inc. (Kaden) announced today that Magellan Health, Inc. (NASDAQ: MGLN) has made a strategic minority equity investment in the New York-based digital behavioral health company. Through the collaboration, Kaden's proprietary behavioral telehealth program and platform will be provided to Magellan's customers, members and patients as well as providers.
Kaden's advanced technologies position the company as a prime enabler for Magellan in providing behavioral health services at scale and virtually – a key consideration given the COVID-19 epidemic which has only accelerated the need to increase access to effective, evidence-based mental health services. Kaden's platform – initially applied for the treatment of patients with opioid use disorder and currently available in New Jersey, New York and New Hampshire – brings important capabilities to Magellan that will enhance interactions with members, including collaborative care.
"We are pleased and excited to collaborate with Magellan as Kaden continues to develop and implement advanced technologies and clinical programs supporting those in need of behavioral health support and treatment for substance use disorders," said Dave Henderson, co-founder and CEO of Kaden. "Both the investment and the business relationship magnify our ability to make access to treatment possible wherever people may be, and to help providers significantly enhance their practices with our purpose-built behavioral telehealth platform."
"As a leading independent payer services company, Magellan Health is driving innovation into the behavioral health market through the acceleration of digital capabilities that will enhance the patient experience across the care continuum," said Kenneth Fasola, Chief Executive Officer of Magellan Health. "A tremendous need exists to bring virtual behavioral health solutions to members, and the COVID-19 pandemic has only heightened this need. Our relationship with Kaden will allow us to integrate digital features into new models of behavioral healthcare, demonstrating our ability to offer disruptive, comprehensive and integrated complex care services and insights to our members and clients."
Kaden delivers its Virtual Medication Assisted Treatment (vMAT) program through its network of affiliated providers throughout the country. The Kaden vMAT program is a fully integrated approach to treating those suffering from opioid use disorder based on the gold standard of Medication Assisted Treatment and leveraging Kaden's advanced, proprietary virtual technology, which provides a convenient, intuitive and data-driven treatment path for patients. Kaden also makes its HIPAA-compliant behavioral telehealth platform available directly to non-affiliated providers as a stand-alone tailored solution which can be quickly and seamlessly implemented to provide material benefit when compared to the use of general videoconferencing or generic telehealth platforms.
"This investment by Magellan supports and affirms our goal to provide unfettered access to populations in need of treatment," said Aran Ron, M.D, co-founder and Head of Clinical Innovation at Kaden. "This collaboration helps further our vision to fundamentally transform how effective behavioral health treatments are delivered through the insight and transparency achieved through Kaden's artificial intelligence, emotional analytics, and real-time reporting, all of which are industry-firsts."
Kaden's coordinated approach to vMAT is centered, from the first visit with a medical professional through all succeeding virtual visits and therapy, on the Kaden Technology Platform. This leading-edge intuitive interface allows the patient, therapist, medical prescriber, and the advocate all to communicate and collaborate in ways that ultimately help the patient to reclaim a healthy, productive lifestyle.
After the first visit with a prescriber, a patient can then attend all following medical and therapy appointments using any smartphone, tablet, or PC with an internet connection from the comfort of their homes or any convenient and private location.
Match Point Partners LLC led by Brad Burkett, Managing Partner, acted as financial advisor to Kaden in this transaction.
Kaden Health is a portfolio company of Leverage Health Solutions, which has been engaged since 2018.
About Kaden:
Based in New York City, Kaden is a data-driven digital behavioral health services company dedicated to addressing strategic marketplace issues with a focus on developing advanced technologies as well as innovative service offerings and products that reduce costs, improve quality, encourage engagement and produce better outcomes. Kaden's first product tackles the opioid addiction crisis by positively influencing human behavior and making advanced technologies and proven treatments accessible to all. Kaden was founded by Dave Henderson, Aran Ron, M.D. and Steve Kessler in 2018. For more information, visit http://www.kadenhealth.com or call 888-88-KADEN.
Company Contact:
Kaden Marketing and Public Relations: Marc Warner (marcw@kadenhealth.com)



START your own Wordpress site, business or personal website, or online store at www.siteground.com

VirtuOx Introduces the World's First Way To Identify Cardiac Arrhythmias From Home Sleep Tests and Overnight Pulse Oximetry Testing

SAN FRANCISCO (PRWEB) OCTOBER 29, 2020
VirtuOx, http://virtuox.net/, a global digital health company announces today, CardioCHECK is saving lives by utilizing artificial intelligence to uncover potential cardiac arrhythmias in the patient's home when patients are ordered other medically necessary diagnostic testing.
The VirtuOx CardioCHECK program reviews more than 40,000 new patients each month who are prescribed home-based diagnostic tests like overnight pulse oximetry (POX) to diagnose hypoxemia and home sleep apnea tests (HSAT) to diagnose obstructive sleep apnea.
Under the strict guidance of medical directors, the VirtuOx case management division contacts the prescribing physician when an at-risk patient is identified by the program. The physician is informed of the risk factors and potential testing that may be medically necessary such as long-term holter, cardiac event monitoring and mobile cardiac telemetry
Kyle Miko, founder and CMO for VirtuOx says, "Research has shown arrhythmias are common with patients who have comorbid conditions like sleep apnea and hypoxemia so now offering additional cardiac testing was a natural progression for VirtuOx."
Lee A. Surkin, MD, a board certified cardiologist, sleep physician and medical director of VirtuOx's cardiac monitoring division shared internal data reviewing the first 146 consecutive mobile cardiac telemetry monitor results indicating an astonishing 57% abnormal rate that reached the threshold of recommending a cardiology consultation.
He states, "What VirtuOx is doing by extracting heart rate data from pulse oximetry studies and home sleep apnea tests has not been done before in this industry and is creating brand new screening tools to identify otherwise asymptomatic patients at risk for severe cardiac arrhythmias."
The abnormal rate seen in the first 146 studies interpreted indicates that we are on track to save many patients from significant cardiac morbidity and likely save lives in the process. This is a game changer in patient care from a cardiac standpoint."
Cardiac arrhythmias affect about 14 million people in the USA (5% of the population). Common disorders include: premature ventricular contractions, premature atrial contractions, atrial fibrillation and atrial flutter. The incidence is highly related to age and the presence of underlying heart disease; the incidence approaches 30% following open heart surgery.
Cardiac arrhythmias signs or symptoms may include shortness of breath, fainting, loss of heart function, breathing, and consciousness that leads to death within minutes unless the person receives emergency medical treatment to restart the heart. So, it's important to figure out when an arrhythmia is serious and merits medical attention.
For more information, visit http://virtuox.net/ or call 877-337-7111.
Media Contact: Kyle Miko • VirtuOx • kyle.miko@virtuox.net • 877-337-7111 ext. 329
About VirtuOx
VirtuOx, Inc. is a privately held healthcare information technology company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals diagnose and treat diseases through vertically integrated platforms, products and services.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Coming soon from iaedp's International Chapter is a two-day virtual training for eating disorders treatment professionals slated for November 13 (8:00 a.m.- 6:00 p.m. EST) and November 14 (8:30 a.m. – 2:30 p.m. EST) delivered in Spanish only by a renowned collective of experts in the field. The International Association of Eating Disorders Professionals (iaedp) is a premiere provider of educational programs and training standards for eating disorder treatment specialists and other healthcare professionals.

PEKIN, ILL. (PRWEB) OCTOBER 29, 2020
Coming soon from iaedp's International Chapter is a two-day virtual training for eating disorders treatment professionals slated for November 13 (8:00 a.m.- 6:00 p.m. EST) and November 14 (8:30 a.m. – 2:30 p.m. EST) delivered in Spanish only by a renowned collective of experts in the field. The International Association of Eating Disorders Professionals (iaedp) is a premiere provider of educational programs and training standards for eating disorder treatment specialists and other healthcare professionals.
The training is hosted by iaedp's International Chapter Chair of Mexico Dra. JulietaVélez-Belmonte, MS, PsyD, CEDS, NCC-OPCA with sponsorship from Neandi Psychological Specialities and Feelink digital Community and with support from the Ibero-American Commission on Human Rights. The theme for the training is "The Body, Land of the Image."
Early registration is already underway for the International Chapter Professional Training and lasts until Monday, November 9, 2020. The cost for the two-day training session is $130 during early registration and $145 after that. A "Friends" group rate for two colleagues registering together will be $100 each.
"As we continue to engage and expand globally, our iaedp International Chapter has set the stage for its second Professional Training in Spanish with an added bonus of being conducted virtually which provides more access and safety to busy professionals," said Blanche Williams, iaedp Director of International Development.
The following are training program presenters:
Dra. Julieta Velez, MS, PsyD, CEDS, NCC-OPCA is a psychologist from the Universidad Nacional Autonoma in Mexico, masters in Clinical Psychology and Psychotherapy, a specialist in brief psychotherapy from the Universidad Anahuac Mexico. She also is a doctor in Family Sciences by the Instituto de Enlaces Educativo with research in families. She is the Dean of the School of Psychology of the Universidad Anáhuac Puebla and a renowned international lecturer.
Dra. Juanita Gempler is a clinical psychologist at Universidad Javeriana de Bogota with a degree in Behavioral Cognitive Therapy from the University of London. She is a Fellow of the Academy for Eating Disorders and Founder and Scientific Director of Equilibrio, a program for the evaluation and management of eating disorders, mood and anxiety in Bogota.
Dra. Aridia Vasquez, MD, MS, RD is a medical doctor, registered dietitian and specialist in eating disorders and intuitive eating. She currently services as the medical director of Renovates by CPE, the first bilingual multidisciplinary treatment center for eating disorders in the Dominican Republic and serves as the iaedp International Chapter Co-Chair of the Dominican Republic.
Dra. Eva Trujillo, MD, FAED is Director and Co-Founder of Comenzar de Nuevo AC, former president of the Academy for Eating Disorders and clinical professor at the TEC Salud School of Medicine. She is also Vice President and Co-Founder of the Mexican College of Professionals in Eating Disorders.
Dra. Zuleika Morillo, MD is a child and adolescent psychiatrist from the Hospital Clinico de San Carlos, Madrid and a child and adolescent medical psychotherapist. She is a specialist in adolescent integral health from the Technological University of Sano Domingo and a specialist in Abuse, Neglect and Wellness from the Universidad de Salamanca, Spain while also serving as the iaedp International Chapter Co-Chair of the Dominican Republic.
Dra. Rosanna Mauro, MS, RD, CEDRD-S, NBC-HWC is a registered dietitian, holds a Master in Group Psychology and is a Certified Integrative Health Coach, through the University of Arizona and the Andrew Weil Center for Integrative Medicine. She is the International Chapter President along with being an iaedp Certified Eating Disorders Specialist (CEDRD-S) and Approved Supervisor.
Dr. Emmett Bishop, Jr., MD, FAED, F. iaedp, CEDS is a psychiatrist with more than 40 years of experience in the research and clinical practice of eating disorders, and the Co-Founder and former Medical Director at Eating Recovery Center in Denver, Colorado. He currently serves on the iaedp Board of Directors, past president and treasurer.
Dr. Antonio Tena, PsyD has a degree in Psychology from the Universidad Iberoamericana, Master in Clinical Psychology from the National Autonomous University of Mexico. He also has a specialty in Dynamic Psychiatry in Mexican Psychoanalytic Association and is a Doctor of Psychology from the Universidad Iberoamericana.
Dr. Rodrigo César León Hernandez, PsyD, has a doctorate in psychology from the National Autonomous University of Mexico, CONACYT professor and member of the National System of Researchers Level I. He has a master's degree in the Taking Control of Your Health program from Stanford University, as well as a master's degree in the chronic disease management program from Flinders University Australia. He is a member of iaedp and of the risk factors research group and director of Centro Alianza para trastornos de alimentación y salud (CAPTAS).
REGISTRATION: https://iaedp.site-ym.com/event/ElCuerpoTerritorioDeLaImagen
Learn more about our International Chapter:
https://membershare.iaedp.com/international-chapter/
https://membershare.iaedp.com/international-chapter/en-espanol/

"As we continue to engage and expand globally, our iaedp International Chapter has set the stage for its second Professional Training in Spanish with an added bonus of being conducted virtually," said Blanche Williams, iaedp Director of International Development.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Chicago's leading breast cancer organization makes groundbreaking investment in its mission through funding The Chicago Health Equity Initiative, Komen Chicago Treatment Assistance Program and Local Community Grant Programming

CHICAGO (PRWEB) OCTOBER 29, 2020
In recognition of October's Breast Cancer Awareness Month, Susan G. Komen Chicago is proud to announce a substantial commitment to initiating change in healthcare access for all Chicagoland women. In 2020 alone, the organization has committed $787,500 to advancing health equity for all and demolishing the racial disparities gap -- a 68 percent increase in funding year over year.
"Although we've seen the breast cancer mortality rate decline in recent years, these benefits have been disproportionate and there is still evidence of a mortality gap between black and white patients nationally, with African American women 42 percent more likely to die from the disease," said Dr. Tiosha Bailey, executive director of Komen Chicago. Also, in Chicago, African American women are 40 percent more likely to die from breast cancer than white women; for African American women aged 40 and under, the disparity increases to 157 percent.
"It is imperative to offer genetic counseling and testing to this demographic, especially here in Chicago, which is why Komen Chicago's ability to commit this funding, while in the midst of a pandemic, is monumental for our community," added Bailey.
Komen Chicago's investment into the local community will help transform direct services and healthcare systems. Of the total investment:

$400,000 is committed to Chicago Health Equity Initiative (CHEI), a cohort of Chicago-area medical leaders who support healthcare systems' transformation. In leading this cohort's formation, Komen Chicago is evolving from exclusively funding breast health services to working collaboratively with a broad spectrum of partners to implement measurable and sustainable solutions that improve care and decrease costs. This is the first funding investment of its kind for Komen Chicago and the largest community investment made in the affiliate's history.

$350,000 is funding local community grant programming that provides direct patient services for navigation, screening/diagnostic, and survivorship support programs in Komen Chicago's five-county service area, including a strategic investment in McHenry County to help target the late stage breast cancer diagnosis rate identified in this area.

$37,5000 supports the Komen Chicago Treatment Assistance Program that provides patients who are in treatment with financial and psychosocial assistance programs to help reduce barriers and increase survival rates.

Komen Chicago has convened the following partners for CHEI: three Federally Qualified Health Centers (Access Community Health Network, Erie Family Health Centers and Friend Family Health Center), six major health systems in Cook County (Cook County Health and Hospital System, University of Chicago Medicine, University of Illinois Cancer Center, Rush University Medical Center, Northwestern University Cancer Center and Sinai Health System), the Illinois Medical District, American Cancer Society and Chicago Department of Public Health. The CHEI implementation plan is currently being developed, with services scheduled to begin in 2021.
The University of Illinois (UI) Cancer Center at UI Health has been designated as the Komen Chicago Lead in the CHEI consortium. The UI Cancer Center's community-facing mission and commitment to promote health equity and eradicate cancer disparities in Chicago communities and beyond make it an ideal lead partner.
"Not only will CHEI work tirelessly to decrease health disparities across our city, but we will be firm advocates for education and access for all by raising awareness of these key initiatives to our community members and neighbors," said CHEI director, Dr. John H. Stewart from UI Cancer Center.
"We are so proud to bring together this revolutionary consortium of Chicago's top medical leaders to create actionable change within the systems of our current healthcare structure," said Dr. Suzet McKinney, president of Komen Chicago's Board of Directors and CHEI partner representing the Illinois Medical District. "We have three key goals at hand -- decrease breast mortality disparities across Chicagoland, reduce the detection-to-diagnosis interval, and increase the number of high-risk women under age 40 who receive genetic screening."
"Through CHEI, we will work to implement genetic counseling and testing in the primary care setting to increase early detection of breast cancer," said Dr. Olufunmilayo I. Olopade, Director of the Center for Clinical Cancer Genetics & Global Health and Medical Oncologist at the University of Chicago Medical Center. "The sooner we can detect signs of breast cancer, the sooner we can begin treatment and lower breast cancer mortality across the board."
Since 1997, Komen Chicago has invested over $18.5 million in local community grants and $6 million in breakthrough research. The organization has reaffirmed its continued mission of investing 100 percent of net proceeds back into local community grantmaking and research initiatives for more than two decades. In the coming months, Susan G. Komen's national headquarters is moving forward with plans to consolidate all Komen affiliates into One Komen.
"As a result of the current climate, changes must occur to maintain Komen's national commitment to preventing and curing breast cancer. Komen Chicago is working with the national team to ensure a strong local impact remains for Chicago-area women," added Bailey.
For more information on Komen Chicago, its programs and the Chicago Health Equity Initiative, please visit http://www.komenchicago.org.
About Komen Chicago
Susan G. Komen's promise is to save lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer. Komen Chicago donates 100 percent of net funds raised to community grants and global research. Komen Chicago's priorities include making sure everyone has access to quality healthcare options, fighting to ensure fewer people die from metastatic breast cancer and shining a light on the importance of early detection. For more information visit komenchicago.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

RESOLVE: The National Infertility Association is pleased to announce the 2020 Hope Award recipients. The Hope Awards, which recognize professionals, companies, volunteers, and the media who truly impact those struggling to build a family, will be presented at RESOLVE's Virtual Night of Hope Gala on November 12.

MCLEAN, VA. (PRWEB) OCTOBER 29, 2020
RESOLVE: The National Infertility Association is pleased to announce the 2020 Hope Award recipients. The Hope Awards, which recognize professionals, companies, volunteers, and the media who truly impact those struggling to build a family, will be presented at RESOLVE's Virtual Night of Hope Gala on November 12, 8:00-9:30 PM EST, http://www.resolve.org/NOH2020. As the organization that supports and provides a voice for all people challenged in their family building journey, RESOLVE established the Hope Awards to recognize professionals, companies, volunteers, and the media who truly impact those struggling to build a family. This year's theme for Night of Hope is Back to the Future as we showcase the outstanding achievements of those that impact access to care and awareness.
The 2020 Hope Award honorees are:

RESOLVE Advocacy Legacy Award – Crystal Wilson

Hope Award for Access – Cadence

Hope Award for Advocacy – Serena Chen, MD

Hope Award for Advocacy – Andy Cohen, Bravo TV

Hope Award for Advocacy – Chloe Melas, CNN

"We celebrate and appreciate our Hope Award honorees for their dedication to ensuring that all people challenged in their family building journey reach resolution through being empowered by knowledge, supported by community, united by advocacy, and inspired to act," said Barbara Collura, RESOLVE's President/CEO. "We want to remind the Night of Hope audience that even though so much of this year felt like a pause, advocating for greater access to care and opening doors to opportunities for all who struggle to build a family is still happening."
The Night of Hope brings together leaders and influencers in the family building community to "party for a purpose" and help make access to care a reality. Past Hope Award honorees include USA Today, Starbucks, Bill and Giuliana Rancic, The View, National Public Radio, Self Magazine, CNN Anchor Alisyn Camerota, The Bob Woodruff Foundation, ABC News, Target, LinkedIn, and the American Society for Reproductive Medicine.
For more information regarding the Night of Hope and the Hope Award recipients, visit http://www.resolve.org/nightofhope.
RESOLVE gratefully acknowledges the 2020 Night of Hope Sponsors: Presenting Sponsor Cooper Genomics; Hope Award Sponsors, EMD Serono, Ferring Pharmaceuticals, Merck, Progyny, and Shady Grove Fertility.
RESOLVE: The National Infertility Association is a national nonprofit patient advocacy organization. One in eight U.S. couples of childbearing-age has trouble conceiving or carrying a pregnancy to term. Founded in 1974, RESOLVE provides free support groups in more than 200 communities; is the leading patient advocacy voice; and serves as the go-to organization for anyone challenged in their family building. For more information, visit http://www.resolve.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The LumaCare Duo is the world's first handheld, wireless and rechargeable Cold Laser device to feature two emitter heads instead of one, an approach that enables users to treat injuries with three pulsating wavelengths from two directions simultaneously. Unveiled at CES 2020 in January in Las Vegas, Nevada, the LumaCare Duo is now available for purchase.

SALT LAKE CITY (PRWEB) OCTOBER 29, 2020
LumaCare today announced that it has begun shipping its first product: The LumaCare Duo.
The LumaCare Duo is a handheld, wireless, and rechargeable "Cold Laser" device that features two rotating emitter heads, one each at opposite ends of jointed arms, treatment heads that offer nearly 180 degrees of motion for delivering three different pulsing spectrums of therapeutic light to injured body parts. Each emitter head has a peak combined power output of 60 Watts from the 15 laser diodes and LEDs, specifically:

    Four Infrared laser diodes at 905nm (nanometer wavelengths),

    Six Infrared laser diodes at 808nm, and

    Five visible Red LEDs at 670nm,

for a total of 30 laser diodes/LEDs per LumaCare Duo system.
Because the patent-pending LumaCare Duo features two articulating emitter heads affixed to the ends of two movable arms, users can manipulate the device to direct therapeutic laser light at injured tissue from two directions at the same time. Additionally, having two separate and movable treatment heads also allows LumaCare Duo users to focus more Infrared and visible Red light over a wider area if needed. Users may also choose to implement only one emitter head if that is what the treatment protocol requires.
"The Cold Laser market has seen steady growth for over five decades, but very little true innovation," said Kevin Waller, COO and co-founder of LumaCare. "So we decided to shake things up and launch a powerful, lightweight, wireless Low-Level Laser Therapy system that can be deployed virtually anywhere, while also giving users the ability the option to deliver healing and pain-reducing Cold Laser light from two emitter heads simultaneously.
"When we first unveiled the LumaCare Duo this January at the CES International trade show, we met with a fair amount of healthcare professionals and consumers who knew about (or were users of) Cold Lasers while we were in Vegas. And the fact that the LumaCare Duo emitter heads could rotate to direct Red and Infrared light from two directions simultaneously at the same pain point was simply mind-blowing to them. Hence, we believe that a lot of healthcare professionals will similarly 'go crazy' once they learn about this unique approach to Low-Level Laser Therapy treatments."
BACKGROUND ON LUMACARE, COLD LASERS, AND LUMACARE DUO DETAILS
The LumaCare Duo was born inside National Laser Company, a Salt Lake City-based industrial, commercial and medical laser company for the past 33 years, a firm that has primarily worked behind the scenes as a private label and/or original equipment manufacturer (OEM) and service provider to other laser companies.
With this 30-plus years of laser industry experience as a foundation, the team at LumaCare was quite familiar with the role of Cold Lasers / LLLT as a treatment protocol for a wide variety of chronic and traumatic injuries. So its team decided to put its industry-leading laser expertise to work at crafting an entirely new paradigm in Cold Laser systems; hence, the birth of the LumaCare Duo.
The very first inkling of the potential therapeutic benefits of LLLT came in 1967 when Endre Mester discovered that treatments of Cold Laser light regrew hair on mice. Studies in the ensuing 50-plus years have shown particular benefit from three wavelength bandwidths: from 650—675nm for surface/skin-level treatments, from 800—825nm for medium depth treatments, and from 900—925nm for deeper tissue/joint treatments.
Since Dr. Mester's finding, hundreds of thousands of Cold Laser systems have been used worldwide to improve blood flow, boost oxygenation, reduce inflammation and pain, and enhance cellular recovery for traumatic and chronic injuries.
The LumaCare Duo weighs 10.75 ounces, measures 4.75- x 5.63- x 2.75-inches (height x width x depth) when folded/closed and 3.25- x 11.50- x 2.75-in. when fully open, while the emitter heads measure 2.1- x 2.7- x 0.6-in. The range of motion of the LumaCare Duo is ~85 degrees per arm and ~130 degrees per emitter head, with a total range of motion of ~180 degrees when the device is fully open.
The LumaCare Duo draws 100-240V 50/60Hz at 0.4A while charging, with an output of 18VDC at 450mA. Continuous treatment time with the LumaCare Duo is over five (5) hours per charge.
The LumaCare Duo is registered with the U.S. Food and Drug Administration as a Class 1 laser and has a suggested retail price of $2,500.00 (US). To purchase or learn more about the LumaCare Duo, please visit https://www.lumacarelasers.com/product/lumacare-duo/.
Or for more information about LumaCare, please call 385-549-1104 or email info@LumaCareLasers.com.
Relevant Hashtags: #LumaCare, #LumaCareDuo, #medtech, #healthtech, #ColdLasers, #LLLT, #CoolLaser, #laser, #lasertech, #healthcare, #medical, #medicine, #treatment #LowLevelLaserTherapy
LumaCare, LumaCare Duo and the LumaCare and LumaCare Duo logos are trademarks of National Laser Company. Any other trademarks are property of their respective owners.
# # #
CONTACT:
David Politis, LumaCare's VP of Marketing & Sales, 385-549-1104 (work), 801-556-8184 (cell), dpolitis@LumaCareLasers.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Keypoint Intelligence, the world's leading independent evaluator of document imaging hardware, software, and services, today announced the recipients of its Buyers Lab (BLI) PaceSetter awards in Healthcare.

FAIRFIELD, N.J. (PRWEB) OCTOBER 29, 2020
Keypoint Intelligence, the world's leading independent evaluator of document imaging hardware, software, and services, today announced the recipients of its Buyers Lab (BLI) PaceSetter awards in Healthcare. Based on research conducted in the North American market, these accolades recognize document imaging OEMs that have proven that they offer the hardware and software portfolios, professional services, support, and thought leadership to best serve healthcare customers.
The winners for 2021–2022 are:
CANON U.S.A., INC.
BLI PaceSetter 2021–2022 in Healthcare: Visionary Leader
HP INC.
BLI PaceSetter 2021–2022 in Healthcare: Visionary Leader
KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC.
BLI PaceSetter 2021–2022 in Healthcare: Visionary Leader
"There is nothing like a global health emergency to drive home the importance of the healthcare sector," said Jamie Bsales, Keypoint Intelligence's Director of Smart Workplace & Security Analysis. "The leading manufacturers of office document technology have stepped up their role in supporting their healthcare customers with time- and money-saving solutions for better workflows. The visionary vendors have expanded beyond the document imaging space to also deliver innovative medical technology to advance healthcare research and improve patient outcomes."
To determine which companies lead the market, Keypoint Intelligence conducted an in-depth evaluation of the healthcare-related offerings of most of the major document imaging OEMs. The granular study drilled into over 50 points of differentiation spread across key categories: market vision and leadership, MFP/printer hardware and security, software, service/support, professional services, and relevant product offerings beyond document imaging. The analysis included a proprietary scoring rubric to codify a vendor's strengths, and those that receive top scores are named as PaceSetters for the industry.
Canon shined in the areas of print technology and solutions, bolstered by its expansive ecosystem of offerings that work together to enable healthcare workers to be productive and focus on patient care. Canon's service capabilities are also a strong suit. "From compact-yet-feature-rich imageCLASS MFPs and printers to reliable imageFORMULA scanners to robust imageRUNNER ADVANCE MFPs, all enhanced with top-notch solutions and service, Canon has the full range of document imaging technology any healthcare provider could require," said Bsales. "And Canon pushes beyond document imaging with technology for patient diagnosis and treatment such as digital radiography solutions, ultrasound products, retinal cameras, and genotyping technology."
In addition to award-winning security, HP's MFP and printer technology incorporates other on-trend capabilities in healthcare. For instance, the HP Workpath Platform supports the development of healthcare-specific workflow tools, while a new Healthcare Edition MFP responds to cleanliness requirements, featuring keyboards, control panels and covers that can be disinfected. The HP Healthcare Advisory Council allows the company to gain insights into what clinicians need to attain that goal. "The focus for HP's healthcare business has been on helping the company's customers improve patient outcomes through innovative technologies," Bsales noted. "The company's expansion into new areas, like microfluidics, gives promise for treating and eradicating disease."
"Konica Minolta goes well beyond document imaging devices and software to provide in-demand solutions for hospitals and group practices across the country," said Bsales. "Its All Covered IT services division aids with HIPAA/HITECH compliance, electronic health records systems implementation and support, healthcare application development, and more, while its Return to Work program is designed to help curb the spread of COVID-19 as employees get back to the office." The unique Return to Work offering combines a range of the company's technologies that together provide a comprehensive step-by-step program to help customers re-open offices safely. The company's IT services for healthcare include HIPAA-compliant cloud services, setup and management of telehealth solutions, and security penetration testing for medical equipment.
ABOUT KEYPOINT INTELLIGENCE
For almost 60 years, clients in the digital imaging industry have relied on Keypoint Intelligence for independent hands-on testing, lab data, and extensive market research to drive their product and sales success. Keypoint Intelligence has been recognized as the industry's most trusted resource for unbiased information, analysis, and awards due to decades of analyst experience. Customers have harnessed this mission-critical knowledge for strategic decision-making, daily sales enablement, and operational excellence—improving business goals and increasing bottom lines. With a central focus on clients, Keypoint Intelligence continues to evolve as the industry changes by expanding offerings and updating methods, while intimately understanding and serving manufacturers', channels', and their customers' transformation in the digital printing and imaging sector.
ABOUT BUYERS LAB PACESETTER AWARDS
Based on exhaustive questionnaires, in-depth interviews, and a proprietary rating scale, Buyers Lab PaceSetter awards recognize document imaging OEMs that have shown market leadership in a variety of categories, including with technologies, services, and key vertical markets.
SOCIAL MEDIA
Connect with Keypoint Intelligence on LinkedIn
Follow Keypoint Intelligence on Twitter
CONTACT
Deanna Flanick
+1 973-797-2100
deanna.flanick@keypointintelligence.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published, October 29, in Radiology: Cardiothoracic Imaging. The findings come three years after the European Union enacted new regulations on the contrast agents.

OAK BROOK, ILL. (PRWEB) OCTOBER 29, 2020
Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in Radiology: Cardiothoracic Imaging. The findings come three years after the European Union enacted new regulations on the contrast agents.
Cardiac MRI is a well-established tool for heart imaging. The majority of cardiac MRI exams use intravenous gadolinium-based contrast agents (GBCAs) to improve visualization of the heart muscle and blood flow. Contrast-enhanced MRI is often used to assess scars to the heart tissue and detect cardiac ischemia, a condition of reduced blood flow to the heart resulting from blockage of the coronary arteries. Contrast-enhanced cardiac MRI is also frequently used to evaluate diseases like cardiomyopathy and myocarditis.
GBCAs rely on an ion of the heavy metal gadolinium to work. Since the ion is toxic to humans, it is bound in a molecule called a ligand to make it safe. GBCAs are classified as either linear or macrocyclic based on the type of ligand used. Linear GBCAs have elongated ligands while macrocyclic GBCAs have a cage-shaped ligand that traps the gadolinium ion inside.
Studies have shown that trace amounts of the toxic gadolinium ions may remain in the body following repeated GBCA administration. Linear GBCAs are thought to have a higher likelihood of deposit compared to macrocyclic GBCAs, as the macrocyclic GBCAs offer better containment of the gadolinium ion and are considered more stable.
"Studies have demonstrated that the likelihood and extent of cerebral gadolinium depositions are increased after administration of linear GBCAs compared to macrocyclic GBCAs, although the clinical relevance of these depositions still needs to be determined," said the study's lead author, Johannes Uhlig, M.D., M.P.H., from University Medical Center in Goettingen, Germany.
As a preventive measure, in late 2017 the European Medicines Agency (EMA) suspended the marketing authorization of linear GBCA types except in liver imaging.
For the new study, Dr. Uhlig and colleagues tapped into the multinational, multicenter European Society of Cardiovascular Radiology MRCT Registry to assess the impact of the EMA's regulatory decision. The study group included 154,779 patients who underwent cardiac MRI, with almost 95% receiving GBCA. While linear GBCAs were used in 15.2% of examinations before and in 2017, their use decreased to less than 1% in 2018 and 2019.
They also tracked GBCA-associated acute adverse events and classified them as mild, moderate or severe. Mild events included allergic reactions such as hives and wheezing, while reactions like chest pain and arrythmia were classified as moderate or severe. Overall, there were 556 acute adverse effects in 145,855 contrast-enhanced MRIs, or 0.38%, with only 47 being classified as severe.
"Using a large-scale patient cohort from several European countries, our study demonstrates that the administration of GBCA for cardiac MRI is safe for the overwhelming majority of patients," Dr. Uhlig said. "In particular, macrocyclic GBCAs exhibit a favorable acute safety profile, and should be considered for cardiac MRI examinations evaluating myocardial scarring, ischemia, cardiomyopathy and myocarditis."
Adverse events occurred even without GBCA administration. Out of the 8,924 cases in the study group that did not involve GBCAs, 231 examination-related events were reported, or 2.59%, the majority being anxiety and shortness of breath.
The results underscore the importance of pre-procedural assessment to look for contraindications to MRI scanning and GBCA administration, as well as the likelihood of GBCA-associated adverse events, Dr. Uhlig said.
"Potentially vulnerable populations include those with orthostatic shortness of breath, prior adverse GBCA reactions and terminal renal insufficiency," he said.
Policies on linear GBCAs vary internationally. No regulatory restrictions have been issued in the United States, although the U.S. Food and Drug Administration recommends that physicians consider gadolinium retention characteristics when choosing GBCAs. Because of their unique properties, linear GBCAs are still considered vital for liver imaging.
"Although there are efforts to advance non-contrast hepatic imaging, linear GBCAs will probably be indispensable for specific patient populations in the near future," Dr. Uhlig said.
The study authors credited the MRCT Registry for helping make their research possible.
"These analyses highlight the importance of establishing and maintaining large-scale prospective data registries, specifically in the field of radiology," said the study's senior author Matthias Gutberlet, M.D., one of the MRCT Registry co-founders.
###
"Gadolinium-based Contrast Agents for Cardiac MRI: Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154,779 European Patients." Collaborating with Drs. Uhlig and Gutberlet were Omar Al-Bourini, M.D., Rodrigo Salgado, M.D., Marco Francone, M.D., Ph.D., Rozemarijn Vliegenthart, M.D., Ph.D., Jens Bremerich, M.D., and Joachim Lotz, M.D.
Radiology: Cardiothoracic Imaging is edited by Suhny Abbara, M.D., University of Texas Southwestern Medical Center, Dallas, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/cardiothoracic-imaging)
RSNA is an association of radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)
For patient-friendly information on contrast materials, visit RadiologyInfo.org.

Using a large-scale patient cohort from several European countries, our study demonstrates that the administration of GBCA for cardiac MRI is safe for the overwhelming majority of patients.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Slumber Bliss anti-microbial seat covers are proudly made in the USA and accepted by all airlines and travel providers around the world. These universal seat covers are launching to high demand as one of the newest traveling necessities preferred by safe and savvy travelers. Slumber Bliss was founded by two African-American sisters, Nichale Denby and Nichole Denby-Jackson.

AUSTIN, TEXAS (PRWEB) OCTOBER 29, 2020
One never knows what kind of germs, viruses and bacteria are lurking on seat surfaces of buses, trains and airplanes, especially during this time of COVID-19. The easy safe solution? Patent Pending Slumber Bliss re-usable antimicrobial seat covers! They are the simplest way to protect yourself and your family during travel from germs, bacteria, allergens, and pathogens that may be on contaminated seats that can cause illnesses or bacterial infections. Proudly made in the USA and accepted by all airlines and travel providers around the world, these universal seat covers are launching to high demand as one of the newest traveling necessities preferred by safe and savvy travelers.
Founded by Nichale Denby and Nichole Denby-Jackson, the dynamic sisters found a way to help travelers in the midst of one of the most uncertain and challenging times that the human race has ever faced. During the early days of the pandemic, the sisters were informed that a family friend tested positive for COVID-19. With the fear of possibly contacting the deadly virus from sitting and touching unsanitary seats while flying, the sisters came up with a superb idea to create reusable antimicrobial airplane seat covers. Nichale and Nichole had a seamstress develop a few samples out of soft, high quality antimicrobial fabric to sell to their close friends and family members.
One of the main goals of launching a company around their popular seat covers was to gather funds to make an impact by giving back to essential workers. The sisters used some of the seat cover sales proceeds to deliver food and much needed medical supplies, including PPE, to local hospitals in Los Angeles and surrounding areas. The duo also made errands and grocery store runs for individuals at high risk for COVID-19 in hopes to mitigate their risk of becoming infected. After receiving so many compliments and praise from fellow airline passengers, friends, and family on their safety seat covers' design, they decided to take it to the next level and mass produce the seat covers for the general public across the globe.
Moving forward, the Denby Sisters will continue their philanthropic efforts and donate a portion of all proceeds to a charitable organization selected by the public through submissions to their website each quarter.
All Patent Pending Slumber Bliss seat covers come with a clear waterproof seat cover tote. The Slumber Bliss product line also includes disposable seat covers, sanitary travel kit, plush blanket attachment, and copper infused compression socks. All seat covers can also be used on most buses, trains, automobiles, and movie theater seats.
Nichale Denby, MBA, is a HBCU graduate that is balancing her respectable career as both a tech executive and entrepreneur. Currently flourishing in a successful career in tech and entrepreneurship like her sister, Nichole Denby-Jackson was also a world class athlete – she ran the 100-meter hurdles for the USA team in the 2007 World Championships, and was an USA Olympic Team alternate in 2008. To date, there have been some high-flying sports figures who were early adopters and are now ambassadors of Slumber Bliss seat covers. These include Bradie James, former NFL Linebacker for the Dallas Cowboys, Darren Sproles, former Pro Bowl and Super Bowl Champion Running Back for the Philadelphia Eagles, and Sanya Richards-Ross, an Olympic Gold Medalist and American Record Holder in the 400 meters.
Sproles notes, "Since retiring from playing in the NFL I took on a Scout Consultant role with the Philadelphia Eagles and with all the traveling I do my Slumber Bliss seat cover has been one of my favorite traveling necessities. I never leave home without it!"



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Medisend College, through the General Richard B Myers Veterans Program, has been training US military veterans for careers as professional biomedical technicians since 2013.

DALLAS (PRWEB) OCTOBER 29, 2020
Siemens Healthineers has donated new X-ray, ultrasound and clinical laboratory equipment, valued at more than $1,000,000, to Medisend College of Biomedical Engineering Technology to help advance the education and training of US military veterans in the General Richard B Myers Veterans Program. The equipment donated by Siemens Healthineers will be housed in the new Touchstone Imaging Laboratories at Medisend College where students will benefit from the latest imaging technologies.
"Siemens Healthineers enables healthcare providers by empowering them on their journey towards expanding precision medicine. We are proud to partner with General Myers and Medisend College to help train our veterans for professional careers in the healthcare industry as they endeavor to return to civilian life," said Ron Pellegrini, VP of Siemens Healthineers.
Medisend College has been training veterans and successfully placing them in positions with major healthcare organizations since 2013. The Siemens Healthineers' relationship with Medisend has played a major role in the college becoming a leading provider of biomedical engineering technology training in the US, playing key advisory roles, offering professional workshops, hiring graduates and donating essential training equipment.
"This new equipment donated by our friends at Siemens Healthineers will be instrumental in providing students with the opportunity to train on the latest imaging technology available. We are grateful to Ron and his team for their consistent support of our mission to provide good jobs and secure financial futures for our veterans," said General Richard B. Myers, 15th Chairman of the Joint Chiefs of Staff, current president of Kansas State University, and Chairman of the Board of Trustees of Medisend College.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Investigating Feasibility of Membrane Delivery

DURHAM, N.C. (PRWEB) OCTOBER 29, 2020
Tergus Pharma and Phenom Pharmaceuticals announced today that they have entered into an agreement for Tergus to develop a unique delivery solution to help prevent infection by the SARS-CoV-2 virus.
Phenom Pharmaceuticals will use a proprietary delivery pathway and unique molecule to prevent viral infection. The SARS-CoV-2 virus causes COVID-19, the source of a current global pandemic that has severely impacted the health of millions of people.
"Tergus is thrilled to work together with Phenom on such an impactful project," said Dr. Vijendra Nalamothu, Ph.D., Chairman and CEO of Tergus Pharma. "This has the potential to have a huge impact on global health and wellness in the future."
Dr. Michelle L. Rivera, MD, founder and CEO of Phenom Pharmaceuticals, said, "Tergus' reputation as a global leader in topical pharmaceutical R&D and manufacturing is a perfect fit for our ground-breaking concept to help prevent the spread of COVID-19."
Once Tergus has completed the initial phases of formulation development, Phenom will begin securing additional funding for further testing and development.
About Tergus Pharma
Tergus Pharma is an end-to-end service provider for topical pharmaceutical research, drug development, testing, and manufacturing, and has been an industry leader for several years with a state-of-the-art facility in Durham, North Carolina. The company has a long and stellar reputation for delivering quality results to clients, from formulation through clinical supplies manufacturing, earning the company the tagline, "Think Topicals, Think Tergus." Tergus will be expanding its capabilities for topical pharmaceutical R&D and manufacturing as it moves to a brand-new, 100,000 sq. ft. facility in Q1, 2021. Tergus scientifically helps its clients achieve the right balance between speed and quality. For more information, please visit https://www.terguspharma.com/
About Phenom Pharmaceuticals
Phenom Pharmaceuticals is an innovative, privately held pharmaceutical company focused on delivering scientifically elegant and revolutionary solutions to worldwide health issues. Our focus is creating highly effective, safe, and timely modern drugs that will significantly protect and improve human health. Phenom's board has over 50 years of combined experience in clinical medicine and research at leading institutions, including Harvard Medical School, Merck, Lever Brothers, Duke University Medical Center, Columbia University, and the University of North Carolina at Chapel Hill.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NDA Partners Chairman Carl Peck, MD, announced today that Julie Ballard, a Clinical Laboratory Scientist, has joined the firm as an Expert Consultant. Ms. Ballard's expertise includes building new clinical laboratories and quality systems, regulatory compliance, laboratory operations and management, CAP and CLIA accreditation, and state regulations. Most recently, she was Senior Director of Clinical Laboratory Quality at Seer, Inc.

ROCHELLE, VA. (PRWEB) OCTOBER 29, 2020
NDA Partners Chairman Carl Peck, MD, announced today that Julie Ballard, a Clinical Laboratory Scientist, has joined the firm as an Expert Consultant. Ms. Ballard's expertise includes building new clinical laboratories and quality systems, regulatory compliance, laboratory operations and management, CAP and CLIA accreditation, and state regulations through the Laboratory Field Services (LFS) program in California and the Clinical Laboratory Evaluation Program (CLEP) in New York.
In addition, Ms. Ballard has experience launching novel high-complexity laboratory-developed tests including liquid biopsy-based next-generation sequencing and tissue-based gene expression profiling oncology tests, and phenotypic/genotypic HIV drug-resistance testing. Throughout her 25-year career, she has provided leadership and operational expertise to biotechnology start-up companies, including her recent position as Senior Director of Clinical Laboratory Quality at Seer, Inc. She also served in Clinical Laboratory and Quality Director positions at GRAIL, Guardant Health, TOMA Biosciences, and Genomic Health.
"Ms. Ballard's expertise in building new clinical laboratories and quality systems, in addition to her knowledge of CAP and CLIA accreditation and state regulations, makes her a valuable resource to our clients developing laboratory-developed tests and establishing CLIA-certified laboratories," said Dr. David Feigal, Manager of NDA Partners' medical device practice.
Ms. Ballard earned her bachelor's degree in clinical science from San Francisco State University. She is a California-licensed Clinical Laboratory Scientist and is certified by the American Society of Clinical Pathologists (ASCP) as a Medical Technologist.
About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle@ndapartners.com




START your own Wordpress site, business or personal website, or online store at www.siteground.com

GOLO, a weight loss and wellness solution company, announced a $10,000 contribution to the Boys & Girls Clubs of Broward County, FL, supporting the "Rick Case Scholarship Fund," continuing its commitment to supporting charitable organizations that promote a diverse and inclusive society that is free from racism, bias, and injustice.

NEWARK, DEL. (PRWEB) OCTOBER 29, 2020
GOLO, a weight loss and wellness solution company, announced a $10,000 contribution to the Boys & Girls Clubs of Broward County, FL, supporting the "Rick Case Scholarship Fund," continuing its commitment to supporting charitable organizations that promote a diverse and inclusive society that is free from racism, bias, and injustice. The company has committed to donating $100,000 over the next 12 months to charitable organizations throughout the U.S. Additionally, GOLO donated twelve (12) AeroTrainer core exercise platforms to each of the Boys & Girls Clubs in Broward County.
"We're delighted to support the Rick Case Scholarship Fund for the Boys and Girls Clubs of Broward County and their excellent mentorship of young people to lead healthy, successful lives," says Jennifer Brooks, President, GOLO. "Rick and Rita Case meant so much to South Florida and particularly this organization."
GOLO is a company dedicated to healthy living with innovative products to support weight-loss, immunity, and a healthy lifestyle.
"At the Boys & Girls Clubs of Broward County, our vision is to provide a world-class club experience that assures that success is within reach for every young person who walks through our doors," says Chris Gentile, co-CEO. "We are excited to work together with GOLO to ensure our members have the tools they need to live a healthy lifestyle."
GOLO for Wellness, GOLO for Immunity, GOLO for Weight Loss, GOLO for LIFE.
About GOLO: GOLO is committed to providing individuals with the knowledge of health and wellness, and the power to take back control of their weight and their lives. The GOLO for Life plan is an all-natural, plant-based supplement and meal plan, designed to address the root cause of weight gain. The GOLO products provide a safe solution to weight-loss and wellness while helping individuals transition to a healthier and sustainable lifestyle. GOLO recently launched The AeroTrainer exercise platform, an inflatable core fitness tool that provides quick, easy, home-based workouts. The developers of GOLO, LLC include a team of dedicated doctors, pharmacists, and researchers. GOLO has reached over a million people worldwide who now have a chance at healthy, sustainable, and affordable weight loss. For more information about the GOLO for Life plan, visit http://www.golo.com or call 800-730-4656 (GOLO). For more information about AeroTrainer, visit http://www.AeroTrainer.com or call 800-799-5838.

"We're delighted to support the Rick Case Scholarship Fund for the Boys and Girls Clubs of Broward County and their excellent mentorship of young people to lead healthy, successful lives," says Jennifer Brooks, President, GOLO.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Breakthroughs in fertility treatment now offer men and women with known genetic mutations a path to reduce the risk of passing mutations on to their children with preimplantation genetic testing of embryos during in vitro fertilization (IVF).

WASHINGTON (PRWEB) OCTOBER 29, 2020
Shady Grove Fertility (SGF) honors National Breast Cancer Awareness Month in partnership with breast cancer advocate and Previvor Founder, Allyn Rose, by expanding awareness of advancements in fertility treatment. Through preimplantation genetic testing, couples can have peace of mind knowing that genetic mutations that can lead to inherited conditions and disease have a strong chance of ending with their generation.
The month of October serves as an important reminder that this year, an estimated 700,000 people in the U.S. will be diagnosed with breast cancer, of which, up to 10 percent of cases are linked to an inherited gene mutation.
"In the last letter that my mother wrote to me before her passing from metastatic breast cancer at age 50, she warned me of my family's predisposition to cancer and rare diseases, encouraging me to undergo in vitro fertilization (IVF) treatment to eliminate this disease," says Rose, a former Miss USA and Miss America contestant, model, and the recipient of the 21st Annual Congress on Women's Health's Advocacy Award and a Breast Cancer Summit Lifetime Achievement Award. "Her forethought, 16 years prior to today, was the catalyst for me to take charge of my reproductive health."
SGF is the largest fertility center in the U.S. with 37 locations and home to more than 85,000 babies born. SGF offers patients the opportunity to screen for over 280 recessive gene mutations, including diseases such as cystic fibrosis, Tay-Sachs disease, and spinal muscular atrophy. In addition, patients at risk for dominant gene mutations, such as breast cancer or inherited forms of colon cancer, can have individualized testing for these diseases.
Couples with known genetic diseases can turn to in vitro fertilization (IVF) with preimplantation genetic testing for monogenic/single gene defects (PGT-M) to reduce the risk of passing that mutation onto their child(ren).
In 2019, a partnership between SGF and Rose blossomed to educate patients of these interventions and the availability of fertility preservation prior to any cancer treatment by sharing Rose's personal journey. Not only did a 16-year-old Rose cope with the loss of her mother from breast cancer at a young age, she also experienced the passing of her grandmother and great aunt to the same fate.
It was from these events that Rose made nationwide headlines with her decision to undergo a preventative (prophylactic) double (bilateral) mastectomy to prolong her life, despite not being a carrier for a genetic breast mutation. Rose's personal experience soon became a platform that encouraged other women to seek preventive healthcare, including her #SelfExamGram social media movement that reminds women to perform routine self-breast exams.
"I knew that my journey of preventive healthcare didn't end with my mastectomy," says Rose. "I'm also a carrier of another very rare X-linked genetic mutation called Wiskott-Aldrich syndrome. This genetic mutation would affect 50% of my male children and 50% of my female children would be carriers of the disease like me. If I was taking steps to prolong my own life, it only made sense that I would do the same for my future children."
Last October, Rose started her IVF journey with Kate Devine, M.D., at SGF's Washington, D.C. - K Street location, opting to undergo PGT-M to reduce the risk of having a child with an inherited condition. Rose is documenting her journey to motherhood with Dr. Devine and SGF in hopes that it will lift the veil of the unknown associated with infertility treatment while serving as a reminder to women to be their own advocates.
"The thing I love about SGF, and what I think makes them stand out, is that a large number of their staff have undergone fertility treatments themselves," says Rose. "I really appreciated that because I felt like they actually understood what I was going through and when they told me that I would be okay – they meant it."
This past July, ironically on the 16th anniversary of the passing of Rose's mother, she announced she was pregnant with her first child after completing 10 months of IVF treatment with SGF.
"Allyn's story is a powerful reminder to women everywhere that they're not alone," says Dr. Devine. "IVF with PGT-M is a safe and reliable means of fertility treatment for women who want to reduce risk of known genetic mutations in their children. I'm so happy that Allyn and her husband will soon welcome a baby who's free of Wiskott-Aldrich gene mutations."
While Rose is cancer-free, SGF has a specially trained team that works specifically with people with cancer to ensure the fertility preservation process before cancer treatment can be expedited in order that cancer treatment can quickly begin. The oncofertility team at SGF helps to guide patients through each step of the treatment process, from finding ways to afford treatment to the actual medical procedure.
If you would like to learn more about SGF's oncofertility treatment options or to schedule an appointment, please call the New Patient Center at 1-888-761-1967 or complete this brief online form.
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

National Sleep Quality Survey by American bedroom company Puffy removes the covers on the dire state of sleep, stress, and mental illness during the pandemic and extended working from home periods. This survey reveals 61% of people are sleeping worse, 82% of people are sleeping later, and 70% of people report poor sleep is impacting their mood.

NORTH HOLLYWOOD, CALIF. (PRWEB) OCTOBER 29, 2020
American-made bedroom company, Puffy, has just released findings from a national sleep quality survey that reveals 61% of people are sleeping worse, 82% of people are sleeping later, and 70% of people report poor sleep is impacting their mood. Amidst the already severe health crisis of the Covid pandemic, experts fear what many are calling a 'sleep crisis' is placing immunity and mental health at even greater risk.
Puffy surveyed over 4,400 adults from all 50 American states to get deeper insights into the sleep patterns, stress factors, and behavioral changes experienced by individuals during working from home orders amid the Covid pandemic.
As well as drastic declines in sleep duration across all demographics, sleep quality data indicates that people are experiencing significant sleep latency levels. Singles are the most at-risk group, with many respondents sighting loneliness and isolation as critical triggers for stress and low sleep quality.
Only 16% of singles reported sleep satisfaction; this number doubles among married respondents (32%). These insights indicate a strong correlation between sleeping alone, living alone, and poor mental health during Covid. Singles are the largest group in America who report staying awake due to thoughts racing through the mind. 74% of singles who participated in the Puffy Sleep Quality Survey report an inability to sleep due to late-night rumination and 71% of singles claim poor sleep negatively impacts mood.
The Puffy Sleep Quality Survey also finds that only 65% of singles prefer working from home, compared to a staggering 80% of married couples. A 2020 study by the Center for Integrative Psychiatry has found that couples who share a bed have increased and less disrupted rapid-eye-movement (REM) sleep compared to single sleepers.
The REM stage of sleep plays a vital role in helping individuals with a range of cognitive functions. Experts agree that improving REM sleep can have a significant impact on overall sleep quality and well-being.
"REM sleep helps to contribute to emotional regulation, learning, and memory. Deep sleep helps the brain to digest what was learned during the day as well as helping moods to be stable," said Alaska Sleep Clinic expert at Jessica Hines.
Singles not only experience poorer sleep quality, they also report lower working from home productivity rates, with 46% of singles in the Sleep Quality Survey claiming they are less productive and 72% of married couples reporting they are more productive. Insights indicate that living in isolation can negatively impact energy, mood, sleep quality, and productivity when remote working.
The Sleep Quality Survey data released by Puffy confirms the comfort companies contention that sleep quality in America is plummeting at record rates and putting mental and physical well-being at risk. The uncertainty of Covid, along with the isolation of global lockdowns, has illuminated just how dire sleep satisfaction is in America and how closely sleep is linked to mental and physical health.
"While we are struck by the degree of sleep dissatisfaction and quality across all demographics in the US, we can't say we are surprised. In stressful situations getting quality sleep can be a difficult task.
There is no doubt that America is experiencing a sleep crisis that may have unprecedented consequences as more and more people transition to remote working. Employers must step in to help employees, especially those living in isolation, create work-life balance where sleep is a priority," said Puffy CEO Arthur Andreasyan.
To view comprehensive insights into Puffy's Sleep Quality Survey click here: https://puffy.com/pages/sleep-survey
About Puffy
Puffy is a mattress and bedroom company currently operating in the United States and Canada. Puffy is deeply rooted in its commitment to develop complete bedroom solutions to help people sleep better and live better. Famous for inventing mattresses that feel like sleeping on a cloud, Puffy aims to deliver luxurious world-class comfort to transform sleep experiences worldwide.
Puffy sells all products direct-to-consumers online and was recently awarded Best Mattress of 2020. Puffy. For more information visit visit https://puffy.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In celebration of National Cat Day, new infographic highlights research supporting the health benefits of cats for people of all ages.

WASHINGTON, DC (PRWEB) OCTOBER 29, 2020
In celebration of National Cat Day, the Human Animal Bond Research Institute (HABRI) has created a shareable infographic on the health benefits of cat ownership. The infographic, "Top 5 Benefits of Cat Ownership", highlights the research supporting the health benefits of cats for people of all ages.
Approximately 43 million American households include a pet cat, with many households owning more than one*, making them the second most popular pet by household, behind dogs.
Scientific research demonstrates that cat ownership can confer benefits to both mental and physical health in their owners. Specifically, cat ownership can reduce risk of cardiovascular disease and improve heart health, alleviate social isolation and loneliness, and reduce stress. In children, living with cats can strengthen immunity in the first year of life, and a pet cat can help those with autism and their families.
HABRI hopes that in sharing this infographic far and wide, we can raise awareness of the benefits of cat ownership and to strengthen human-cat bonds everywhere. This infographic is part of an ongoing series to help share human-animal bond research and the message that pets enrich our lives, in good times and in bad. Earlier this year, HABRI released the "Can Pets Help You Live Longer?", the "Top 5 Mental Health Benefits of Pets" and the "Top Benefits of the Human-Animal Bond" infographics.
About HABRI
HABRI is a not-for-profit organization that maintains the world's largest online library of human-animal bond research and information; funds innovative research projects to scientifically document the health benefits of companion animals; and informs the public about human-animal bond research and the beneficial role of companion animals in society. For more information, please visit https://habri.org/.
*American Pet Products Association's 2019-2020 National Pet Owners Survey



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Kathleen H. Hong, Dr. Marcus Jurema, Dr. Leo Doherty, Dr. Shefali M. Shastri, Dr. Micheline Chu, and Dr. Susan L. Treiser of the Reproductive Medicine Associates of NJ have been reviewed and approved by NJ Top Docs for 2020.

SCOTCH PLAINS, N.J. (PRWEB) OCTOBER 29, 2020
Dr. Kathleen H. Hong, Dr. Marcus Jurema, Dr. Leo Doherty, Dr. Shefali M. Shastri, Dr. Micheline Chu, and Dr. Susan L. Treiser of the Reproductive Medicine Associates of NJ have been reviewed and approved by NJ Top Docs for 2020.
Dr. Kathleen Hong is a board certified Reproductive Endocrinologist Infertility specialist and an Obstetrician and Gynecologist. Her research interests include embryo culture in the IVF laboratory, comprehensive chromosome screening (CCS), endometrial synchrony, and heritable genetic disorders.
Dr. Marcus Jurema is a board certified Reproductive Endocrinologist and an Obstetrician and Gynecologist. His areas of clinical expertise include assisted reproductive technologies, recurrent pregnancy loss/implantation failure, ovarian reserve issues, fertility preservation, third-party reproduction and reproductive surgery
Dr. Leo Doherty is a board certified Reproductive Endocrinologist Infertility specialist and an Obstetrician and Gynecologist. His areas of expertise include improving infertility diagnosis and treatment, particularly in the areas of recurrent pregnancy loss, uterine fibroids, embryo and oocyte cryopreservation, uterine anomalies, and minimally invasive endoscopic and robotic-assisted surgeries.
Dr. Shefali Shastri is a board certified Reproductive Endocrinologist and an Obstetrician and Gynecologist. She has extensive experience in the field of in vitro fertilization and has a particular interest and expertise in genetic disorders, preimplantation genetic diagnosis, diminished ovarian reserve, fertility preservation and egg freezing.
Dr. Micheline Chu is a board certified Reproductive Endocrinologist Infertility Specialist and an Obstetrician and Gynecologist. Dr. Chu's areas of specialty include polycystic ovarian syndrome (PCOS), male infertility, and non-traditional family building.
Dr. Susan Treiser is a board certified Reproductive Endocrinologist and an Obstetrician and Gynecologist. Her areas of specialty include improving infertility diagnosis and treatment, particularly in the areas of third party reproduction, gestational surrogacy, egg donation, and reproductive ethics.
Dr. Melissa C. Yih is a board certified Reproductive Endocrinologist. Her areas of specialty include improving infertility diagnosis and treatment, particularly in the areas of fertility preservation for patients diagnosed with cancer (oncology), adolescent gynecology and gestational surrogacy.
To learn more about these NJ Top Docs, please visit: https://njtopdocs.com/nj-doctors/reproductive-medicine-associates/
----
About Us
NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.
For more information, please click here to contact us or visit http://www.njtopdocs.com.
You can also follow us on Facebook, Twitter, & Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Partnership will extend benefits to home health and hospice members.

OZARK, MO. (PRWEB) OCTOBER 29, 2020
HealthRev Partners, the leader in tech-driven, consultative revenue cycle management services for home health and hospice agencies, today announced that it is partnering with the South Carolina Home Health & Hospice Association (SCHCHA) to offer comprehensive coding, billing, billing recovery, and consulting services to its members.
Delivering financial security and stability, HealthRev Partners' scalable revenue cycle management solutions will enable SCHCHA members to focus on advancing their missions to provide exceptional care and touch more lives. Member benefits include:

High quality, expert coding, billing, and billing recovery services provided at reduced rates

Performance guarantees that ensure a higher level of service and transparency

Expert cost reporting services through approved CPA partnerships

"SCHCHA is on the cutting edge of offering its members the very best benefits," said Michael J. Greenlee, Founder and CEO of HealthRev Partners. "We are excited to be a preferred partner to its members and look forward to helping them drive better financial performance and ensure regulatory compliance."
"The timing of this partnership could not be better," remarked Tim Rogers, CEO of SCHCHA. "Part of our mission is to provide a wealth of resources to our member agencies, and right now they are experiencing so much change and so many challenges. We are thrilled to partner with an organization like HealthRev Partners who can provide solutions that are scalable to fit their individual needs."
Home health and hospice agencies looking for an innovative approach to managing revenue cycle operations can contact HealthRev Partners at 866.780.3554 or visit the company's website at http://www.healthrevpartners.com to learn more.
About HealthRev Partners
Delivering financial security and stability, HealthRev Partners inspires possibilities for home health and hospice agencies across the nation through high quality, personalized revenue cycle management services and consulting enabled by Velocity, a proprietary technology system. The company's innovative, scalable solutions accelerate cash flow, spark continuous growth and reinvestment, and provide peace of mind, allowing agencies to focus on advancing their mission to provide exceptional care and touch more lives. To learn more about HealthRev Partners' solutions, call 866.780.3554 or visit http://www.healthrevpartners.com.
About South Carolina Home Health and Hospice Association
The South Carolina Home Care & Hospice Association (SCHCHA) is a nonprofit trade association representing providers of home health, hospice, palliative care, and personal care services. The Association currently has a membership of over 300 provider agencies and vendors who provide products and services to providers. SCHCHA's mission is to provide Resources, Education, Advocacy and Leadership. Services include: technical assistance, monthly newsletters, quality educational programs, annual directory, email alerts, and political lobbying. To learn more, visit http://www.schcha.org.

We are excited to be a preferred partner to [SCHCHA's] members and look forward to helping them drive better financial performance and ensure regulatory compliance.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Portland's TriMet, Hampton Jitney and more have tapped CURIS to revolutionize their disinfection practices with the only pulse fogging system on the EPA's List-N for efficacy against SARS-CoV-2 (COVID-19)

OVIEDO, FLA. (PRWEB) OCTOBER 29, 2020
CURIS System is proud to announce today that is has been awarded the 2020 Innovative Solutions Award for Safety by METRO Magazine for its pulse fogging system that fights SARS-CoV-2 (COVID-19). When the novel coronavirus hit the transportation industry, some companies scrambled to find solutions to help keep drivers safe and routes operational. Traditional cleaning methods often miss areas, and disinfectants that kill 99.9% of germs can still leave up to 1,000 harmful organisms behind on the surface. This was once considered acceptable, but after the pandemic hit that was no longer the case.
Portland, Oregon's TriMet and N.Y. motorcoach operator Hampton Jitney tapped CURIS System's hydrogen peroxide fog to revolutionize their disinfection practices and cleaning protocols, changing expectations of germ safety from attempts to "just clean better" to an achievable, measurable kill of 99.9999% of dangerous germs*. TriMet uses the CURIS device daily on every piece of equipment to make sure each and every day they start out with a fresh, clean and safe piece of equipment.
"We're very pleased that our transportation customers have been recognized for their proactive initiatives to increase the safety and cleanliness of their vehicles with the safest and most effective pulse system on the market today," said Frances Grinstead, CEO of CURIS System. "As the CARES Act for transportation companies is set to expire on November 1st, we have ramped up our production and delivery to make sure any transport company that is making safety a priority has access to the CURIS System."
The Coronavirus Aid, Relief, and Economic Security (CARES) Act provides $25 billion to transit agencies to help to prevent, prepare for and respond to the COVID-19 pandemic. CURIS' sporicidal disinfectant is a hospital-grade, EPA-registered low-level 7% hydrogen peroxide (EPA Reg. No. 93324-1) with a 99.9999% efficacy on the hardest to kill germs* in a tri-part soil load. The hydrogen peroxide decomposes to water and oxygen leaving no harmful residues.
"Knowing that a hospital-grade disinfection process is being utilized on our coaches, and that the hydrogen peroxide mist solution reaches virtually everywhere is a huge comfort to our passengers," said Andrew Lynch, vice president at Hampton Jitney. "Adding the CURIS fogging system as a part of our sanitizing protocols provides us with a gold standard solution for the COVID-19 era."
Using the CURoxide Hydrogen Peroxide blend, CURIS is the first portable, hydrogen peroxide-based fogging system capable of disinfecting a room or enclosed area via patented pulse technology, and the most efficacious in protecting passengers against COVID-19 and other infectious disease. CURoxide is the only pulse fogging system included on the EPA's List-N for efficacy against SARS-CoV-2 (COVID-19) and has shown to be 99.9999% effective in killing the most resistant pathogens, while equally as important proving safe to administer and leaving behind no toxic or damaging residues. Staff easily place the portable, suitcase-sized CURIS fogging device into the bus and use an app to control the fogger from a safe location. While the bus quickly fills with germ-killing fog, staff move on to other tasks and use the app to monitor the treatment in progress. When fogging is done, doors are opened for a quick airing out and re-entry. The healthy bus is ready for use and a report of the treatment is saved for future planning and as proof of disinfection.
The CURIS Decontamination System is designed to effectively work in such environments as:

Transportation systems, including buses, airplanes, subways, taxis

Emergency Response Operations, including fire stations, police stations

Universities

Medical facilities, including hospitals, assisted living/long-term care facilities

Laboratory spaces

Sports facilities and gyms

Military facilities

Research facilities

About CURIS System
Headquartered in Oviedo, Florida, CURIS System provides the most efficacious germ-killing disinfectant solution with no harmful residues available on the market today. Established in 2014, CURIS' innovative and patented hydrogen peroxide fogging system has revolutionized portable, high-level disinfection, making hospital-grade decontamination accessible across multiple markets. Its EPA-registered "No Touch" disinfection system uses pulse hydrogen peroxide fog to kill germs and odors. The system is easy to use, portable (roll-behind or hand carry), eco-friendly, non-corrosive and leaves behind NO harmful residues. The CURIS app can be used for remote activation and cloud-based data storage for optimal tracking, management and reporting. For more information, please visit http://www.curissystem.com
*kills 99.9999% of c.diff in a tri-part soil load.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Six-year-old Liam began receiving treatment for early onset scoliosis at Shriners Hospitals for Children — Portland when he was just 2 years old. Liam's mother Sarah was afraid that his medical condition would create a negative experience in his childhood, so she immediately went to work on turning it into a positive one. She embraced Liam's scoliosis treatment by using his braces to create fantastical photos of her son depicted as his favorite superheroes.

PORTLAND, ORE. (PRWEB) OCTOBER 29, 2020
Six-year-old Liam began receiving treatment for early onset scoliosis at Shriners Hospitals for Children — Portland when he was just 2 years old. To help prevent the progression of the 30 degree spinal curve, Liam's pediatric orthopaedic physician (Joseph I. Krajbich M.D.) recommended the Mehta-Cotrel casting method, which requires Liam to wear a series of corrective casts as he grows. Liam's mother Sarah was afraid that his medical condition would create a negative experience in his childhood, so she immediately went to work on turning it into a positive one. She embraced Liam's scoliosis treatment by using his braces to create fantastical photos of her son depicted as his favorite superheroes.
Sarah has coordinated and staged photoshoots of Liam as Spider-Man, Batman, Buzz Lightyear, Captain America, Thor, Superman, Hiccup, and even Seattle Seahawks superstar Russell Wilson – who Liam got to meet! His most recent photoshoot shows Liam channeling The Force as the famous Star Wars character Obi-Wan Kenobi.
"The casting treatments were a difficult pill to swallow as a parent. You think about the things your child will be missing out on because of the cast," said Sarah, who is a professional photographer based in Puyallup, WA. "Ultimately, the big picture becomes the most important thing, and knowing you are doing everything possible to give your child the best possible outcome overpowers the small things you may miss."
As part of his treatment plan, Liam is typically fitted for a new brace every 9 to 12 months by Certified Orthotist Prosthetist Todd DeWees, and every time he gets a new brace, the transformation begins. Using a variety of outdoor vinyl materials to design the costumes, Sarah creates the ensemble needed for Liam to save the world. "Todd has definitely figured out what we're up to," said Sarah. "Every time Liam gets a new brace, Todd asks 'What color do you need this time?'"
"Liam loves the photoshoots. It is the highlight of our week. We have turned them into adventures each time. It is always an absolute blast for him," said Sarah. "Liam has a long road ahead of him. I'm trying to teach him that through hard times come good moments – that if you look hard enough at the hard road in front of you, you will see a positive path. My hope is that when he looks back at this time in his life, it will make him smile."
About Shriners Hospitals for Children
Shriners Hospitals for Children is changing lives every day through innovative pediatric specialty care, world-class research and outstanding medical education. Our health care system provides advanced care for children with orthopaedic conditions, burns, spinal cord injuries, and cleft lip and palate. All care and services are provided regardless of the families' ability to pay. Shriners Hospitals for Children is a 501(c)(3) nonprofit organization and relies on the generosity of donors. All donations are tax deductible to the fullest extent permitted by law. For more information, please visit ShrinersHospitalsforChildren.org
Video and Photo Assets for Download:
Image Gallery
Full interview of Liam's mom
Q&A video clips:
Can you explain Liam's condition and treatment?
How did the superhero idea come about?
Liam, who is your favorite and second favorite super hero?
How did the orthotics team at Shriners Hospital in Portland help with Liam's superhero transformations?
What do you hope Liam will get out of this experience?



START your own Wordpress site, business or personal website, or online store at www.siteground.com

To help raise awareness about stomach cancer and the devastating effects it can have on the lives of patients and their families, Hope for Stomach Cancer is hosting an interactive webinar with a cancer survivor and four esteemed physicians who are specialists in this terrible disorder. "Surgical Strategies for Stage IV Stomach Cancer" will explore PIPAC, HIPEC, and IP chemo for late stage cancer patients. It will take place online on November 7, 2020 between 10 am and 11:30 and PST. The event is free, but registration is required at http://www.hopewebcast.org.

LOS ANGELES (PRWEB) OCTOBER 30, 2020
To help raise awareness about stomach cancer and the devastating effects it can have on the lives of patients and their families, Hope for Stomach Cancer is hosting an interactive webinar with a cancer survivor and four esteemed physicians who are specialists in this terrible disorder. "Surgical Strategies for Stage IV Stomach Cancer" will explore PIPAC, HIPEC, and IP chemo for late stage cancer patients. It will take place online on November 7, 2020 between 10 am and 11:30 and PST. The event is free, but registration is required at http://www.hopewebcast.org.
"This is our inaugural webcast," said Aki Smith, Founder and Executive Director of Hope for Stomach Cancer. "It's part of a series of Hope webcasts that are designed to share treatments for this disease at every stage. By sharing treatment information with both patients and physicians, we hope to improve survivability and comfort."
This event will include some of the nation's most respected surgeons and oncologists:
– Moderator: Dr. Samuel Klempner, Massachusetts General Hospital
– Dr. Andrew M. Blakely, National Cancer Institute
– Dr. Yanghee Woo, City of Hope
– Dr. Brain D. Bagwell, MD Anderson Cancer Center
The event will also feature Lexy Patton, a 27-year-old cancer patient who was only given months to live in February 2020. Lexy's story is a powerful testament to the work that needs to be done for Stage IV stomach cancer patients around the world.
Every November, many organizations like Hope for Stomach Cancer, work to raise awareness of this deadly disease. Each year, 27,600 cases of stomach cancer are diagnosed in the US alone. With an overall survivability rate of just 31 percent (just 5 percent for Stage IV patients), stomach cancer is one of the deadliest. While overall incidents of stomach cancer have dropped in recent decades, incidents in young victims are on the rise for reasons unknown.
This disease disproportionately affects minorities, with African-American men 2.5 times more likely and African-American women 2.2 more likely to die from it than their non-Hispanic white counterparts.
Worldwide, over 700,000 people die annually from stomach cancer making it the third-leading cancer-specific killer.
"Hope for Stomach Cancer is sponsoring this event to help bring patients and doctors more information and more weapons to fight this terrible disease," Smith said. "The Hope Webinar Series will deliver hope to everyone affected by this disease. We work to deliver awareness all year long with November being the time when there is a national awareness drive."
This educational event is being sponsored in part by Bristol-Myers Squibb, Taiho Oncology and Daiichi-Sankyo. Hope for Stomach Cancer is grateful to their sponsors, their guests, and all their volunteers for giving hope to those with stomach cancer worldwide.
Hope for Stomach Cancer is a 501(c)(3) that provides resources to patients, caregivers and loved ones while promoting early detection and prevention to the general and medical communities. Hope creates and facilitates programs that enable those affected by stomach cancer to take actionable steps to live the best possible life through each phase of the disease. Their Vision: Bridge the Gap between Research and Patient Care.
For more information about this topic or for sponsorship opportunities, please contact Aki Smith at 424-239-9943 or email at hope@stocan.org.
To Register: https://zoom.us/webinar/register/6916039199190/WN_OQRFBww_T4--qfBeEWhpQw

"This is our inaugural webcast," said Aki Smith, Founder and Executive Director of Hope for Stomach Cancer. "It's part of a series of Hope webcasts that are designed to share treatments for this disease at every stage."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Austin Attorney Mary Jones has been named in the 2020 edition of Super Lawyers in the family law category.

AUSTIN, TEXAS (PRWEB) OCTOBER 30, 2020
Austin Attorney Mary Jones has been named in the 2020 edition of Super Lawyers in the family law category.
Mary graduated from the University of Illinois in 1980 with a Bachelor of Science Degree in Education and in 1992 from the University of Kentucky College of Law with a Doctorate of Jurisprudence.  After spending almost a decade teaching and coaching at the middle school and high school levels in public schools in Illinois, Texas and North Carolina, she pursued her law degree and has continued her service to parents and children in the legal realm for over 25 years.  Prior to establishing her private practice in 1997, she practiced family law with the firm of Hearne, Knolle, Livingston and Holcomb, and Douglass D. Hearne, Sr. for 5 years.  She has represented clients in Travis, Williamson, Hays, Burnet, and Blanco Counties.  Ms. Jones is a Texas Bar Foundation Fellow,  Lifetime Member Texas Family Law Foundation, continuous Member of The College of the State Bar of Texas since 2004, and a founding member of the Travis County Bar Foundation.  She is a member of Collaborative Divorce Texas and sits on the board of directors for Collaborative Divorce Austin. 
For more than 25 years Mary has represented clients in Travis, Williamson, Hays, and Burnet counties. She is a founding fellow of the Travis County Bar Foundation and a section board member of the Williamson County Bar Association. She is also a Director of Collaborative Divorce Austin. Ms. Jones is a Texas Bar Foundation Fellow, a high distinction as each year only one-third of one percent of State Bar members are selected to become Fellows.

It is a great honor to be selected for this prestigious recognition.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Team reports results from safety study of propranolol with pembrolizumab in patients with metastatic melanoma. Results lend important insights on how to manage stress in people with cancer.

BUFFALO, N.Y. (PRWEB) OCTOBER 30, 2020
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive. A team of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to disrupt that dynamic so that cancer treatments can be more effective. Their latest work, published today in Clinical Cancer Research, a journal of the American Association for Cancer Research, suggests that a drug widely prescribed to control blood pressure may improve patients' response to cancer immunotherapy.
The new publication reports results from the first prospective clinical trial to show that the beta-blocker propranolol is safe in combination with pembrolizumab, an immunotherapy also known as Keytruda that has become standard therapy for patients newly diagnosed with advanced or metastatic melanoma. The researchers also document preliminary evidence that these two drugs work together to engage the immune system against tumor cells.
"We know that stress can have a significant negative effects on health, but the extent to which stress may impact the outcome of cancer therapy is not well understood at all. So building on the compelling preclinical work of our colleague Dr. Elizabeth Repasky documenting the role of adrenergic stress in the immune response to cancer, we set out to better understand this relationship and to explore its implications for cancer treatment," says Shipra Gandhi, MD, Assistant Professor of Oncology at Roswell Park and co-first author on the new study.
In a small phase 1 study at Roswell Park, patients with newly diagnosed metastatic melanoma were given escalating doses of propranolol, which blocks the ability of stress hormones to interact with cells, in addition to standard treatment with the anti-PD-1 checkpoint inhibitor pembrolizumab. The team reports that this combination is safe and shows preliminary evidence of promising activity, demonstrating higher anticancer responses than expected with standard therapy alone.
The findings also suggest that stress reduction could be an important component to achieving optimal stimulation of a patient's immune system and reducing tumor growth.
"In repurposing propranolol, which has been in use for decades to treat or prevent conditions including migraine headache and various heart problems, for this study in melanoma, we've gained important insights on how to manage stress in people with cancer — who can face dangerously elevated levels of mental and physical stress related to their diagnosis and treatment," says Manu Pandey, MBBS, Hematology-Oncology Fellow at Roswell Park and co-first author on the new publication.
The work was guided by two co-senior authors: Elizabeth Repasky, PhD, who is the Dr. William Huebsch Professor in Immunology and Co-Leader of the Cell Stress and Biophysical Therapies Program at Roswell Park, and Marc Ernstoff, MD, who was Chair of Medicine at Roswell Park when this study was conducted and now is ImmunoOncology Branch Chief with the National Cancer Institute (NCI) Division of Cancer Treatment and Diagnosis, Developmental Therapy Program.
Additional research is needed to confirm the team's findings. A larger study of this approach is under way at Roswell Park and three other cancer centers.
This work was supported by grants from two National Institutes of Health agencies: the NCI and the National Center for Advancing Translational Sciences (project numbers P30CA016056, R01CA205246, KL2TR001413 and UL1TR001412). Additional support was provided through The Melanoma Fund and generous donations to Roswell Park.
This release is also available at: https://www.roswellpark.org/newsroom/202010-roswell-park-sees-suggestion-benefit-first-clinical-trial-combine-beta-blocker
Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer's grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

In repurposing propranolol, which has been in use for decades, for this study in melanoma, we've gained important insights on how to manage stress in people with cancer — who can face dangerously elevated levels of mental and physical stress related to their diagnosis and treatment.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Langland appoints Angela Rochelle as Account Director, Head of Diversity Initiatives in Clinical Trials, where she will act as the agency's leading advocate for diversifying patient representation in Clinical Trial Experience (CTE).

NEW YORK (PRWEB) OCTOBER 30, 2020
Langland is proud to announce the appointment of Angela Rochelle as Account Director, Head of Diversity Initiatives in Clinical Trials. In this role, Angela is the agency's leading advocate for diversifying patient representation in Clinical Trial Experience (CTE). In addition, Angela collaborates with Langland's established clinical trial inclusivity taskforce—a team committed to designing and deploying clinical trial communications that proactively address common barriers experienced by underrepresented communities, and advising on best practices throughout the agency's US, UK, and Australia offices. Angela's appointment comes as the agency reaffirms its commitment to equity and fair representation in clinical trials, and in the broader healthcare communications industry.
"It's exciting to join Langland and their long tradition of excellence in healthcare communications," Angela said. "Langland is known for developing creative and strategic approaches that insist inclusivity is addressed at every stage of the process, and I'm so glad to continue advancing this important work."
Prior to joining Langland, Angela spent time at some of the country's leading multicultural advertising agencies working with high-profile clients such as Unilever, General Motors, Walmart, and Proctor & Gamble. Her more than 2 decades of industry experience has also involved successful roles in healthcare advertising account management, including recent clinical research and patient advocacy work with Bristol Myers Squibb and Merck. Angela now brings her considerable expertise to Langland's established legacy of excellence in clinical trial recruitment and experience.
"Angela has been developing initiatives to engage with multicultural audiences since before it was top of mind for many companies," said Klaira Simon, Managing Director of CTE at Langland US. "We're proud to have seized this pivotal moment to solidify our commitment to conducting equal and representative clinical trials—in our ranks, in our business practices, and in how we serve our clients."
Recognizing that equitable representation should be a goal across the industry, Langland has also increased its focus on practices that build a more diverse and inclusive workplace. Across all of its locations, these practices include anonymized resumé submissions, mandatory unconscious bias training, career programs, and school relationships for people from mixed socio-economic backgrounds, as well as internal support communities for women, LGBTQ+ (Lesbian, Gay, Bisexual, Transgender, Queer/Questioning, and Related Communities) , and BIPOC (Black, Indigenous and People of Color) employees and their allies.
In Langland's US office, as more staff have been brought on to support expanding CTE business, 80% of new hires self-identify as BIPOC; overall, 40% of total US staff—including 40% of agency leadership at the account director level and above—self-identify as BIPOC.
Victoria Wright, Group Managing Director at Langland, added: "The appointment of Angela Rochelle is yet another example of thinking further. Driving a step-change in diversity and inclusion takes more than a statement or a black square on social media. We understand that and are taking action now to positively influence our tomorrows. We firmly believe that diverse perspectives lead to more imaginative, intelligent and inspirational solutions, and that is exactly what Langland, our industry and our clients really need."
About Langland
Langland is a health communications agency that helps people, brands and businesses think further. We believe in the power of different perspectives. It's why we have brought together four key health disciplines–Clinical Trial Experience; Medical Strategy & Education; PR & Policy; and Advertising. This close collaboration allows our clients to have the very best minds in health caring for the most important parts of their business. For more information, visit us at http://www.publicislangland.com.
About Publicis Health
At Publicis Health, we are united around one purpose: to create a world where people are equipped and motivated to take control of their health. We transform healthcare marketing and communications into healthcare engagement. We believe healthcare marketing is healthcare, fostering healthy conversations, healthy behaviors and healthy people. Publicis Health is a Dynamic Health Engagement Platform, an organizing principle that seamlessly connects data, content and technology; is driven by marketing and business transformation; and offers our clients fluid access to world-class talent and game-changing capabilities. With 40 offices and 11 brands across the globe, Publicis Health's worldwide staff is comprised of more than 3,000 healthcare professionals who are experts in advertising and branding, data and analytics, strategic planning, service design, digital media and technology, science, and medicine. Publicis Health companies include Digitas Health, Heartbeat, Insync, Langland, Payer Sciences, PlowShare Group, Publicis Health France, Publicis Health Media, Razorfish Health, Saatchi & Saatchi Wellness, and Verilogue. For more information, visit us at http://www.publicishealth.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Cannabis Consumers Coalition issues monumental report pulling back the veil on the licensing process in Missouri out of abundance of concern over anti-trust violations via market manipulation and monopolization. The struggle to control medical marijuana licenses & market share in Missouri has been hotly contested since at least 2014. In January 2020, some 1800 out of 2200 license applications were denied, sparking a public controversy & legislative investigations into the process.

DENVER (PRWEB) OCTOBER 30, 2020
In response to the controversial denials of 1800 out of 2200 of medical marijuana applications in the state of Missouri, the Cannabis Consumers Coalition today published "What Happened in Missouri? America's Most Controversial Medical Marijuana Licensing Process Explained", an exhaustive, well-documented report on the history of marijuana reform in Missouri with a focus on the special interests behind the license caps and barriers to market entry in Missouri's $500 million a year medical marijuana market. The full report is available at https://www.cannabisconsumer.org/publications
"Missouri has seen almost a decade of well-funded entities promoting marijuana legislation that would benefit themselves through the creation of license caps and licensing processes that virtually guarantee non-insiders are left in the cold," said Larisa Bolivar, founder of the Cannabis Consumers Coalition. "These practices violate the US Constitution's numerous barriers to states enacting laws undermining the civil right to economic self-sufficiency and Congress's authority to regulate any market that substantially affects interstate commerce. Worse, the same special interests who have already won licenses in Missouri's market are now funding a ballot initiative campaign 'Legal Missouri 2022' that provides current medical marijuana market incumbents with primacy in the recreational marijuana market in what is likely an illegal market allocation scheme."
The Missouri report follows on the heels of the CCC's report on Arizona's Proposition 207, the first in a series of white papers examining protectionist campaigns to restrict marijuana business ownership to members of a growing cartel of wealthy, politically connected, multi-state marijuana license operators.
Springfield businessman Desmond Morris said, "Missouri's medical marijuana law gave opportunity to a privileged few who wrote the language of the Constitutional ballot amendment, had privileged access to the Department of Health & Senior Services (DHSS) during the implementation process, referred DHSS to the third party scorer who both ranked applications, wrote applications for direct competitors while earning millions of dollars, and ultimately won a monopoly of the market to the exclusion of hundreds of ordinary Missouri entrepreneurs who applied in good faith. We had a real opportunity to create lasting economic security for communities impacted by the drug war and missed the mark completely."
"Over 800 Missourians are currently fighting for the right to own and operate a cannabis business after being arbitrarily denied, and the state of Missouri is using millions of dollars of application fees to litigate against its own citizens in the process," said Leisa Stevens, a Kansas City applicant fighting the denial of her application, "The Missouri General Assembly needs to stand up for the people of Missouri in the 2021-2022 legislative session and ensure that this does not happen again."
The Cannabis Consumers Coalition, a 501(c)3 cannabis consumer watchdog organization, opposes anti competitive market restrictions in cannabis licensing and works to protect consumer interests in legal cannabis markets. http://www.cannabisconsumer.org
Press Contact: Larisa Bolivar, info@cannabisconsumer.org, (703) 244-4857
Approach Missouri's initiative petition, Constitutional Amendment 2, implementing medical marijuana in Missouri (now Amendment XIV to the Missouri Constitution). In January 2020, some 1800 out of 2200 license applications were denied, sparking a public controversy & legislative investigations into the process.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Disinfectant Product Company, Anti3 Protect Series Has Released New Easy-To-Make Disinfecting Wipes, Wipe and Protect, To Help Keep Surfaces Bacteria-Free

HICKSVILLE, N.Y. (PRWEB) OCTOBER 30, 2020
Anti3 Protect Series, a product line of EPA registered disinfectants, has released easy-to-make disinfecting wipes. Wipe and Protect by Anti3 Protect Series offers consumers a way to wipe down surfaces efficiently and effectively while eliminating 99.9% of bacteria and germs.
Now, more than ever, it is crucial to keep high-touch surfaces clean and disinfected to protect from harmful bacteria and minimize the risk of getting sick. Counters, door handles, cell phones, keyboards, steering wheels, gym equipment, and more can be breeding grounds for bacteria that can cause illness or infections. However, taking the critical measure of disinfecting these surfaces every day can ensure anyone who comes into contact with them will be safe.
Anti3 Protect Series Wipe and Protect Disinfecting Wipes are ideal for use on surfaces that people often touch. The wipes come in two convenient sizes, including a 500-count refillable bucket and a 75-count bag, which are easy to use with the Anti3 Protect Series Disinfecting Gallon or 16 ounce bottle. Whether an office, a gym, or a home, Wipe and Protect Disinfecting Wipes are easy-to-use on surfaces to help stop the spread of germs.
More about Anti3 Protect Series: Anti3 Protect Series was formulated to be the ultimate protection against a broad spectrum of virulent microorganisms, including COVID-19 Coronavirus, MRSA, Influenza A, SARS, and Norovirus. Anti3 Protect Series line of disinfecting products can be used on various surfaces to protect against harmful germs and bacteria.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Silver and Bronze Quality Awards Earned in Missouri Demonstrate Tutera's Dedication to Highest Quality of Care; Awards presented during AHCA/NCAL's virtual 71st National Quality Award Ceremony on October 22

KANSAS CITY, MO. (PRWEB) OCTOBER 30, 2020
Tutera Senior Living & Health Care is proud to announce two of its communities in Missouri have earned prestigious Quality Awards from the American Health Care Association (AHCA)/National Center for Assisted Living (NCAL), the leading association for long term and post-acute care providers. The annual award honors association members across the nation that have demonstrated their commitment to improving quality of care for seniors and persons with disabilities.
With 70 facilities, communities and agencies in nine states throughout the United States, Tutera is one of the nation's premier providers of diversified, post-acute senior health care services. The following two Tutera communities have earned the 2020 Silver Achievement in Quality or Bronze Commitment to Quality Award:

Monterey Park Rehabilitation & Health Care Center (Independence, Missouri) earned the SILVER AWARD. Monterey Park was the only 2020 Silver Quality Award winner in Missouri.

Northland Rehabilitation & Health Care Center (North Kansas City, Missouri) earned the BRONZE AWARD. Northland Rehabilitation was one of only 21 recipients in Missouri of the 2020 Bronze Quality Award.

"We are proud to see these communities recognized for their unwavering commitment to residents," said Joe Tutera, chief executive officer of Tutera Senior Living & Health Care. "I commend the staff at these two communities on their hard work and dedication to our valued residents."
The Bronze Commitment to Quality Award and the Silver Achievement in Quality Award are two of three progressive award levels through the National Quality Award Program, which AHCA/NCAL established in 1996. It is based on the core values and criteria of the Baldrige Performance Excellence Program, which is also the foundation of the metric-based AHCA/NCAL Quality Initiative. The Baldrige program helps organizations in different business sectors improve and achieve performance excellence.
"It's rewarding to be recognized with a prestigious quality award that underscores the standards that guide what we do every day," said Randy Bloom, Ph.D., chief operating officer of Tutera Senior Living & Health Care. "Our ongoing YOUNITE initiative is designed to ensure we are continuously asking, listening and responding in ways that are personally meaningful to residents, family members and staff in all our communities across the nation."
Bronze applicants must demonstrate their ability to implement a performance improvement system. Silver applicants must have previously received the Bronze Commitment to Quality Award. Silver award winners demonstrate effective approaches that help improve performance and health care outcomes. Trained examiners thoroughly review each application to determine if the center has met the demands of the criteria.
The 2020 awards were presented during AHCA/NCAL's virtual 71st National Quality Award Ceremony on October 22, 2020.
About Tutera Senior Living & Health Care
Tutera Senior Living & Health Care is a locally owned, diversified post-acute senior health care provider operating 70 senior living communities in nine states throughout the country. As one of the nation's premier senior care providers, Tutera Senior Living & Health Care offers its residents independent living, assisted living, skilled nursing, post-surgery rehabilitation, memory care, home health and hospice care. In 1983, Dominic F. Tutera, M.D., founded Tutera to provide compassionate patient care with the uncompromising values of integrity, accountability and commitment. Tutera Senior Living & Health Care still embodies those values today. Tutera is committed to making a positive difference in the lives of its residents and their families through senior living and health care experts who inspire and promote individuality and personal happiness. For more information, visit http://www.tutera.com.
About AHCA/NCAL
The American Health Care Association and National Center for Assisted Living (AHCA/NCAL) represent more than 14,000 non-profit and proprietary skilled nursing centers, assisted living communities, sub-acute centers and homes for individuals with intellectual and developmental disabilities. By delivering solutions for quality care, AHCA/NCAL aims to improve the lives of the millions of frail, elderly and individuals with disabilities who receive long term or post-acute care in our member facilities each day. For more information, please visit http://www.ahcancal.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Patients suffering from gum disease in the Greenville, SC area can make an appointment to see Dr. Ravenel for a less invasive, less painful laser-based treatment.

GREENVILLE, S.C. (PRWEB) OCTOBER 30, 2020
Greenville Periodontist Dr. Lisa Ravenel now offers the LANAP protocol to treat patients with gum disease and LAPIP protocol for ailing dental implants. As a LANAP-trained clinician, Dr. Ravenel is at the forefront of the future of dentistry, joining a top-tier class of clinicians who put their patients first using FDA-cleared LANAP treatment.
"Gum Disease is a rampant problem and tied to systemic diseases including heart disease and diabetes," states Dr. Ravenel. "The goal is always to treat the disease, but some patients simply don't want traditional surgery. Patients love the fact that LANAP treatment is less invasive with a quicker recovery time."
LANAP treatment targets the bacteria and endotoxins causing gum disease without harming healthy tissue. The recovery time is much quicker and patients report less pain when compared to traditional surgery. The LANAP protocol is also the only treatment of its kind with FDA clearance based on scientific research to regenerate the bone and tissues lost to gum disease.
Studies have shown a link between gum disease and other serious illnesses, such as heart disease, stroke, cancer, diabetes and more. With such a widespread impact on our total health and because it will lead to the gradual destruction of the gums and supporting bone if left untreated, it's important to address gum disease as early as possible.
If you have gum disease, it may be possible to save many of the teeth that might otherwise be extracted. Research shows that retention of natural teeth has been shown to increase your lifespan!
For information on the LANAP protocol, call Ravenel Periodontics at (864)626-4777 or visit us at RavenelPerio.com
About Dr. Ravenel
Dr. Lisa Ravenel is a Greenville-area native whose love of human physiology and pathology became evident to her in her early 20's. On a personal note, she takes time to get to know her patients, understand patient goals, and educate them on viable and available options.
She holds degrees from the University of South Carolina and the Medical University of South Carolina for her Bachelor of Science in Biology, Doctorate of Dental Medicine, and specialty training for periodontics and implant surgery, as well as a Masters in Health Sciences. Dr. Ravenel is a member of various organizations, including the American Dental Association, the South Carolina Dental Association, the American Academy of Periodontology, and the Southern Academy of Periodontology.
What she loves most about the specialty is the science-based nature of patient care. Each situation is different and the challenge is to determine what components are needed for success.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This is the 3rd COVID-19 testing option in Potawatomi Support Services' COVID-19 Testing Solution.

MILWAUKEE (PRWEB) OCTOBER 30, 2020
Potawatomi Support Services, LLC (PSS) now provides FDA Emergency Use Authorized (EUA) rapid, COVID-19 Antigen Test Kits. The rapid Antigen Test Kits is the 3rd COVID-19 testing option PSS offers, including Rapid Antibody Test Kits and PCR testing.
PSS rapid Antigen Test Kits can provide test results in 10 minutes or less, with a minimally invasive nasopharyngeal specimen collection. Antigen Tests are produced at a much lower cost than conventional PCR testing, and other rapid Antigen Tests. PSS's rapid Antigen Test Kits do not require a separate machine for processing results. Each box comes with everything needed to perform, process, and read the results (20 test kits per box).
PSS has the rapid Antigen Test Kits and the rapid Antibody Test Kits available for immediate shipment. We offer a full COVID-19 testing solution from supplying the test kits as a stand-alone option, to providing full-spectrum testing services, licensed medical personnel, PCR testing, CLIA oversight, training, and reporting. Test kits are intended for Point of Care use, for surveillance and/or screening purposes.
About the Potawatomi Support Services:
Potawatomi Support Solutions is an SBA-Certified 8(a) subsidiary of Potawatomi Business Development Corporation (PBDC). As an American Indian Tribal (AIT) Corporation, PBDC-Federal Group provides Potawatomi Support Services with the corporate infra-structure, processes, and financial support of a much larger organization, allowing our customers to recognize the benefits while still maintaining access to small and agile Primes. As part of the PBDC family of companies, PSS shares common administrative services with each other. This support grants us access to human capital, well-proven processes, and a wealth of knowledge that spans over all twelve companies.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will provide an overview of imaging biomarkers in Alzheimer's clinical trials. They will discuss the challenges in imaging operations for Phase III Alzheimer's clinical trials, and how they can be overcome by streamlining imaging operations and harnessing AI technology.

TORONTO (PRWEB) OCTOBER 30, 2020
Phase III clinical trials are required to prove the effectiveness and safety of a drug in a larger population. After decades of research, Alzheimer's disease still has no disease-modifying drug that is approved as many of the drug development programs fail in later-stage phases. Due to the complexity of the disease and challenges associated with large scale later phase studies, Phase III Alzheimer's clinical trials require neuroimaging approaches that successfully blend robust operational infrastructure, effective data management platform and advanced analytics.
This webinar will address practices to optimize the entire operational lifecycle including site qualification, investigator training and radiological reads in Alzheimer's clinical trials.
In view of the large and complex data sets within Phase III trials, this webinar will present the advanced TrialTracker platform for scaling-up processes and systems to manage imaging data, from radiological read workflow to imaging analysis. It will additionally cover the AI-driven LEAP platform used to perform advanced segmentation and volumetric analysis in Alzheimer's trials.
Join Roger Bullock, Chief Medical Officer, Oryzon; Shona Clegg, Senior Project Manager/Portfolio Lead, IXICO; and Richard Joules, Imaging Science Manager, IXICO in a live webinar on Friday, November 13, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Advancing Imaging Operations & Analysis in Alzheimer's Disease Late-Stage Clinical Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/




START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will explore how comparators are used in different clinical trial phases and the risks associated with the supply chain in each phase. The speakers will discuss how risks can be identified, proactively addressed and managed. The presentation will also highlight why and how a partner with a global reach can mitigate risks.

TORONTO (PRWEB) OCTOBER 30, 2020
Running a successful clinical trial relies heavily on the management of risks within the supply chain. Risk management is an essential part of clinical trials to ensure that sponsors can generate a clear return on investment without disruptions. It's a complex process of identification and management depending on a number of factors that can impact the effectiveness of the trial. There is no 'one size fits all' approach. Each clinical trial has its own complexities based on the comparator, data and stock shortages which can delay timelines and increase costs. Mistakes can prove very expensive and more importantly, put patient safety at risk.
Successful clinical trials need effective supply chain management procedures to make sure risks are identified and managed in a timely manner, so that the required medication is available at the site when needed. Taking a holistic approach to assessing and managing risks makes sure that sponsors can prevent things that will impact the trial and the data generated. There needs to be a robust methodology in place for identifying, evaluating and proactively managing the risks involved in clinical trials. Having the benefit of a global reach and multiple sources can make a tremendous difference to the options available.
So, what are the risks involved in clinical trial supplies and comparator sourcing and how can you manage these risks to ensure a successful clinical trial on a global scale?
Join Vanessa Dekou, PhD, Managing Director, Clinical Services International (CSI) and Kotaro Yoshizawa, Chief Representative Japan-Global, CSI in a live webinar on Monday, November 16, 2020 at 9am EST (2pm GMT/UK) to find out.
For more information or to register for this event, visit How to Identify and Manage Risks in Clinical Trial Supplies and Comparator Sourcing: The Benefits of the Global Reach.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will be virtually celebrating World Children's Day, which commemorates the Convention on the Rights of the Child. The speakers will discuss the parameters of the Convention with respect to health disparities and social determinants, diversity (and the lack thereof) in clinical trial participation, inclusion of adolescents in adult clinical trials and clinical trial education of the public. The webinar will also feature a panel discussion with young adult participants who have participated in and contributed to clinical trials speaking to their healthcare journey.

TORONTO (PRWEB) OCTOBER 30, 2020
The PRA Health Sciences Center for Pediatric Clinical Development's second annual acknowledgement of World Children's Day will be celebrated virtually on November 16, 2020. World Children's Day is celebrated to commemorate the Convention on the Rights of the Child, which is the most widely ratified human rights treaty in history and has helped transform children's lives around the world. It sets defined parameters to ensure humanity recognizes the equality necessary for children to develop to their full potential.
PRA Health Sciences is promoting international togetherness and awareness of children worldwide, as well as improving children's welfare.
In this webinar, the speakers will discuss ongoing health disparities and social determinants, diversity (and the lack thereof) in clinical trial participation, inclusion of adolescents in adult clinical trials, clinical trial education of the public and survey results of the "Pediatric Perceptions and Insights" study conducted by the Center for Information and Study on Clinical Research Participation (CISCRP).
Being a member of a racial or ethnic minority, compounded with the lack of awareness and health care access, continue to be a barrier to bringing appropriate clinical trial participation and safe and effective treatments for chronic and debilitating diseases to the pediatric population. Panelists will discuss experienced barriers and how to defy prejudice and encourage diversity.
Inclusion of adolescents in adult clinical trials will increase young patients access to safe and efficacious treatments in a timely manner. Including the ages of 12 to under 18 years in adult clinical trials will eliminate the extended time while waiting for the adult trial results and may help for trial design to support pediatric indications when warranted based on preliminary results. Not including adolescents leads to off label prescribing lacking scientific evidence of safe and efficacious dosing.
The live webinar will include a panel discussion with three young adults moderated by Dr. Gaspar. Two of the young adult panelists have participated in adult clinical trials as adolescents and one panelist with a rare disease sharing barriers of participation and advocacy to create a collaborative platform for patients and researchers.
Join Dr. Hemant Malhotra, Medical Oncologist, Department of Medical Oncology, Mahatma Gandhi College Hospital; Dr. Nathalie Gaspar, Paediatric Oncologist, Gustave Roussy Cancer Campus; Annick deBruin, Senior Director of Research Services, CISCRP, in the live webinar on Monday, November 16, 2020 at 10am EST (3pm GMT/UK).
The webinar will also feature youth panelists Benjamin James, an MSc (Merit) Science communication graduate from the University of Sheffield who has Duchenne Muscular Dystrophy (DMD) and is a trustee for Pathfinders Neuromuscular Alliance; Rime Allouche, who is a member of KIDS France and advocates to ensure the voice of children and young adults is represented in clinical trials; and Max Williamson, a young cancer patient and patient advocate on the Teenage and Young Adult Cancer research group of the UK's National Cancer Research Institute.
For more information, or to register for this event, visit PRA's World Children's Day Event: Defying Health Care Disparities and Clinical Trial Barriers in Pediatric Populations.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

During RSV Awareness Month, Platinum Research Network excels in supporting maternal immunization projects. Most of the work done in this area has recently been conducted to protect potential newborns from respiratory syncytial virus (RSV). The pharmaceutical industry looked to PRN to expand their capabilities and lead the way.

AUSTIN, TEXAS (PRWEB) OCTOBER 30, 2020
Platinum Research Network (PRN) is a multi-specialty site network with specialized therapeutic support for vaccines, women's health, and pediatric research. Maternal vaccines (a.k.a., vaccines for expectant mothers) is an exciting development in vaccine research. PRN excels in supporting these maternal immunization projects with diverse urban, suburban, and rural populations.
"It's long overdue that we are studying vaccines like this in pregnant mothers," said Jason Roth, VP at PRN.
Most of the work done in maternal immunization has recently been conducted to protect potential newborns from respiratory syncytial virus (RSV). More than 25 PRN investigators have enrolled over 1,700 pregnant participants into clinical trials in the last 5 years. PRN expects to enroll at least 1,000 more participants during the 2020-2021 RSV season.
John Paul Roberts, MD, Principal Investigator at Ventavia Research Group, leads RSV vaccine trials at his research site in the Dallas-Forth Worth metroplex. "Our expectant mothers and our colleagues have sought more data regarding the safety and effectiveness of maternal immunization," said Dr. Roberts "It's a great time in medical history, and we're at the forefront of this research."
Keith Vrbicky, MD, has delivered more than 12,000 babies and conducts clinical trials at Meridian Clinical Research's site in Norfolk, NE. Patients often drive two or more hours to participate in clinical trials and visit his practice as patients. "It's a natural progression to take on maternal vaccine trials," said Dr. Vrbicky. "We have the experience to lead the way, and as a woman-owned and -led company, Meridian has made women's health research a special focus."
"Given our experience in conducting maternal immunization trials, the pharmaceutical industry looked to us to expand our capabilities and enroll expectant mothers for their research projects," said Roth. "We're prepared to accommodate the industry's need."
For more information or to request an interview, contact Jason Roth at jason.roth@platinum-research.net.
#maternalvaccines #clinicaltrials #rsvawareness



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New division created to accelerate development and adoption of health data algorithms in consumer wearables and connected fitness devices based on FDA-cleared SphygmoCor technology for arterial waveform and central blood pressure measurement.

IRVINE, CALIF. (PRWEB) OCTOBER 30, 2020
CardieX Limited (ASX: CDX), a global health technology company focused on hypertension, cardiovascular disease, and vascular health disorders, today announced the launch of ATCOR·X, a new division focused on developing and licensing clinically meaningful health data algorithms for consumer wearables and connected fitness devices. ATCOR·X wearable features are based on the company's FDA-cleared and patented SphygmoCor technology for measuring arterial waveforms and central blood pressure.
"The seismic shift to remote care driven by COVID-19 has created an unprecedented opportunity to create a healthcare ecosystem integrated into people's homes and daily lives using innovative home devices and wearables," said Craig Cooper, CEO and Managing Director of CardieX. "We're launching ATCOR·X to accelerate development and drive adoption of our SphygmoCor technology – the global gold-standard for non-invasive measurement of central blood pressure waveforms and arterial stiffness – and to improve the health of millions of Americans with hypertension as well as those who have lasting cardiovascular damage as a result of COVID-19."
Under the ATCOR·X brand, CardieX will develop and license its Arty platform consisting of a unique feature set of enhanced biometric heart and arterial health measurements that can be tailored for risk assessment and to manage cardiovascular and renal disease, dementia and Alzheimer's disease, arterial stiffness and vascular aging, diabetes, maternal health, and other chronic disease.
These include:

Heart Stress (HS) – Measures the level of stress on the heart due to the hardening of arteries, which can be a sign of cardiovascular risk.

Exercise Capacity (eCap) – Measures the heart's ability to provide oxygenated blood to cells based on the body's performance demands. Unlike VO2 max, eCap indicates potential exercise endurance based on cardiovascular health.

Heart Rate (HR+) – Provides accurate, medical-grade, beat-to-beat heart rate (HR) measurement equivalent to standard ECG-based methods with greater accuracy than HR measurements common in other wearables.

Arterial Age – Compares an individual's heart health with healthy people their age to indicate the biological age of their heart compared to chronological age.

Arterial Stiffness Factor (ASF) – Measures the flexibility of an individual's arterial and vascular system to indicate risk for cardiovascular events tied to arterial stiffness, such as heart attack, stroke, and dementia.

Irregular Heartbeat – Helps an individual identify if they are experiencing an abnormal heartbeat without the use of an ECG, which may be a sign of atrial fibrillation.

HRV+ – Heart Rate Variability Plus provides beat-to-beat HR measurement of a user's autonomic nervous system (ANS), parasympathetic (rest and relax) and sympathetic (fight or flight) nervous systems to indicate biological stress.

Vitals Risk – Identifies the risk of heart, brain, and other organ damage from cardiovascular disease based on the user's own data.

BP Variability (BPV+) – Shows the variability of brachial blood pressure, representing how stable one's blood pressure is over time.

Heart Performance Index (HPX) – Measures how efficiently an individual's heart works to meet the body's demand for oxygen and blood flow indicating how healthy an individual is. Research has shown exercise and a healthy lifestyle can help improve your HPX score and improve your day to day performance.

Arty Score – Combines Heart Stress, Exercise capacity (eCAP), Heart Rate (HR+), and Arterial Age to quantify an individual's unique heart and arterial health risk profile.

The above measures can be combined into comprehensive cardiovascular dashboards and also can be used to develop personalized fitness, diet and lifestyle coaching services to help individuals improve their health through nutrition and exercise.
ATCOR·X builds on the Company's recently announced commercial partnerships and integrations with both Mobvoi, one of the world's largest smartwatch and AI companies, and Andon, one of Chinas largest manufacturers of home medical devices.
About CardieX
CardieX is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders. The company's ATCOR division is the world leader in medical devices for measuring arterial stiffness and central blood pressure waveforms based on its unique FDA-cleared and patented SphygmoCor technology. Under the ATCOR·X brand, the company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The company's digital platform, ArtyNet, is a connected SaaS ecosystem providing physicians with a complete telehealth solution for remotely managing patients' health (2021 launch). CardieX is listed on the Australian Stock Exchange (ASX:CDX).



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Two physicians from the emergency medical services (EMS) fellowship program in the Long School of Medicine at UT Health San Antonio are aiding the El Paso medical community during the COVID-19 surge there.

SAN ANTONIO (PRWEB) OCTOBER 30, 2020
Two emergency medical services (EMS) physician specialists from the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio are in El Paso to aid with the response to hospital overflow caused by the surge of COVID-19 infections there.
Katherine Raczek, MD, assistant professor in the Department of Emergency Medicine, and Bryan Everitt, MD, EMS fellow, flew to El Paso on Oct. 29. They are working in a Mobile Medical Unit (MMU) set up in front of University Medical Center, caring for patients whose condition is a step down from needing the intensive care unit (ICU).
"The MMU is a mini-hospital with pharmacy services, doctors, nursing, lab and cots," Dr. Raczek said. "We can do the whole range of medical procedures and interventions there. It is like a field hospital you might see in a military deployment setting."
The Long School of Medicine physicians are in El Paso as part of Texas Emergency Medical Task Force 8, which is composed of partners from the Southwest Texas Regional Advisory Council (STRAC) and the Golden Crescent Regional Advisory Council.
"This is obviously a bad situation, but it is a good opportunity for us to get involved and serve and do what we love to do, so we are excited," Dr. Raczek said.
Disaster response, including pandemic disaster relief, is part of an EMS specialist's job, Dr. Everitt said.
"Emergency medicine physicians deal with a variety of patients," he said. "We are right at home taking care of both a critically ill patient and a non-ICU patient. If for some reason the ICUs at an event become overloaded, we have that ability to flex."
EMS physicians are used to working in PPE (personal protective equipment).
"Even before COVID-19 hit, we saw patients who required special precautions," Dr. Everitt said. "It's just a fact of life in the emergency department."
"One of the unique things about UT Health San Antonio is we have several fellowships in the Department of Emergency Medicine," Dr. Raczek said. "Among them, we have EMS, Wilderness Medicine, Disaster Medicine, Global Health and Ultrasound. We train in disaster situations like this, mass casualty incidents, and that gives us an edge because we are prepared."
"It's important that people know there are physicians who are trained in EMS and that we provide this service to our citizens," Dr. Everitt said. "I don't think most people know there is a specialty in EMS. It is a new specialty full of very motivated and high-speed people."
Dr. Raczek is glad to serve in El Paso for another reason: She trained at University Medical Center for three years as a resident physician.
"For me it's an opportunity, Texans helping Texans, to serve in general, but also I have a special place in my heart for El Paso because it was my training institution," she said.
# # #
The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school's clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer's disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.
The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country's leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways "We make lives better," visit http://www.uthscsa.edu.
Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
To see how we are battling COVID-19, read inspiring stories on Impact.

This is obviously a bad situation, but it is a good opportunity for us to get involved and serve and do what we love to do. -- Katherine Raczek, MD, UT Health San Antonio



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Current Ph.D. in Business Administration student, Wlad Pierre-Francois, presented "Factors that influence HIPAA Secure compliance in small and medium-size health care facilities" at the Kennesaw State University Conference on Cybersecurity Education, Research, and Practice on October 23. Co-presenting was Dr. Indira Guzman, Doctoral Studies Director in Trident's College of Business.

CHANDLER, ARIZ. (PRWEB) OCTOBER 30, 2020
Wlad Pierre-Francois, a student in Trident at American InterContinental University's (Trident) Ph.D. in Business Administration program, presented the literature review, "Factors that influence HIPAA Secure compliance in small and medium-size health care facilities," at the Kennesaw State University Conference on Cybersecurity Education, Research, and Practice on Friday, October 23.
The co-presenter for this proceeding was Dr. Indira Guzman, Doctoral Studies Director in Trident's Glenn R. Jones College of Business.
Mr. Pierre-Francois's research aims to understand how the potential risk of sanctions impacts organizational adherence to the Health Insurance Portability and Accountability Act (HIPAA) Security Rule (SR) at small and medium-sized healthcare facilities.
The Security Rule provides a national standard for the safeguard of electronically protected health information and was created to ensure that U.S. citizens' electronic health data is protected from loss or abuse.
"According to previous research, small and medium-sized healthcare facilities have had difficulties maintaining compliance with the Security Rule," states Wlad Pierre-Francois. "Some of the contributing factors that have led to past non-compliance include lack of executive management support or interest in SR adherence, low information security awareness, and organizations whose cultures do not value information security."
This literature review serves as an important building block for Mr. Pierre-Francois's Ph.D. dissertation.
Mr. Pierre-Francois is the President of P-Bon Services, a managed service provider with more than 20 years of experience in managing information systems. He is a military veteran and has experience in various sectors, including health, legal, retail, and financial.
Mr. Pierre-Francois is a current Ph.D. in Business Administration student at Trident. He holds a Master of Business Administration, I.T. Management concentration, from Western Governors University.
About Trident at American InterContinental University
Founded in 1998, Trident at American InterContinental University (Trident at AIU) is part of an online postsecondary university serving adult learners. Trident at AIU uses the EdActive learning approach, which employs case-based learning in an online setting to teach real-world relevant critical thinking skills designed to enhance the lives and education of students. Trident offers quality associate, bachelor's, master's, and doctoral degree programs and certificates, led by a qualified faculty team, over 80% of whom have doctoral degrees. Trident at AIU is regionally accredited by the Higher Learning Commission (hlcommission.org) and has more than 22,000 alumni with a military affiliation. Trident has received acknowledgements from Washington Monthly, Military Times, and Military Advanced Education & Transition for their dedication to student success. Visit http://www.trident.edu or call at (855) 290-0290 to learn more about Trident at AIU's wide range of educational options.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Lincoln Military Housing (LMH), the nation's leading provider of homes for military families, hosted a blood drive where generous donors who came together to save an estimated 150 lives.

CAMP PENDLETON, CALIF. (PRWEB) OCTOBER 30, 2020
Lincoln Military Housing (LMH), the nation's leading provider of homes for military families, hosted a blood drive where generous donors who came together to save an estimated 150 lives.
The Oct. 8, 2020 event, held at LMH's Camp Pendleton community just outside its housing assignment office in San Diego County, had 62 participating donors who collectively gave 52 pints of blood. Another dozen donors were deferred.
Each unit has the potential to save up to three lives.
The drive, which practiced COVID-19 safety measures and was a partnership with the Armed Services Blood Program (ASBP), had a lot of social media buzz in anticipation. LMH families, residents and staff participated in the drive from all over Camp Pendleton to support the cause that coincided with Breast Cancer Awareness Month. They were eager to learn about the next event.
"We are so happy with the results of this drive," Jill Dorflinger, Regional Vice President. "Everyone really stepped up in a time of need to donate. Their generosity demonstrates the heart and camaraderie our military families and team members have for their community."
The ASBP and the LMH Community Services Team are currently planning future blood drive events for communities in the San Diego area.
The ASBP is the official military provider of blood products to U.S. armed forces. Service members are often confused and erroneously believe that a civilian collection agency provides blood products to the military community. That is not true. The ASBP is one of four organizations that ensure our nation has a safe, potent blood supply. We work closely with our civilian counterparts in times of need. However, the ASBP is the official blood collection, manufacturing, transport, and transfusion program for the U.S. military.
For more information on the Armed Services Blood Program visit https://www.militaryblood.dod.mil/.
About Lincoln Military Housing
Lincoln Military Housing (LMH) was formed in 2001 through a Department of Defense (DOD) contract with parent company Lincoln Property Company. The goal has always been to increase the quality of military housing for our nation's servicemen and women. Since its inception more than a decade ago, Lincoln Military Housing now provides more than 36,000 family homes for military members across the US. Lincoln is much more than a property management company. LMH acts as a support system for military families and offers community-building activities and 24-hour maintenance assistance programs, free, to all of their residents. Services are available for members of all branches of service -- Marine Corps, Army, Navy, Air Force, United States Coast Guard, and National Guard. For more information about Lincoln Military Housing, please visit http://www.lincolnmilitary.com for more information.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New non-surgical body contouring treatment offers a convenient liposuction alternative

HOUSTON (PRWEB) OCTOBER 30, 2020
Dr. Ravi Somayazula's award-winning, Houston-based practice Body By Ravi Plastic Surgery & Aesthetics is pleased to be adding the breakthrough treatment EVOLVE body contouring to its services. EVOLVE is an FDA-cleared procedure that helps reshape areas of the body. It is a non-surgical way to reduce stubborn areas of fat, tighten skin and improve muscle definition.
The EVOLVE treatment focuses on problem areas like the abdomen, thighs, arms, buttocks and back. While liposuction accounts for over 250,000 plastic surgery procedures annually in the United States, EVOLVE body sculpting is a new, non-invasive alternative. This innovative body contouring approach harnesses radiofrequency energy to sculpt the body while improving the skin. EVOLVE body contouring can stimulate collagen production while simultaneously reducing fat and encouraging muscle stimulation.
Dr. Ravi Somayazula is adding the EVOLVE body contouring treatment as a non-surgical option for his clientele. Dr. Ravi's dedication to his patients' aesthetic needs translates to specialization in a wide variety of procedures and technologies. His vast experience with every kind of plastic surgery from breast augmentation and liposuction to fat transfers and body lifts places Dr. Ravi as one of the top cosmetic surgery experts in Texas. With his primary objectives being his patients' comfort and the use of cutting-edge technology, adopting EVOLVE body contouring is a natural progression for Dr. Ravi's practice.
Regarding the introduction of the new procedure to his practice, Dr. Ravi Somayazula has expressed his enthusiasm for this innovative technology:
"We are really excited to bring EVOLVE to our practice, it is truly a game-changer for patients. More than ever, people are looking for non-invasive body contouring treatments that work. EVOLVE helps us target three separate but complementary issues by helping with fat reduction, skin tightening and muscle building. Not everyone is ready for surgery or is a surgical candidate, and EVOLVE is perfect for them!"
In terms of the procedure's advantages over other body contouring solutions, Dr. Ravi states:
"In comparison to other non-invasive body contouring treatments on the market, EVOLVE is definitely much more technologically advanced. With built-in Artificial Intelligence to monitor body temperatures several times a second, this is the safest hands-free procedure currently. Plus there is absolutely no downtime and there is no post-procedural pain."
The founder of Body By Ravi Plastic Surgery & Aesthetics in Houston, TX, Dr. Ravi is a board-certified plastic surgeon bringing over a decade of experience to his patients. Dr. Ravi's awards and distinctions include membership in the American Society of Plastic Surgeons, being selected by Super Doctors 2019 in Texas for excellence in plastic surgery and membership in the Texas Society of Plastic Surgeons, among others.
To find more information about Dr. Ravi's services, call 281-242-1061. Alternatively, for a virtual consultation, fill out the contact form on his website. Call with any questions you may have about EVOLVE body contouring and the office staff will be happy to help you.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Aetna has expanded their longstanding relationship with Inpathy, an online behavioral health service, to bring care to Aetna members in Illinois, Texas and Florida. This relationship ensures members in need of behavioral and mental health treatment have access to timely, quality care.

MOUNT LAUREL, N.J. (PRWEB) OCTOBER 30, 2020
Aetna, a CVS Health company, and Inpathy are pleased to announce that their relationship has expanded to provide access to mental health care to additional Aetna members in Illinois, Texas and Florida. Aetna and Inpathy have collaborated since 2016. This expansion ensures that individuals have access to convenient online psychiatry and therapy services anytime, anywhere. As of September 1, 2020, Inpathy, a telehealth provider service can be used in-network with Aetna health insurance by residents of Illinois, Texas, Florida California, Colorado, Delaware, Missouri, New Jersey, New York, Pennsylvania and Virginia.
Inpathy has been providing mental health care entirely virtually for the past seven years and is a covered benefit for more than 25 million individuals across the country. Not only has telebehavioral health services like Inpathy proven to be an effective form of delivering care, but now, due to COVID-19, it is the preferred form of care. According to the MMWR and Morbidity and Mortality Weekly Report, in June 2020, 40% of U.S. adults reported struggling with mental health or substance use associated with COVID-19. The same report showed that the prevalence of anxiety disorder symptoms were up approximately three times than the same prevalence in 2019 while the prevalence of depressive disorder was approximately four times higher.
Telebehavioral health allows payers to meet the growing mental health needs of their members who may be experiencing additional stress and anxiety caused by social isolation and the spread of COVID-19. Through Inpathy, Aetna members can fit sessions into busy days, cut out any travel time and expense, skip the waiting room, reduce expensive ED visits and hospitalizations, and connect to a large network of clinicians to receive the high-quality care they deserve. An Inpathy survey showed that 96% of their members prefer online to in-person care and 98% of members felt more engaged in their care.
"We are pleased to expand our long-time partnership with Inpathy to offer additional options to our members and increase access to mental well-being services in even more states," explained Dr. Hyong Un, Chief Psychiatric and Innovation Officer at Aetna Behavioral Health. "More members will be able to access mental health televideo counseling services from the safety of their home. Having easy access to providers is extremely beneficial for improving mental and emotional health."
"Aetna recognized the rising need for mental health services. We are proud to partner with them to bring these services to their members," said Justine Mitchell, Vice President of Inpathy. "Our care navigation team will work with members to find the right behavioral health provider and support members pre and post appointments."
About Inpathy
Inpathy is InSight + Regroup's direct-to-consumer division and is designed to deliver psychiatric, behavioral and mental health care to individuals through secure, convenient, online video calls. Inpathy has a platform for delivering behavioral health services, an online marketplace for finding those services and a network of clinicians who operate under InSight + Regroup's support and management to deliver high quality care. While InSight + Regroup's other divisions bring psychiatrists and mental health clinicians to community-based facilities and organizations through telehealth, Inpathy uniquely brings life-changing behavioral health care directly into people's homes or any private place that they choose to access it.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Brain Center TMS, a mental health treatment center in San Diego, has begun helping veterans treat their tinnitus through insurance-covered Transcranial Magnetic Stimulation, also known as TMS.

SAN DIEGO (PRWEB) OCTOBER 30, 2020
Brain Center TMS, a mental health treatment center in San Diego, is now helping veterans treat their tinnitus through insurance-covered Transcranial Magnetic Stimulation, also known as TMS.
According to Military.com, tinnitus affects at least one in every 10 American adults. And, it is the number one disability among veterans. The U.S. Department of Veterans Affairs states that there were 993,000 veterans in 2014 claimed disability from hearing loss and 1.3 million claimed disability for tinnitus.
Tinnitus is a disability where the victim hears ringing in one or both ears. It falls under two categories. The first being subjective tinnitus, whereby only the sufferer can hear the noise. The second being objective tinnitus, where the noise can be in the middle ear heard by an examiner.
Veterans are often affected by tinnitus because of what they experienced while in service. Loud gunfire, machinery, and aircraft noise military personnel are exposed to can lead to both hearing loss and tinnitus.
In 2018, National Center for Rehabilitative Auditory Research (NCRAR) at the VA Portland Health Care System developed the Progressive Tinnitus Management program to help nearly 2 million veterans with tinnitus. In this plan, NCRAR lists TMS under their "First Approach: Eliminate Tinnitus or Reduce its Loudness."
Before TMS, there were not many effective treatments for subjective tinnitus. Symptoms have historically been treated with prescription drugs and psychological approaches. In rare cases, surgery has been one approach for objective tinnitus.
Improvements and research in TMS technology have allowed scientists and doctors to treat tinnitus with a well-tolerated procedure. Though TMS is not a popular treatment at the moment, facilities like Brain Center TMS have been leading the push for a newer approach to tinnitus as well as other disabilities.
Brain Center TMS in San Diego has been providing inpatient and outpatient psychiatric treatment since 2005. They have seen TMS therapy become an effective approach for ailments such as treatment-resistant depression and obsessive-compulsive disorder.
Because it is a newer treatment, many popular insurance providers only cover TMS in certain circumstances. However, the Defense Health Agency (DHA) issued TRICARE insurance that covers many military veterans now covers TMS for tinnitus as well as other conditions.
Brain Center TMS claims that many of their tinnitus patients who have received TMS see significant improvement in their symptoms. Outside research points to similar results.
Research center JAMA Otolaryngology published a randomized clinical trial on 64 veterans with tinnitus. Thirty-two veterans received 10 sessions of TMS, while the other 32 received fake TMS treatment.
In the study, 56 percent of the veterans who received real TMS saw significant improvement while only 22 percent of those who received the fake TMS saw improvement.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Quality Home Care Providers Inc. Increases Durable Medical Equipment Deliveries due to COVID-19 Pandemic

LEONIA, N.J. (PRWEB) OCTOBER 31, 2020
With more people stuck at home due to the COVID-19 outbreak, there has been a surge in demand for durable medical equipment delivery services. Quality Home Care Providers Inc., has taken additional steps across the company to address the COVID-19 outbreak and protect patient access to medical supplies by increasing delivery services.
Quality Home Care Providers Inc. Leonia location has seen a 75 percent increase in delivery services for the months January-May in 2020 compared to 2019. The company, at both the Leonia and Hamilton Township NJ locations, provide delivery service to customers throughout the tristate area, Monday through Friday from 9 a.m. to 7 p.m. All delivery vehicles are routinely cleaned and sanitized out of an abundance of caution.
"This service is designed and utilized to offer our patients peace of mind knowing they can get their medical supplies delivered. Our patients have had a high concern about entering the office due to risk of exposure to germs, especially our elderly patients, homebound patients or those with underlying health issues," said CEO of Quality Home Care Providers Inc., Dr. Munr Kazmir.
Both Quality Home Care Providers Inc. locations provide in person services for patients, and have implemented COVID-19 safety precautions since the start of the pandemic.
Employees working at Quality Home Care Providers Inc. are required to undergo a series of precautions every day. Each employee is required to get a temperature check every day and are distributed masks and gloves, as well as antiseptic wipes. Hand Sanitizer stations are located all over the office, as well as on each employee's desk.
Both locations are sanitized twice a week by an outsourced cleaning company, including the door knobs, light switches as well as personal work areas like keyboards, phones, toilets and kitchen surfaces.
Should an employee test positive for COVID-19, he or she will be required to stay out of office and will be able to return to work once a doctor allows and test results are negative. Signs for masks and social distancing are placed all over the office for both employees and patient safety and both are encouraged to frequently wash their hands and avoid touching their faces, especially eyes, nose and mouth.
The Quality Home Care Providers Inc. company is located at 345 Grand Ave in Leonia, NJ and 1544 Kuser Road in Hamilton Township, NJ. Outside of normal operating hours, a 24/7 hour call service is available, where trained technicians are available to answer any questions patients may have about medical supplies and insurance related issues. Patients are also able to purchase medical supplies by visiting the Quality Home Care Providers Inc., website, https://qualityhomecareproviders.com.
For more information on Quality Home Care Providers Inc., and a detailed description of the medical equipment offered, visit https://qualityhomecareproviders.com or call the 24-hour support at (201) 585-9234.
About Quality Home Care Providers
Accredited by the Joint Commission on Accreditation of Health Care Organizations, Quality Home Care Providers Inc., is a medical supply company founded in 1991, providing the highest quality home medical equipment and service to patients and their families. Whether working as part of a care team or teaching your patient and patient's family how to operate home medical equipment, we are available 24 hours a day, 365 days a year to provide patients the equipment and services they need.

"This service is designed and utilized to offer our patients peace of mind knowing they can get their medical supplies delivered."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

On Nov. 2, the Davis Phinney Foundation will join with Dr. Laurie Santos, Professor of Psychology and Head of Silliman College at Yale University, for a highly informative webinar: "Parkinson's and the Good Life." The webinar will be held on Monday, Nov. 2 at 1 p.m. MT, 3 p.m. ET.

LOUISVILLE, COLO. (PRWEB) OCTOBER 31, 2020
CONTACT: Jenna Deidel
Director of Programs & Outreach
303-489-2000 | jdeidel@dpf.org
The Davis Phinney Foundation Announces Webinar with Renowned Professor of Pyschology Dr. Laurie Santos
Louisville,·Colo. — On Nov. 2, the Davis Phinney Foundation will join with Dr. Laurie Santos, Professor of Psychology and Head of Silliman College at Yale University, for a highly informative webinar: "Parkinson's and the Good Life." The webinar will be held on Monday, Nov. 2 at 1 p.m. MT, 3 p.m. ET.
As an organization focused on fitness, wellness and every aspect of living well with Parkinson's we are delighted to talk in detail about "the good life" with one of the premier experts in the country on this topic.
Register for this free webinar here.
In Spring 2018, Dr. Laurie Santos taught "Psychology and the Good Life" for the first time at Yale. She created this course because she was worried about the levels of student depression, anxiety, and stress she was seeing as a Professor and Head of College. It became the most popular class ever taught at Yale.
During the first half of this webinar, Dr. Laurie Santos will discuss what new results in psychological science teach us about:

How to be happier

How to feel less stressed

How to flourish more no matter your situation

During the second half of the webinar, Davis Phinney and Connie Carpenter Phinney will help us unpack what we learned and open the floor for questions. At the end, we'll offer some ideas for "rewirement" activities to help you create new happiness habits, boost your mood, and improve your overall well-being.
To provide more resources to our treasured clientele and their supporters, past webinar recordings are available as well. More online resources, including a blog, podcasts, an exercise essentials video, worksheets, and much more are available here.
The Davis Phinney Foundation was founded by Olympic cyclist Davis Phinney in 2004 to help people with Parkinson's live well today. The organization's focus is to provide programs, early stage research, and resources that offer inspiration, information and tools that enable people living with Parkinson's to take action that can immediately improve their quality of life. Parkinson's is the No. 2 neurodegenerative disease – second to Alzheimer's – and affects more than 1 million people in the United States. The Foundation's work impacts hundreds of thousands of individuals and families each year.

Davis Phinney and Connie Carpenter Phinney will help us unpack what we learned and open the floor for questions. At the end, we'll offer some ideas for "rewirement" activities to help you create new happiness habits, boost your mood, and improve your overall well-being.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The first dedicated CBD store in Illinois, 180 Pure is celebrating its second anniversary with a large amount of fanfare and national recognition.

DEER PARK, ILL. (PRWEB) OCTOBER 31, 2020
The first dedicated CBD store in Illinois, 180 Pure is celebrating its second anniversary with a large amount of fanfare and national recognition. While this exciting anniversary will bring together a launch of new products at the brick and mortar location along with the hugely successful eCommerce store, the focus will be on continuing to deliver the same supreme quality products they have been known for. The existing product line will continue with an array of new affordable THC-free CBD products including 4 new Gummie offerings and the expansion into CBD Beauty products. The brand is already widely known for its offering of tinctures, soft gels, along with the critically acclaimed salves that the brand has built a solid consumer reputation nationally with.
The anniversary celebration for 180 Pure takes place this weekend during a special Celebration Weekend on Friday, October 30 – Sunday, November 1 at 20530 N. Rand Rd Ste 340, Deer Park, IL 60010. As a special offering for the surrounding community, the store will offer 40% off 180 Pure products throughout the weekend, along with daily giveaways and other wonderful surprises and socially distant appropriate in-store activities.
"It's been a crazy couple months for a young company" says Sandra McFarland, owner of 180 Pure. "We've gotten creative during COVID with how we serve our customers. Our focus has been on curbside pickup, online orders, private shopping events, consultative phone calls, etc. Being a central touchpoint for our community has all been a part of our sustainability."
The 180 Pure values and mission remain the same going into its third year. 180 Pure is founded on the principle that consumer education and understanding is critical to success. "We are obsessed with quality in every regard", explains McFarland. "Whether it is with the formulations and ingredients, the manufacturing, the transparency by which we do business, or just the service we provide, our goal is a well-informed consumer that walks away with a solution that betters their quality of life. We invest in our products and customer experience because we know that our consumers invest in us". McFarland, an Illinois native, believes in being present with her customers throughout this strange time and values the benefit that being proactive in her local community has garnered the brand. At the height of the COVID outbreak, she remained close to the community providing free products to all first responders to help them navigate the difficulties of what they were experiencing on a personal level.
This celebration is truly meant to honor the community and consumers that have helped the 180 Pure brand survive this ongoing crisis. "The community outpouring of support has been incredible", states McFarland. " Now more than ever, individuals are seeking alternative methods to cope and heal with everything that is being tossed at them. We are here to continue to serve the community and our online consumers through products that have been created to make a solid difference."
ABOUT 180 Pure:
180 Pure is a woman-owned business, operates both an eCommerce store and a brick and mortar location located at 20530 N. Rand Rd Ste 340, Deer Park, IL 60010 that is staffed with a well-trained compassionate team of CBD experts focused on helping customers cut through the confusion surrounding CBD products currently available in the marketplace, and find what best meets their individual needs. All 180 Pure products are THC-Free, Broad Spectrum, non-GMO and made from organically grown hemp on American farms. The 180 Pure brand is founded on the core value that natural, 100% organically grown hemp from American farms have the power to promote wellness and bring balance to your life.
To learn more about 180 Pure, visit:180Pure.com or contact the store at (847)481-6030. Media and Press Inquiries should be directed to the brand's global marketing partner, TLK Fusion, Inc to the attention of Meridith Wynne at meridith@tlkfusion.com or (818) 208-4582



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CHICAGO (PRWEB) NOVEMBER 02, 2020
The MPN Research Foundation is proud to announce the appointment of Kapila Viges as the Chicago, IL-based nonprofit's new Executive Director. Through MPN research, advocacy, and education, the MPN Research Foundation brings together patients, researchers, and clinicians around the common goal of realizing new treatments and, ultimately, a cure for polycythemia vera, essential thrombocythemia, and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN).
Kapila Viges comes to us with a long and strong background in supporting cancer research, biopharma interactions, and the development of creative partnerships to accelerate new therapy development. Kapila brings experience from public, academic, and industry sector leadership roles.
"The MPN Research Foundation has an impressive history in enabling disease knowledge and advancing new therapies for patients. It is a privilege to be part of the team and help navigate to the next chapter for the foundation."
"Although we spoke to a number of very qualified candidates, our goal was to find someone with leadership skills and sense of strategy, but who would also be able to propel the Foundation to a new level of research funding and innovation. Kapila meets these criteria with flying colors," said Barbara Van Husen, Chairman of the MPNRF Board. "Her experience includes management and strategy consulting in biomedical industry, biomedical startup incubation and seed investing of translational research, and public-private-partnerships in economic development. Kapila joined us this fall."
About the MPN Research Foundation
The mission of the MPN Research Foundation is to stimulate original research in pursuit of new treatments -- and eventually a cure -- for the blood cancers polycythemia vera, essential thrombocythemia, and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN). MPNRF is celebrating its 20th anniversary of funding research, connecting patients to the latest discoveries, sharing educational resources and building hope. For more information, visit http://www.mpnrf.org.


START your own Wordpress site, business or personal website, or online store at www.siteground.com

DeltaMed to offer marketing and support for healthcare organizations in the People's Republic of China

SANTA ROSA, CALIF. AND HANGZHOU CITY, CHINA (PRWEB) NOVEMBER 02, 2020
DeltaMed Co., Ltd., a leading specialized Contract Research Organization dedicated to providing professional services in the area of pharmacovigilance, medical monitoring and writing and Advera Health Analytics, Inc., a market leader in cloud based, software-as-a-service pharmacovigilance solutions, today announced an agreement that will enable DeltaMed to market and support Advera Health's Evidex, a next generation drug safety signal detection and management platform, in the People's Republic of China.
With this agreement DeltaMed will formally launch the availability of Evidex's signal detection and management platform to pharmaceutical, biotech, and regulatory organizations in China. DeltaMed's clients will be able to leverage Evidex to manage safety signals, inquiries, and requests from detection through resolution, and elicit actionable intelligence from drug safety data.
"We are excited by this partnership and the launch of Evidex in the People's Republic of China. 2020 has been a pivotal time in the global adoption of Evidex as a market leading pharmacovigilance signal detection and management platform. Expanding access to the particularly important China market has been a priority for Advera for quite some time," said Brian Overstreet, President and CEO of Advera Health. "We are especially enthusiastic by the reach and success of DeltaMed in pharmacovigilance services and we know that they are ideally suited to help us expand our marketing reach in China and increase the use of Evidex internationally."
"We are eager to meet the demands of our clients in China for a next generation signal detection and management software solution," said Howe Li, Founder and CEO of DeltaMed. "After surveying the market, it became clear that the Evidex platform is the ideal pharmacovigilance solution to help our clients with the pharmacovigilance challenges and opportunities that lie ahead in the coming decades."
Since launching Evidex, Advera Health has been creating a next generation pharmacovigilance platform to connect disparate drug safety data sources and provide a user experience that elicits actionable intelligence from those data. The Evidex platform links to internal ICSR databases, FAERS, VigiBase, EDC, EVDAS, and other data and provides for a validated, audit ready environment to track and manage safety issues that are found in those data.
About Advera Health Analytics
Advera Health Analytics is a global leader in pharmacovigilance software, analytics, and data at the leading edge of drug safety science. Founded by a group of passionate healthcare entrepreneurs, Advera Health's mission is to mitigate risk in the healthcare system by improving the transparency and actionability of drug safety data through the curation and aggregation of large disparate datasets and the application of advanced analytics and workflow.
Please visit http://www.adverahealth.com for more information about the company.
About DeltaMed
DeltaMed is an innovative clinical iCRO focusing on life-cycle risk management for pharmaceutical products. As a leading pharmacovigilance service provider in China, DeltaMed is committed to providing one-stop efficient and high-quality pharmacovigilance and medical services throughout the whole product life-cycle with global standard and high regulatory compliance for local and global pharmaceutical and medical device companies.
Please visit http://www.deltacro.com for more information about the company.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Robert G. Salazar, Dr. Alireza Abdollahi-Fard, and their team of specialists at California Advanced Pain & Spine Specialists bring care to personal injury victims in Fresno and surrounding Central California.

FRESNO, CALIF. (PRWEB) NOVEMBER 02, 2020
California Advanced Pain & Spine Specialists, a pain management group in Fresno, California, is now providing treatments on a lien basis to personal injury victims.
Serving central California and beyond, California Advanced Pain & Spine Specialists is a comprehensive and multi-modal pain management practice offering interventional treatments for pain.
"Patients who were involved in accidents and their personal injury attorneys already have to deal with repairs, bills, insurance companies, opposing lawyers among many things," says Dr. Robert G. Salazar, pain specialist. "They shouldn't also worry about finding liens doctors too."
Dr. Robert G. Salazar completed his undergraduate degree at Stanford University, medical degree at USC School of Medicine, residency at UCSF Department of Anesthesia, and pain fellowship at Virginia Mason Clinic. Dr. Salazar has been an independent medical examiner in California since 2006. Dr. Salazar also speaks fluent Spanish.
"Pain is one of the most common symptoms of personal injuries and can be bothersome for years if not treated immediately," said Dr. Alireza Abdollahi-Fard, pain specialist. "We are focused on helping patients and seek to make this process as efficient as possible."
Dr. Alireza Abdollahi-Fard graduated from UCLA with a BS in Microbiology, Immunology, Molecular Genetics. He received his medical degree from UCSD School of Medicine and completed his residency at UCSF Department of Anesthesia. Following residency, he was a pain management fellow at UCSF Pain Management Center. Dr. Abdollahi is an expert at treating whiplash, neck and back pain, shoulder and knee pain, as well as strain injuries.
With double board-certified pain doctors, spine surgeons, psychologist, and in-house surgery center, California Advanced Pain & Spine Specialists offer a variety treatment options.
Standard Pain Treatments

Minimally invasive injection

Epidural steroid injection

Facet joint injection

Diagnostic discography

Peripheral nerve injection

Trigger point injection

Advanced Pain Treatments

Intrathecal pump

Spinal cord stimulation

Peripheral nerve stimulation

MILD procedure

Indirect decompression

Radiofrequency ablation

Additionally, California Advanced Pain & Spine Specialists assists with personal injury case management by providing:

Detailed documentation of injuries and pain

Med-legal reports completed within two weeks of appointment

Dedicated attorney liaison for thorough communication with personal injury law firms

Same week appointments to provide prompt relief

A convenient surgical center next door for minimally-invasive procedures

Contact California Advanced Pain & Spine Specialists by calling (559) 432-6807 or by visiting https://www.calpainspine.com
California Advanced Pain & Spine Specialists
7152 N Sharon Ave, Suite 102
Fresno, CA 93720
(559) 432-6807



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dedicated ICD-10 codes for Dravet syndrome will make it easier for the field to conduct epidemiologic research and retrospective studies, determine true prevalence and morbidity and mortality rates, recruit patients for clinical trials, track outcomes of clinical interventions, and develop protocols for standard of care.

CHERRY HILL, N.J. (PRWEB) NOVEMBER 02, 2020
In honor of Epilepsy Awareness Month, the Dravet Syndrome Foundation (DSF) is pleased to announce that the National Center for Health Statistics has designated specific ICD-10 codes for Dravet syndrome, a neurodevelopmental disorder. The designation of the ICD-10 codes resulted from a combined effort from DSF and their Medical Advisory Board, made up of specialists in the field of Dravet syndrome. The new ICD-10 codes took effect on October 1, 2020.
Dedicated ICD-10 codes for Dravet syndrome will make it easier for the field to conduct epidemiologic research and retrospective studies, determine true prevalence and morbidity and mortality rates, recruit patients for clinical trials, track outcomes of clinical interventions, and develop protocols for standard of care. Until this point, Dravet syndrome was included in the ICD-10 code G40.8 Other epilepsy and recurrent seizures, which contained a broad group of epileptic disorders with different causes and treatment strategies that are not specific to Dravet syndrome.
"We truly appreciate the work of our Medical Advisory Board members who contributed their extensive expertise, as well as the other community stakeholders who supported DSF in applying for and receiving these ICD-10 codes," said Mary Anne Meskis, Executive Director of DSF. "Having these unique codes will lead to improved clinical care for our patient community and will help healthcare professionals to better understand the lifelong impact of Dravet syndrome and associated health issues."
The ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list from the World Health Organization (WHO). Approximately 27 countries use ICD-10 to document an individual's medical condition for epidemiology, research, health insurance billing and reimbursement, and administration.
Dravet syndrome has received three new ICD-10 codes: G40.83 Dravet syndrome; G40.833 Dravet syndrome, intractable with status epilepticus; G40.834 Dravet syndrome, intractable, without status epilepticus. Health care providers should now begin utilizing these codes when caring for an individual with Dravet syndrome and the patient-community can spread awareness by ensuring their providers know about these new codes at their next visit.
Said DSF Research Coordinator, Veronica Hood, PhD, "These ICD-10 codes have the potential to improve outcomes for individual patients and broadly increase our overall medical and scientific knowledge of Dravet syndrome. This represents an important step in the process of increasing awareness and improving treatments for patients with Dravet syndrome."
About Dravet syndrome
Dravet Syndrome is a catastrophic form of epilepsy that begins in infancy. It is a debilitating, life-long condition. Patients experience frequent seizures, poor seizure control, developmental delays and another associated health issues.
About Dravet Syndrome Foundation
Dravet Syndrome Foundation is a 501(3)c nonprofit organization whose mission is to aggressively raise funds for Dravet syndrome and related epilepsies; to support and fund research; increase awareness; and to provide support to affected individuals and families. Since its inception in 2009, DSF has awarded almost $5M in research grant awards and over $176K in patient assistance grants. More information is available at http://www.dravetfoundation.org.

Having these unique codes will lead to improved clinical care for our patient community and will help healthcare professionals to better understand the lifelong impact of Dravet syndrome and associated health issues.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Olive Fertility Centre lab receives multiple awards, including Top Clinic Award for Superior Outcomes in Egg Vitrification and Leaders of Vitrification Excellence Awards, at this year's LOVE Awards (Leaders of Vitrification Excellence) by Donor Egg Bank USA

VANCOUVER, BRITISH COLUMBIA (PRWEB) NOVEMBER 02, 2020
Olive Fertility Centre is delighted to announce that the Olive lab has received multiple awards, including Top Clinic Award for Superior Outcomes in Egg Vitrification Warming as well as Leaders of Vitrification Excellence Awards, at this year's LOVE Awards (Leaders of Vitrification Excellence) by Donor Egg Bank USA.
These awards recognize Olive Fertility as the Top Clinic in Canada for the outstanding practice and results that Olive Fertility has achieved in the thawing techniques of frozen donor eggs.
After careful evaluation of 28 partner practices and over 150 reproductive specialists in the U.S., Canada and Puerto Rico, Donor Egg Bank USA selected recipients for awards in Fertility Practice Excellence in a number of categories. Candidates were evaluated based upon clinical pregnancy rates achieved per egg lot thawed and overall practice excellence.
"It is our pleasure to present Olive Fertility Centre with multiple Donor Egg Bank USA 2020 LOVE Awards – including our overall Top Practice Award in Canada. The Leaders of Vitrification Excellence Awards were designed to recognize superior embryologists who have mastered the highly technical skill of vitrification freezing and warming. We are honored to work with Olive Fertility Centre's fantastic physicians, embryologists and clinical team," says Heidi Hayes, Co-Founder, Donor Egg Bank USA by Generate Life Sciences.
Donor Egg Bank USA provides frozen donor eggs to infertility patients in Canada and the US who are unable to conceive a child using their own eggs.
"We are thrilled to be recognized for the excellence of our lab and egg thawing protocol," says Dr Gary Nakhuda, Co-director Olive Fertility Centre. "These prestigious awards are a testimony to the quality of our lab and the skill of our highly trained team of embryologists and andrologists. We have devoted an extreme level of attention to detail to every aspect of the design of the lab to create the best possible environment to ensure excellent outcomes and patient safety. But beyond our technology, what really sets us apart is the outstanding group of scientists that run our lab."
At the lead is Salah Abdelgadir, PhD, who has been a laboratory director for nearly 20 years, with certification as a Technical Supervisor (TS) and High Complexity Lab Director (HCLD) from the American Board of Bioanalysis. He is the only PhD-educated lab director in British Columbia who works on-site, full time to maintain strict and direct supervision of all laboratory processes and procedures. Working with Dr Abdelgadir is an entire team of some of the best embryologists and andrologists in the field.
"Our world class lab is why Olive has among the highest pregnancy rates in Canada and is part of our commitment to provide families with the best chance of having a healthy baby," says Dr Nakhuda.
"Oocyte survival is not the main measure of vitrification performance, but rather high-quality embryo development resulting in a viable pregnancy. I congratulate Olive Fertility Centre on consistent performance in achieving high outcomes," says Wayne Caswell, Senior Director of Laboratory Quality for Donor Egg Bank USA.
Olive Fertility Centre is one of Canada's largest fertility clinics, offering an advanced IVF lab, personal care teams and innovative programs that include specialized genetic testing, egg freezing, and prenatal NIPT testing.

We are thrilled to be recognized for the excellence of our lab and egg thawing protocol. These prestigious awards are a testimony to the quality of our lab and the skill of our highly trained team...



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Teledentix email, chat, and text capabilities are now consolidated into one Message Center that allows for communications template libraries as well as centralized control.

IRVINE, CALIF. (PRWEB) NOVEMBER 02, 2020
Teledentix, by Virtual Dental Care, has increased the ability for patients to more easily participate in their healthcare communications. Patients and providers can now email, text, and instant chat with patients all from one secure, consolidated Message Center. The Message Center also offers an easy way for providers to share diagnostic-specific educational materials.
In the wake of the global pandemic, teledentistry has been primarily associated with patients and providers interacting via live video conferencing. While that certainly is one component, teledentistry can also extend to asynchronous exchange of information, including messaging.
Text, email and instant chat serve as a way for providers, office staff, patients and responsible parties to all communicate with one another to handle administrative communications, questions, appointment scheduling or even the delivery of records.
The Teledentix Message Center was created to help providers and staff organize communication threads in a single environment, helping increase efficiency and accuracy for Teledentix users.
Customizable email and text template libraries can be created and accessed across multiple locations with multiple patients.
The instant chat feature, also available in the Teledentix Message Center, gives offices the ability to communicate with patients in real time, directly from the Patient Portal. This end-to-end HIPAA-secure environment allows instant chat messages to contain private information such as records or health information.
"The Message Center is a direct result of user feedback and was built with the input of some of our most successful dental partners. We're excited to launch such an important feature that will ultimately provide tighter and more personalized patient communication that can be delivered at scale," noted Richard Lee, Virtual Dental Care CEO and Co-Founder.
About Virtual Dental Care and Teledentix
Teledentix, by Virtual Dental Care, is the most comprehensive teledentistry software on the market. Teledentix was built with a vision to help teledentistry become a widely used industry norm, expanding dentistry and a dentist's role beyond the walls of a dental office - even into the broader healthcare system. For more information about Teledentix, visit https://get.teledentix.com/.

We're excited to launch such an important feature that will ultimately provide tighter and more personalized patient communication that can be delivered at scale.



START your own Wordpress site, business or personal website, or online store at www.siteground.com